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Abstract
The corpus luteum (CL) is a tissue formed from the remnants of an ovulated follicle in
the ovary, and it produces the progesterone needed for a healthy pregnancy. CL growth
is highly dependent on a growing nutrient supply, and can be compared with the most
aggressive vascular tumours. Angiogenesis, the growth of new blood vessels from
existing ones, plays a key role in the growth and function of the CL. Inadequate angio-
genesis has been linked to infertility in cows. The CL is composed of several vascular
(e.g. endothelial cells (ECs), pericytes (PCs)), and avascular (e.g. luteal cells (LCs),
immune cells) cell types, and several pro-angiogenic factors (e.g. Fibroblast Growth
Factor 2, FGF2) found to be important in the angiogenic process.
The objective of this thesis is to shed light on the cellular and extracellular level deter-
minants of angiogenesis in the bovine CL.
We begin with the relevant biological and mathematical literature in Chapter 1. In
Chapter 2, an ordinary differential equation model of CL growth is introduced. We as-
sume that the CL volume is a continuum of three cell types, ECs, LCs, and stromal cells
(such as PCs). The fourth variable in the model, FGF2, enhances the EC proliferation
rate. The model is able, by varying parameters such as the maximal proliferation rate
of the ECs, to distinguish cases where the CL shifts from a ‘normal’ to a ‘pathological’
growth.
In Chapter 3, we present in vitro CL published and novel studies from Robinson’s
Lab. Preliminary results demonstrate interesting endothelial and pericyte behaviours
regarding cell aggregation and sprout formation, which are the motivation for the next
two Chapters. In these experimental studies, all the CL cell types were incorporated
in the same in vitro culture, hence providing a closer approximation to the in vivo envi-
ronment compared to other in vitro cultures which use only a single cell type (mainly
ECs). However, this complicates matters in terms of distinguishing cell behaviours and
factors which contribute on the overall cell dynamics. Therefore, in the Chapters 4 and
5 we use data from literature.
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In Chapter 4, by using the Cellular Potts Model (CPM) framework, we focus on EC-
PC interactions, and particularly on the mechanism which is responsible for the EC
growth inhibition. Our model incorporates two possible mechanisms for inhibition.
That is, the mechanical cell-cell contact inhibition, and the inhibition mediated from
diffusive TGF-β secreted once the two cell types come in contact. Interestingly, our
model results suggest that the effective range of TGF-β is a crucial determinant of the
degree of EC growth inhibition.
Chapter 5, by using a CPM, is devoted to sprouting angiogenesis (the formation of new
blood vessel). The dynamic interchange between stalk and tip EC phenotype is incor-
porated through the Notch signalling pathway, with the leading tip cell moving up
macrophage-mediated VEGFA gradients in a non-uniform matrix environment. The
model reproduces phenomena in sprouting angiogenesis, including sprout morphol-
ogy, tip competition, and explains knockout experiments on the Notch signalling path-
way.
Finally, we close with Chapter 6 where we summarise the main results from each chap-
ter and propose model extensions for future directions.
ii
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CHAPTER 1
Introduction
1.1 Introduction and motivation
Themammalian corpus luteum (CL) is an exceptionally dynamic ovarian tissue formed
from the remnants of an ovulated follicle. It produces high amounts of the hormone
progesteronewhich acts on the uterus to support early embryo development. A rapidly
increasing supply of nutrients is required to meet these demands. As a result the
growth and development of the CL is extremely rapid, and associated with a short
period of intense angiogenesis. Inadequate angiogenesis has been linked to infertility
in cows [146].
The CL provides a uniquemodel system in which to study not only the cellular but also
the hormonal regulation of angiogenesis. Although the CL is well studied experimen-
tally, mathematically it has not received the attention it deserves. With angiogenesis in
the CL being equalled only in the fastest growing tumours [197], more focus needs to
be placed upon understanding the cellular dynamics during CL growth along with the
role of angiogenesis.
The main objective of this study is to build a bridge between theoretical modelling of
the CL growth and the available experimental data. Mathematical modelling of the CL
growth and cell-cell interactions along with the interplay of angiogenesis may lead to
an improved understanding of CL tissue growth and, therefore, reduce infertility.
In this chapter we present an overview of the relevant background biology and math-
ematical modelling for this study, beginning with a discussion on the bovine oestrous
cycle and CL formation.
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1.2 Biological background
1.2.1 The bovine oestrous cycle
Oestrous cycles give females repeated opportunities to become pregnant throughout
their reproductive lifetime. The cycle is regulated by the hypothalamic-pituitary-gonadal
axis, which produces hormones that dictate reproductive events. The reproductive axis
is composed of the hypothalamus, pituitary, and the ovary.
The sequence of hormonal release essentially begins with the synthesis and release of
gonadotropin-releasing hormone (GnRH) from the hypothalamus (a specialised por-
tion of the brain). Its primary function is to produce GnRH in response to circulating
oestrogen, or to cease GnRH production in response to progesterone (see Figure 1.1).
The anterior pituitary produces the gonadotropins, follicle-stimulating hormone (FSH)
and luteinizing hormone (LH), in response to GnRH and oestrogen. FSH and LH pro-
duction is inhibited by progesterone. The third portion of the reproductive axis con-
sists of the ovaries. Follicles are structures on the ovarian surface that contain the egg
cells (oocytes) and produce oestrogen. Follicles range in size and maturity at different
stages of the cycle, but usually only one is selected to ovulate. The corpus luteum (CL)
is a tissue formed from the remnant of an ovulated follicle and is responsible for pro-
gesterone production. Both oestrogen and progesterone are produced following FSH
and LH stimulation of the ovary. The uterus also contributes to reproductive control,
as it produces prostaglandin F2a (PGF2a), a hormone which helps to initiate ovula-
tion by causing the regression of the CL, which results in withdrawal of progesterone’s
negative feedback mechanism. Progesterone produced by the CL prevents cyclicity
by acting on the anterior pituitary in a negative feedback fashion, consequently, de-
creasing the release of FSH and LH. Figure 1.1 illustrates the relationships between the
hormones that control the oestrous cycle of the bovine female as discussed above.
Elevated concentrations of progesterone can be detected about 5 days after oestrous
(ovulation). If a cow does not become pregnant, concentrations of progesterone will
begin to decrease around day 17 of the oestrous cycle and this allows the cow to show
oestrous again around day 21.
2
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Hypothalamus 
Anterior Pituitary 
Ovary 
Follicle 
 Oestrogen 
Corpus luteum 
     Progesterone 
Uterus 
 PGF2ɲ 
GnRH 
FSH/LH 
(+) 
(+) 
(-) 
(+) 
(-) 
Figure 1.1: Schematic diagram showing the hypothalamic-pituitary-gonadal axis
which is responsible for the control of the bovine female oestrous cycle.
Key: solid curve (positive regulation); dashed curve (negative regulation).
1.2.2 The corpus luteum
De Graf was the first to record the presence of the CL in the ovaries of pregnant rab-
bits, and, by studying the histology of this tissue, he deduced that it was an endocrine
gland (e.g. CL secretes its hormones directly into the blood). De Graf also removed
the ovaries of pregnant rabbits and observed that the pregnancy was terminated. Fur-
ther studies byMagnus in 1901 in ovariectomised rabbits revealed that the CL steroidal
hormone progesterone played a key role in supporting gestation [170].
The CL is formed following ovulation as a result of cell proliferation in the ruptured
follicle (see Figure 1.2). It develops specifically from the granulosa and theca cells of
the pre-ovulatory follicle, after the LH surge. The resulting structure usually protrudes
from the ovary and is yellow-brown in colour. As already noted, the CL is a tissue that
secretes progesterone. In the non-pregnant cow, the function of the CL dominates the
cycle from around day 5 to day 17. Alternatively, if the animal becomes pregnant, the
CL is maintained for the duration of pregnancy. Progesterone has numerous physio-
logical effects, one of the more prominent being its role in maintaining and supporting
pregnancy in mammals. Without adequate levels, the developing foetus cannot be
supported and pregnancy fails [167]. If there is no pregnancy, the CL regresses and
allows follicular growth and ovulation to begin again. Otherwise, if implantation of a
fertilised egg occurs, the levels of progesterone needed to support gestation, especially
before the placenta can produce progesterone, increase exponentially. In order for the
CL to meet these hormonal needs, it grows at a phenomenal rate during its early de-
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velopmental stages. The rates of tissue growth and angiogenesis in the CL rival those
of even the fastest growing tumours [199], although unlike tumours, the growth of the
CL is a controlled physiological process. In order for this rapid growth to take place,
an extensive and continuous supply of blood is needed, so a controlled physiological
process known as angiogenesis (the growth of new blood vessels from existing ones) is
triggered, which is described in more detail in section 1.2.4.
time 
1. primary           
follicle 
2. growing           
follicle 
egg cell 
follicular 
fluid 
3. mature 
follicle 
4. ovulation 
5. empty 
follicle 
6. corpus 
luteum 
7. corpus 
luteum 
regresses 
Figure 1.2: The diagram shows the formation of the corpus luteum (CL) after ovula-
tion in the ovary. By the end of the follicular phase of the menstrual cycle,
the mature follicle ruptures (ovulation), the egg cell (oocyte) is released
and the ruptured follicle undergoes a transformation into the CL. Key: fol-
licular phase (1-3); ovulation (4); luteal phase (5-7).
1.2.3 Cellular composition of the corpus luteum
The CL consists of several cell types that differ in morphological and physiological
characteristics: steroidogenic (which produce hormones) small and large luteal cells,
and non-steroidogenic endothelial cells (ECs), smooth muscle cells (SMCs), pericytes
(PCs), fibroblasts, and immune cells. These cell types interact to maintain normal func-
tion during growth, differentiation and regression of the CL. The cellular interactions
are mediated by both contact-dependent (e.g. via gap junctions [199], Notch signalling
[255]) and contact-independent mechanisms (e.g. secretion of growth factors [213]).
In the remainder of this section we provide basic knowledge on the different cell types
which compose the CL.
In the CL there are more non-steroidogenic cells (e.g. ECs, fibroblasts) than steroido-
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genic cells (small and large luteal cells). O’Shea et al. in [176] have estimated that in the
mid-cycle bovine CL 60-70% of cells are non-steroidogenic. Steroidogenic small luteal
cells (SLCs) account for 27% and large luteal cells (LLCs) for 4% of the CL by number.
Although the number of LLCs is relatively low, these large cells do comprise 40% of
the total CL volume.
The vast majority of non-steroidogenic cells in the CL are ECs. The ECs express the
neural cell adhesion molecule (NCAM), and it has been postulated that this molecule
would mediate adhesion between ECs and LCs that also express NCAM. A functional
interaction between ECs and LCs has been suggested, since ECs stimulate progesterone
production by LLCs [77].
PCs are regulators of endothelial function and have been shown to produce angiogenic
factors [18]. Redmer et al. [195] confirmed vascular endothelial growth factor (VEGF)
localization to PCs/SMCs in the CL. Interestingly, during luteolysis (CL regression)
ECs degenerate, but the number of SMCs and PCs remains high [197]. Therefore, it is
possible that during early CL regression, PCs and SMCs may serve to regulate tissue
remodeling and maintain integrity of larger blood vessels, allowing normal luteolysis
to occur.
Lobel and Levey in [140] first observed immune cells, lymphocytes and macrophages,
in the bovine CL, describing their presence as significant fromday 14 onwards. Niswen-
der et al. in [168] suggested that the immune cells are present primarily as a result of
the high blood flow to the CL and that they play a passive role for most of the oestrous
cycle until the time of luteolysis. The main function of the immune cells at luteolysis
is thought to be destruction of the CL tissue through a variety of processes, including
phagocytosis [181]. However, Adashi in [1] suggested that immune cells may have an
active role in controlling the lifespan and function of the CL. There has been particu-
lar interest in tumour necrosis factor α (TNF-α), because its cytotoxic action on tumour
cells has been compared with CL regression [104]. TNF-α has also been detected in the
bovine CL [223].
1.2.4 Angiogenesis in the corpus luteum
In this section, we will explain why angiogenesis is an essential process underpinning
CL growth and development. Angiogenesis, the process by which new capillary blood
vessels sprout from pre-existing ones, is a physiological process involving the prolifer-
ation and migration of ECs, and is essential for normal tissue growth and development
[116]. Because the CL grows so rapidly, and because tissue growth depends on con-
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comitant vascular growth, it has long been appreciated that angiogenesis is a critical
aspect of growth and function of the CL [266].
In a complex tissue, like CL, the various cell types must interact to ensure normal
growth and development. Tissue growth depends upon the growth and establishment
of a functional blood supply [213]; therefore, angiogenesis is one of the prominent fea-
tures of the early CL. Numerous investigators have studied mechanisms associated
with CL development; however, a number of important questions remain unanswered.
Mechanisms that remain controversial and on which there has been recent progress in-
clude the regulation of neovascularisation and tissue remodelling during CL develop-
ment [233].
Angiogenesis in the CL is a tightly regulated and highly coordinated process, which
has its origins in the vasculature of the developing follicle [65]. The preovulatory fol-
licle consists of two layers: the theca (exterior) and the granulosa (interior). These two
layers are divided by the basement membrane which separates the layers. In many
tissues (like tumours), hypoxia is the stimulus for the synthesis of angiogenic factors.
However, in the CL angiogenesis is hormonally regulated by LH [66]. After ovula-
tion (and breakdown of the basement membrane) the theca-derived PCs invade the
granulosa-derived region (see Figure 1.3). Pericyte invasion is stimulated by growth
factors produced by the granulosa cells, most likely basic fibroblast growth factor 2
(FGF2) and/or platelet derived growth factor (PDGF). The PCs then produce VEGF,
which stimulates theca-derived ECs to migrate into the granulosa-derived region [66].
Extensive tissue remodelling and a period of intense angiogenesis follow over the next
2-3 days, with newly formed microvessels extending throughout the tissue. Subse-
quently, the PCs and ECs form the mature capillary bed.
theca 
granulosa 
BM 
mature 
follicle 
LH 
(ovulation) 
breakdown  
of BM 
BM 
theca 
granulosa granulosa 
- granulosa secrete                              
FGF2,PDGF 
- Pericytes invade  
granulosa region 
FGF2 
PDGF 
ECs 
VEGF 
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region from the theca ahead of the ECs 
- CL/tissue 
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- Intense 
angiogenesis 
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Figure 1.3: Schematic diagrams showing the evolution of the CL structure after ovu-
lation. Key: luteinizing hormone (LH); basement membrane (BM).
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1.2.5 Angiogenesis: general overview
In this section we provide a general overview of angiogenesis. The angiogenic process
consists of at least three steps: (1) fragmentation of the basement membrane of the ex-
isting vessel, (2) migration of ECs from the existing vessel toward the angiogenic stim-
ulus, and (3) proliferation of ECs [116]. Neovascularisation is completed by formation
of capillary lumen and differentiation of the newly formed capillaries into arterioles
and venules.
1.2.5.1 Historical overview
In the last three decades there has emerged a new field of vascular biology. Dr. John
Hunter (British surgeon), in 1787, was the first who used the term ‘angiogenesis’ to
describe blood vessels growing in reindeer antler, while in 1935, Boston pathologist Dr.
Arthur Tremain Hertig described angiogenesis in the placenta of pregnant monkeys.
In the 20th century, several investigators noted the tremendous vascularity of ovarian
follicles and corpora lutea and recognised the importance of the ovarian vasculature
in supporting growth and development of these tissues [197]. While in the 1960s, the
endothelium was considered to be simply a passive container for the blood, it is now
known, by the cytokines and mitogens it releases, to be an active participant in inflam-
mation, coagulation, and repair.
Forty years ago there was little idea of how arteries and veins form in the embryo, to
say nothing of the development of whole vascular networks of tubes and branches.
Additionally, tumour vessels were assumed to be simple dilated host vessels. Today it
is widely accepted that tumours are angiogenesis-dependent. In 1971 surgeon Judah
Folkman (who is considered by many to be ‘the father of angiogenesis’) hypothesized
that tumour growth is dependent upon angiogenesis [59]. Since then, angiogenesis
itself has become a major target of tumour therapy. In 1989 Dr. Napoleone Ferrara
identified and isolated the protein VEGF, a component that plays a crucial role in vessel
development [57].
Numerous other promoters of angiogenesis have been identified. These factors and
compounds differ in cell specificity and also in the mechanisms by which they induce
new blood vessel growth. The action of many angiogenic factors can be studied in vitro
by measuring their effect on EC migration and proliferation [40].
Angiogenesis is a complex process in which a delicate balance between promoters and
inhibitors is maintained. Disturbance of this balance may result in a disrupted physio-
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logical state or various pathologic conditions (see Figure 1.4).
proangiogenic angiostatic 
Ang1 
VEGF 
TGF-ɴ ? 
Leptin 
MMPs 
angiostatin 
endostatin 
INF 
Ang2 
TNFɲ 
IL-4 
physiological angiogenesis 
pathological angiogenesis 
embryogenesis 
wound repair 
psoriasis 
vascular tumour 
PDGF 
FGF2 
TIMP 
CL growth 
impaired wound healing 
developmental abnormalities 
anti-angiogenic cancer therapies 
Figure 1.4: Diagram depicts how changes in the tissue balance between pro-
angiogenic and anti-angiogenic (angiostatic) agents determine whether an
angiogenic response is physiological (e.g. embryogenesis and CL growth)
or pathological (e.g. vascular tumour), depending on the context.
1.2.5.2 Angiogenic factors
The process of angiogenesis is driven by two counteracting groups of mediators: acti-
vators and inhibitors (Figure 1.4). The activators control the different steps that lead to
the formation of a new capillary, whereas the inhibitors block ormarkedly attenuate EC
proliferation, migration, and survival, signal transduction, matrix metalloproteinase
(MMPs) expression, and EC precursor development and/or recruitment.
Angiogenic factors provide the necessary ‘checks and balances’ required to maintain a
normally quiescent yet highly responsive population of ECs by overriding signals that,
if left unchecked, would lead to a relentless and destructive angiogenic response. In
physiological settings, the activators and inhibitors function in a coordinated fashion
to induce and sustain angiogenesis for a limited period of time, e.g. just enough to get
an injured tissue sufficient nutrients to repair itself (wound repair) or in the case of the
endometrium, to prepare the uterus to receive a fertilized egg. Therefore, normally the
inhibitors outweigh the activators.
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For angiogenesis to occur the balance must tilt in favour of the pro-angiogenic factors;
this is known as the angiogenic switch. The switch may be turned on by either upreg-
ulation of angiogenic activators (inducers) or downregulation of angiogenic inhibitors.
The female reproductive organs exhibit marked periodic growth and regression, ac-
companied by equally striking changes in rates of blood flow. It is not surprising
therefore, that they are among the few adult tissues in which angiogenesis occurs as
a normal process. Ovarian follicles and corpora lutea have been shown to contain and
produce angiogenic factors [196]. To better understand the complexity underlying the
angiogenic response, examples of several of the better-known activators and inhibitors
of angiogenesis will now be discussed in some detail, showing emphasis on their role
in CL angiogenesis.
Vascular endothelial growth factors (VEGFs): Vascular endothelial growth factor
(VEGF or VEGF-A) is the founding member of a family of pro-angiogenic growth ac-
tors composed of six closely related members: VEGF-A, placental growth factor (PGF),
VEGF-B, VEGF-C, VEGF-D, and VEGF-E. This gene family plays a central role in reg-
ulating the growth and function of vascular and lymphatic endothelium in developing
adult organisms and is a key participant in the angiogenic response that accompanies
the development of malignant tumours, ocular lesions, and chronic inflammatory dis-
eases [189].
VEGF is expressed in a wide variety of tissues, including brain, kidney, liver, and
spleen, and by numerous cell types. VEGF influences many steps in the angiogenic re-
sponse. It stimulates degradation of the extracellular matrix (ECM) surrounding ECs,
and it promotes EC proliferation, migration, and organisation into tubular structures
[189].
Oxygen tension is an important regulator of VEGF. Exposure of tissues to hypoxic con-
ditions typically induces VEGF expression. In contrast, normoxic conditions down-
regulate VEGF production and promote regression of newly formedmicrovessels [172].
VEGF production increases in luteinizing granulosa cells of the ovulatory follicle and
is stimulated by addition of human chorionic gonadotrophin (hCG) to luteinized gran-
ulosa cells in culture [66].
VEGF acts through two receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1), with
the first being a decoy receptor; that is, it can prevent VEGF from binding to its nor-
mal receptor (VEGFR-2). Hunigen et al. suggest that the CL development (associated
with intense angiogenesis) is driven mainly by VEGF-A and its receptor VEGFR-2 [95].
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The highest expression of VEGF-A and VEGFR-2 mRNA1 is detected during the early
developmental stages of the CL and is followed by a significant decrease during the
mid- and late-developmental stages and a further decrease after regression [214]. In
contrast, VEGFR-1 mRNA expression does not change during the oestrous cycle. The
VEGF protein concentration in CL tissue follows the trend of mRNA expression. The
VEGF protein is localised predominantly in luteal cells. The targets for VEGF are ECs
where both receptors (VEGFR-1 and VEGFR-2) are found [214]. Theca-derived cells are
believed to contribute on the vascularisation of the CL. For example, in the bovine CL,
VEGF is predominantly localised in luteal connective tissue, and also in capillary PCs
[19]. In fact, the first theca-derived cells to invade the granulosa-derived regions of the
CL immediately after ovulation seem to be VEGF-containing PCs [167]. These findings
suggest that theca-derived perivascular cells may direct vascularisation of the CL via
production of VEGF.
Angiogenesis in the bovine CL is normally completed by day 5 of the oestrous cycle. In
association with this, Tsang et al. found that by day 4 bovine corpora lutea were capable
of producing high amounts of progesterone in vitro [249]. However, high expression of
VEGF and its receptors after day 5 and during pregnancy had been observed [249].
This suggests a maintenance function of VEGF for the ECs of surrounding capillaries
or LCs, in addition to the role of VEGF in stimulating vascular development. It has also
been suggested that VEGF may be involved in stimulating follicular and luteal vascu-
lar permeability and blood flow [167].
Fibroblast growth factors (FGFs): The fibroblast growth factors (FGFs) are some of
the most extensively studied pro-angiogenic substances, with FGF1 and FGF2 the best
characterised. Both promote mitosis and migration of ECs [233]. Despite the fact that
both are powerful angiogenic factors, FGF2 appears to be more potent in stimulating
EC growth and is probably the major angiogenic factor in the CL [116]. This is sup-
ported by Robinson et al. [204], who found that FGF2 is up-regulated while VEGF-A
remains constantly expressed during the follicular-CL transition in the cow.
FGFs signal through two receptors FGFR1 and FGFR2 [213]. FGFR1 is expressed at
relatively high levels throughout the oestrous cycle. Its localisation to luteal steroido-
genic cells is greatest during the mid-cycle and dramatically reduced during luteolysis.
In contrast, strong staining for FGFR1 is present in ECs at all stages and is especially
abundant in larger microvessels late in the oestrous cycle. Although FGFR2 in the CL
1messenger ribonucleic acid (mRNA): the template for protein synthesis; the form of RNA that carries
information from deoxyribonucleic acid (DNA) in the nucleus to the ribosome sites of protein synthesis
in the cell
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is present at relatively low levels, it is localised to steroidogenic cells at all stages but is
present in the vasculature (primarily the larger microvessels) only late in the oestrous
cycle [197].
Platelet-derived growth factors (PDGFs): The PDGFs (PDGFA, PDGFB, PDGFC, and
PDGFD) are pro-angiogenic growth factors that are expressed in a variety of tissues
and produced by macrophages and ECs. PDGFs play a vital role in regulating cell
growth and angiogenesis, and they exert their effects through binding and subsequent
activation of two related receptors: PDGFRA and PDGFRB. PDGFs consist of either
homodimers (AA, BB, CC, DD) or a heterodimer (AB) that binds two receptors simulta-
neously, thereby inducing a wide variety of cell responses, including proliferation, sur-
vival, and chemotaxis. PDGFs and their receptors are often expressed by neighbouring
cells, suggesting a paracrine interaction. PDGF has been demonstrated to stimulate in
vitro proliferation of theca cells from both rat [55] and pig [151], while inhibiting theca
LH-induced steroid hormone synthesis [246]. In addition, the classic PDGF isoforms,
PDGFA and PDGFB, were shown to contribute towards growth of preantral (without
antrum - a fluid filled cavity) follicles [231].
The expression of PDGFs and receptors in the mature follicle gives rise to the question
of the possible involvement of this system in the post-LH life of the follicle (the CL). It
has been well established that PDGFB and PDGFRB are components of the vasculature
and play an important role in angiogenesis [61, 88]. The properties of PDGFs and their
receptors in inducing cell proliferation and migration suggest that signalling through
these receptors may be important in the development of the CL, either by affecting
migration and/or proliferation of theca cells and/or cells of the vasculature in response
to the ovulatory surge of LH.
In [231], Sleer et al. elucidated the presence of components of the PDGF ligand-receptor
system in the CL of the rat. Because of the LH-induced increase in levels of mRNA for
several PDGFs and receptors, the authors suggested a role for this growth factor sys-
tem during CL development. That was confirmed by the observation that inhibition
of PDGF receptor signaling prior to ovulation resulted in a significant decrease in the
average percentage of corpora lutea in the ovaries [231].
Angiopoietins - determinants of vessel maturation: Ang-1 and Ang-2, two members
of the angiopoietin family, are of particular interest with respect to regulation of the
rapidly-changing CL vasculature. Both angiopoietins bind to Tie-2 receptor which is
expressed on the vascular endothelium. Ang-1 is thought to play a stabilising role:
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maintaining cell-cell interactions, inhibiting apoptosis and mediating interactions be-
tween the EC and the basement membrane. In angiogenesis, Ang-1 is necessary for the
maturation of newly formed vessels by recruiting PCs [66].
Ang-2 is a natural antagonist for Ang-1. It binds to the same receptor, but does not
activate it, thus blocking the normal effects of Ang-1. Therefore, the ratio of Ang-2
to Ang-1 appears to play a crucial role for vascular stability. The high Ang-2/Ang-1
ratio induces vessels to become destabilised: cell-cell and cell-matrix connections are
loosened and both the basement membrane and the peri-endothelial support cells be-
come dissociated from the endothelium [187]. In such conditions, when VEGF is high,
a destabilisation of blood vessels results in the formation of a new vascular network,
whereas a lack of VEGF support results in a regression of blood vessels [66] (see Figure
1.5).
In [214], Schams et al. showed that in the early CL, Ang-1 but not Ang-2 mRNA expres-
sion changed according to the stage of the oestrous cycle. Particularly, they found that
the Ang-2/Ang-1 ratio increased because of the lower expression of Ang-1 mRNA.
Hence, they suggested that the Ang-Tie system is involved in the local mechanisms
regulating angiogenesis in the bovine CL [214].
Ang-2 
Ang-1 
+ VEGF 
- VEGF 
maturity 
plasticity 
Disruption of  
cell-cell interactions 
Maintenance of  
cell-cell interactions 
apoptosis and  
regression 
proliferation and 
sprouting 
mature immature 
Figure 1.5: Schematic showing the regulation of EC behaviour by the angiopoietins
and VEGF. An absence of Ang-2 allows Ang-1 to maintain vessels in the
quiescent state (maturity); expression of Ang-2 allows either angiogenic
outgrowth, or vessel regression, depending on the presence or absence of
VEGF.
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1.2.6 Summary
The corpus luteum (CL) plays a central role in the reproductive process because of its
production of progesterone, a hormone responsible for a healthy pregnancy. The CL
growth is extremely rapid and highly angiogenesis-dependent. Central to the growth
and development of the CL, therefore, is vascular growth, which appears to be regu-
lated by several angiogenic growth factors, e.g. FGF2 and VEGF. Inadequate angiogen-
esis has been linked to infertility in the cows. The CL is a complex tissue composed
of various vascular (e.g. endothelial cells, vascular smooth muscle cells, pericytes) and
non-vascular (e.g. luteal cells, fibroblasts, immune cells) cell types. Since the rates of
tissue growth and angiogenesis in the CL rival those of even the fastest growing tu-
mours, in the next section, our aim is to provide a brief review of different theoretical
approaches that have been used mainly in tissue/tumour growth and angiogenesis.
We believe that mathematical modelling could lead to an improved understanding not
only of angiogenic function, but also of tissue growth and development in the CL in
order to alleviate infertility in cows.
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1.3 Mathematical background
1.3.1 Introduction
Over the last decades, mathematical modelling has progressed to encompass a wide
range of biological systems. Within the broadening sphere of mathematical biology,
there has been increasing activity in the modelling of various problems related to tissue
growth and angiogenesis and, in this section, we briefly provide the basic mathematical
background related to these aspects.
1.3.2 Mathematical modelling of tissue growth and angiogenesis
Mathematical modelling of tissue growth and angiogenesis has been gaining momen-
tum as a means to shed light on the biological complexity underlying normal and tu-
mour growth, wound healing, tissue engineering, and blood vessel development. A
variety of mathematical models have been developed, each focusing on different as-
pects of these processes. However, as stated in section 1.2 the angiogenesis-dependent
growth of the CL has been compared to the tumour and, therefore, in the following we
mainly focus on models inspired by tumour growth and angiogenesis.
Modelling of angiogenesis could be regarded as an attractive area for research since an-
giogenesis is fundamental to both the development of vasculature as well as its main-
tenance in the adult. Impaired angiogenesis is a feature of a wide range of clinical
conditions, and predictive theoretical models of angiogenesis have a clear role in de-
veloping suitable therapeutic strategies.
Many phenomena exist on a wide range of scales and the proper modelling tool is basi-
cally dictated by the question of interest. Mathematical models may be divided broadly
into two categories: continuum models at the cell density level and discrete models at
the individual cell level. In particular, at the coarse-grained level (continuum models)
one erases cell identity and uses continuous cell densities to describe the system. At the
next finer scale (discrete models), cells within the population are modeled as discrete
objects.
1.3.3 Continuum models
Continuummodels focus on the dynamics of the gross tissue behaviour, includingmor-
phology, shape, and extent of vascularisation, with capillary networks being described
in terms of EC densities. Microscopic details of tissue structure are averaged over short
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scales to produce a description of the macroscopic-level tissue properties. At this scale,
because the number of cells in the model is sufficiently large, it becomes possible and
sometimes necessary to treat some or all of the cells as a single continuum. Therefore,
continuummodels use either systems of ordinary differential equations (ODEs) or par-
tial differential equations (PDEs).
1.3.3.1 Ordinary differential equation (ODE) models
Some of the simplest models for tissue growth are the exponential (equation (1.3.1)),
logistic (equation (1.3.2)), and Gompertz growth (equation (1.3.3))
dx
dt
= kx, (1.3.1)
dx
dt
= kx(1− x
K
), (1.3.2)
dx
dt
= kxln
(
K
x
)
, (1.3.3)
where, x(t) can be the tissue mass and K the carrying capacity (maximum tissue size).
For instance, the exponential model can be relevant for the early stages of tumour
growth only, whereas logistic and Gompertz model represent growth limitations (with
maximal growth), due to mechanical pressure or nutrient scarcity.
The logistic model, frequently used in population dynamics, was also used in the de-
scription of tumour growth [217]. However, probably the most popular non-linear
model that can be found in the literature in connection with tumour growth is the
Gompertz model from Laird [125], where the Gompertz curve in [126] was fitted to
experimental data.
In an attempt to design a more realistic model of tumour growth under angiogenic
stimulator and inhibitor control, Hahnfeldt et al. in [82] proposed a two-variable model
derived from the Gompertz model. The authors introduced as a variable the carrying
capacity of the environment, K:
dx
dt
= kxln
(
K
x
)
,
dK
dt
= −λK+ bS(x,K)− dI(x,K)− eKg(t).
(1.3.4)
The first term of the second equation in (1.3.4) represents the spontaneous loss of func-
tional vasculature; the second term represents the stimulatory capacity of the tumour
upon the inducible vasculature (through, e.g. angiogenic factors); the third term reflects
endogenous inhibition of previously generated vasculature (through, e.g. endothelial
15
CHAPTER 1: INTRODUCTION
cell death); and the last term represents inhibition of tumour vasculature due to admin-
istered inhibitors with concentration g(t). This model enables to take into account the
vasculature, that provides nutrients and oxygen to tumour cells, and thus to study the
effects of several anti-angiogenic factors on tumour growth.
Gyllenberg et al. [81] and Kozusko et al. [120] used ODEmodels with two cell compart-
ments, proliferating and quiescent, by revisiting Gompertz growth.
In addition, ODE models have been widely used to study the growth of avascular
multicellular spheroids (MSS) (for example, see [24]). MSS are used in the laboratory
because the reproducible manner in which they growmimics the initial phase of in vivo
avascular tumour growth.
Many other ODE models have been created for tissue/tumour growth, but we will
briefly refer to some of those.
Kuznetsov et al. in [123] used an ODE model to describe the interaction between the
immune system (via cytotoxic T lymphocytes) and a growing tumour. It was predicted
that if the number of tumour cells injected into the mice was less than a threshold the
resultant tumour growth could be controlled. However, at certain parameter values,
solutions were possible that can be interpreted as tumour sneaking through, a phe-
nomenon in which low doses of tumour cells can escape immune defenses and grow
into a large tumour. They found that one of the most critical parameters was the rate at
which cytotoxic cells were inactivated due to interactions with the tumour [123].
Owen and Sherratt in [179] also developed an ODE model for the early, avascular
growth of a tumour, focusing on the temporal dynamics of the tumour-macrophage in-
teraction. In particular, the authors concentrated on the inhibitory effect ofmacrophages
due to their cytolytic activity. It was shown that although the presence of macrophages
had important effects on the tumour composition, their immune responsewas not suffi-
cient to prevent tumour growth. However, the extension of the model by incorporating
exogenous chemical regulators admitted the possibility of tumour regression.
Although compartmental ODEmodelling can contribute a lot in tracking the density of
cells, tissue/tumour growth over time, in many cases spatial dependencies such as gra-
dients arise. Obviously tissue growth in vivo depends on its environment. For instance,
it depends on the mechanical properties of the supporting tissue, the local quantity of
nutrients and oxygen, the local concentrations of pro- and anti-growth chemical fac-
tors. Therefore, incorporation of spatial dimensions is needed to meet these demands.
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1.3.3.2 Partial differential equation (PDE) models
Reaction-diffusion PDEs describe the space and time evolution of the concentrations of
chemical substances and of cell densities. Such equations allow to take into account the
interactions of a diffusing chemical or of a population of cells with the environment.
To construct a PDE model we use the law of mass conservation to formulate generic
‘conceptual’ equations as given below

rate o f
change o f
species c

 =
(
transport o f
species c
)
+


rate o f
production
o f species c

−


rate o f
decay/uptake
o f species c

 ,
(1.3.5)
describing time rates of change of substances of interest, their movement and their rates
of production/decay.
A typical continuum PDE model of the type described in equation (1.3.5) (for instance,
see [149]) is given by the following governing equations
∂n
∂t
= −∇ · Jn + g1(n, c), (1.3.6)
∂c
∂t
= D∇2c+ g2(n, c), (1.3.7)
where, n(x, t) is comprised of the densities of all cell types involved in the process
(e.g. ECs, pericytes), c(x, t) is containing the concentrations of substances influenc-
ing cell migration and/or proliferation, g1, g2 contain the appropriate source and sink
terms, andD is a diagonal matrix containing the diffusion coefficients of each chemical
species.
The cellular fluxes (Jn) typically include a random diffusive component and directed
terms, given in the form
Jn = Jdiffusion + Jchemotaxis + Jhaptotaxis = −Dn∇n+ χcn∇c+ χhn∇ f , (1.3.8)
where, χc and χh is the strength of chemotaxis and haptotaxis, respectively, and f the
concentration of the ECM (e.g. fibronectin). Note that chemotaxis is the directional
motility of cells up a gradient of a chemoattractant, and haptotaxis is the movement up
a gradient of cellular adhesion sites or substrate-bound chemoattractants.
Several PDE models in angiogenesis have been developed to study the distribution
in space and time of variables such as EC density, capillary tip and branch density,
and angiogenic factor concentration. Next we describe a selection of one- and two-
dimensional PDEmodels, focusing on the model constituents and their main biological
intuition.
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PDE models in one space dimension
Models in one space dimension focused on tumour-induced angiogenesis and angio-
genesis in wound healing include those of [6, 12, 24, 32, 174].
Particularly, in [174], Orme and Chaplain focused upon the early stage of angiogenesis
wherein the ECs group together in the parent vessel to form the initial capillary sprout
buds. The model postulates that the vascular ECs that form capillary tips migrate up
a gradient of angiogenic factor released by a tumour. The density of new capillaries
as well as the concentrations of angiogenic factors evolve according to coupled non-
linear PDEs (of the type (1.3.6)-(1.3.7)). Haptotaxis was also incorporated in the model
with fibronectin being secreted by the ECs and diffusing into the surrounding area.
This model was the first that addressed the question of site location (e.g. ‘Does the
site at which a capillary bud forms simply coincide with the site at which the VEGF
concentration is highest, or is a more complex process involved?’). As was expected,
by increasing the parameter γ which represents the size of the (1-D) domain, the num-
ber of EC clusters (buds) formed along the parent blood vessel increased. In addition,
similar effects were obtained by varying two other parameters; ζ (the rate of matrix
secretion per cells), and λ (the loss of matrix per unit matrix). These results suggested
that the site(s) of bud initiation is not related only to the local distribution of VEGF in
the tissue, but that is also determined by the role of haptotaxis.
In [12], Balding and McElwain developed one of the earliest mathematical models of
angiogenesis (in the cornea), modelling capillary and sprout tip density in response to
a diffusive tumour angiogenesis factor (TAF) governed by the equation of type (1.3.7)
with constant diffusion coefficient. The model was considered in one dimension, with
the TAF source situated at the one edge of the domain and a capillary at the other. The
solutions exhibited a wave-like behaviour, with a wave-front of tips advancing from
the parent vessel towards the TAF.
In [24], Byrne and Chaplain extended the model in [12]. The authors incorporated both
random and chemotactic fluxes (see equation (1.3.8)) for the tip cell motion, whereas
in [12] the authors incorporated only the chemotactic flux, by assuming that sprouts
are never observed directed away from a tumour and, therefore, random motion is
negligible. In [24], the authors attempted to capture the increased vessel density (or
brush-border effect), by adding a second, more rapid, proliferation term, which only
becomes active when TAF concentration is above a certain threshold value. That term
was also incorporated in the TAF equation as a consumption term from the tip cells.
The main weakness of this continuum model was its inability to distinguish between
anastomosis (tip cell fusion) and tip death. This is because angiogenesis is essentially
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a two-dimensional process, with tip cells sprouting in directions other than that of the
propagating front.
PDE models in two space dimensions
Models of angiogenesis considered in [29, 31, 133, 171, 175], were able to account for
the spatiotemporal distribution of capillary sprouts due to their two-dimensional ap-
proach. Particularly, these models studied the interactions between ECs and the ECM
during angiogenesis in order to understand how cells respond to not only chemical
signals via chemotaxis, but also to mechanical signals via haptotaxis. In haptotaxis, the
EC populationmigrates up the concentration gradient of ECM,whichmediates cell-cell
and cell-matrix adhesion.
As an example, the model of Orme et al. in [175] incorporates just the role of ECs and
the ECM (fibronectin), since the authors assumed the TAF concentration to be at steady
state. The model examined the relative importance of various parameters, such as the
chemotactic and haptotactic coefficients, the EC proliferation rate, and the diffusion
coefficient on the dynamics of the angiogenic process. Without haptotaxis, the model
predicted early anastomosis of the initial sprouts, and the authors used this result to
suggest that haptotaxis is important for successful angiogenesis.
However, EC-ECM interactions are not only chemical (e.g. secretion of growth fac-
tors), but also mechanical since the ECs exert traction forces on the ECM fibers in order
to move. These interactions were incorporated into mechano-chemical models intro-
duced by Oster and co-workers [163, 177]. In [177], Oster et al. used a cell traction
model which was able to reproduce morphogenetic phenomena in fowl dermis. Their
aim was to show how various combinations of cell and matrix properties (e.g. cell di-
vision, traction, motility, haptotaxis, matrix elasticity) can, individually and in concert,
produce equivalent patterns. For example, a decrease in cell traction was compensated
by an increase in ECM density or adhesiveness, or by increased cell division, to arrive
at the same spatial structure. This introduced the notion of equivalent and compensat-
ing effects in morphogenesis, and as a result, the authors suggested that many patterns
are not the result of a single process, but rather emerge as the consensus of a number
of interacting phenomena [177].
In [133], Levine et al. continued the line of investigation as in [174] (to predict the site
of sprout formation), by considering the EC migration as a reinforced random walk1
where transition probabilities are dependent on cell concentration, proteolytic enzymes
1Extensive reference on the concept of reinforced random walks can be found in Othmer and Stevens
[178]
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and fibronectin that forms the basal lamina (a layer of ECM secreted by the epithelial
cells, on which the epithelium sits). Michaelis-Menten kinetics describe reactions in
which EC receptors are regarded as catalysts for converting TAF into proteolytic en-
zyme, which in turn breaks down fibronectin and destroys the basal lamina. Themodel
also includes secretion and uptake of fibronectin by ECs, chemotaxis to TAF and hap-
totaxis to lower concentrations of fibronectin. As expected, results showed that if there
is enough TAF supplied to the capillary wall, the basal lamina would break down.
Mechanical forces (e.g. shear stress) on the developing capillary network are examined
by other two-dimensional models [148, 162] in which the ECM is represented as a vis-
coelastic material interacting with the ECs. Particularly, in [162], Murray showed that if
cellular traction is sufficiently high, then traction forces alone can lead to formation of
networks. Additionally, it was suggested that the matrix thickness is an important fac-
tor influencing the pattern. More specifically, cells spread on a matrix whose thickness
increased from one end of the dish to the other, formed polygon networks whose size
increased with increasing thickness of the gelled basement membrane matrix [162].
Because the same genetic machinery regulates both angiogenesis and vasculogenesis
(the process of blood vessel formation occurring by a de novo production of ECs) [26], a
common set of mechanisms is plausible. In [147], Manoussaki extended her mechanical
model of vasculogenesis to describe angiogenesis by adding long-range, chemotactic
guidance cues. In her simulations, ECsmigrated from an aggregate towards a chemoat-
tractant source and cell-traction-driven migration contracted the sprout into a narrow,
vessel-like cord.
Moving now from the mechano-chemical models, in [30], Chaplain presented a mathe-
matical model based on the experimental system of the implant of a solid tumour in the
cornea of a test animal. The model focused on the ‘tissue response unit’ which consists
of ECs, a generic TAF (e.g. a cytokine such as VEGF) and a generic matrix macro-
molecule known to affect cell adhesion (e.g. fibronectin), where EC proliferation terms
were not included. This work mainly aimed at explaining the experimentally observed
fact that in the absence of EC proliferation, angiogenesis is incomplete, in the sense
that the ECs fail to reach the tumour. EC migration was determined by their response
to the concentrations of TAF and matrix macromolecules in the micro-environment.
Therefore, EC movement consisted of a random diffusive flux, a chemotactic flux and
a haptotactic flux as in equation (1.3.8). The chemotactic sensitivity was described by
χc =
χ0
1+ αc
. (1.3.9)
This reflects the fact that, as the concentration c(x, y, t) of TAF increases, the EC lose
the ability to efficiently detect the concentration gradient, so the chemotactic sensitivity
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decreases. Note that the classic chemotaxis (χc = χ0: constant) is recovered in the limit
α → 0.
In [220], Serini and co-workers also used a two-dimensional continuummodel to study
cell aggregation (the early stage of network formation) by ECs randomly plated on a
Matrigel film. The PDE system was based on the following assumptions: the EC pop-
ulation can be described by a continuous distribution of density and velocity, the EC
population in the early stages of its evolution (e.g. low densities) can be modelled as
a fluid of non-directly interacting particles, with the ECs accelerating by gradients of
chemoattractants, where the latter are released by ECs, diffuse and degrade. The hy-
pothesis here is that the early EC aggregation is supported by chemotactic intercellular
cross-talk mediated by chemoattractants. The authors suggested that the EC number
and the range of activity of chemoattractant factor regulate the vascular network for-
mation and size. Particularly, it was shown that VEGF triggered directed EC migration
and that the cell number over or below an interval was not permissive for network
formation. The model also predicted that the diffusivity and the half-life time of the
chemoattractant determine the size of the vascular structure (e.g. with smaller diffu-
sivity they obtained vascular networks with larger mesh).
In summary, continuum models are only meaningful when describing the average be-
haviour of a large number of individuals. The smaller the number of individuals in
the population, the less accurate the macroscopic description becomes. This raises the
question of whether a continuum description is appropriate for angiogenesis, a process
controlled by the behaviour of a small number of individual cells. In contrast to these
deterministic, continuum models, several different types of discrete models have been
used to model the branching morphology of capillary network formation and angio-
genesis.
1.3.4 Cell-based models
Continuum models provide valuable insight into the processes of angiogenesis, but
they are limited in their prediction of the structure of vascular networks. To determine
the procedures that describe the morphology of vascular networks cell-based models
have been developed.
Each cell is treated as a discrete entity, with a set of rules which governs the actions of
the cells. The cells must have some explicit set of actions which they will follow based
on their current state and the states of neighbours.
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Much of biological modelling use an averaged approach: a single variable represents
a property of a collection of objects (populations, cells, genes, etc). Cell-based models
use the reductionist view that these averaged variables should be observable or emerge
from the actions and interactions of the individuals which make up the system. The
objective is to describe the basic processes which control the actions of individuals, and
combine them to determine the resultant macrodescriptors which give rise to higher
levels of organisation.
We separate our review of cell-based models into six main groups: lattice-based mod-
els, cell-centre, cell-vertex models, cellular potts models (CPM), lattice and off-lattice
multi-agent models, and particle models. We discuss the CPM in more detail since
Chapters 4 and 5 are based on this framework.
1.3.4.1 Lattice-based models
The majority of cell-based models of angiogenesis simulate EC movement on a regular
lattice, and in this section we provide details on some of those.
In [6], Anderson and Chaplain used a discretisation (using standard finite-difference
methods) of a PDE for the EC density (n). This involves approximation of the continu-
ous two-dimensional domain as a grid of discrete points (with a mesh size, h, between
grid points), and time (t) by discrete increments of length k. That is x = lh, y = mh,
t = gk, with l,m, g ∈ N+. The probabilities of movement of an individual EC are
generated by the coefficients of the five-point finite-difference stencil in response to its
local micro-environment. The discretisation of the PDE governing the migration of an
EC, as given in [6], has the form:
n
q+1
l,m = n
q
l,mp0 + n
q
l+1,mp1 + n
q
l−1,mp2 + n
q
l,m+1p3 + n
q
l,m−1p4, (1.3.10)
where the subscripts specify the location on the grid and the superscripts the time
steps. The probabilities p0, ..., p4 are functions of the fibronectin and TAF concentra-
tions at the neighbouring spatial points of an individual EC. As a result, the motion
of an individual cell at the sprout-tip is governed by its interactions with angiogenic
factors (e.g. TAF) and matrix macromolecules (e.g. fibronectin) in its local micro-
environment. Therefore, the above probabilities obviously contain contributions from
diffusion, chemotaxis, and haptotaxis. The discrete model allows for branching (pro-
duction of new sprouts), and anastomosis (formation of loops), and incorporates cell
proliferation which additionally results in sprout extension.
In [144], Mallet and De Pillis used a hybrid (discrete-continuum) cellular automaton
model to describe the interactions between a growing tumour and the immune system.
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This approach incorporates both deterministic and stochastic mechanisms allowing for
the consideration of individual cell behaviour and associated randomness. The model
simulated chemical diffusion through deterministic PDEs and cell behaviour through
a set of probabilistic rules. The spatial domain in the cellular automaton represents a
two-dimensional patch of tissue supplied with nutrients by blood vessels. In the ab-
sence of the immune system, the model was able to reproduce tumours. However,
introducing the immune system leads to various results depending on the choice of the
T-lymphocyte (immune cells) recruitment and death parameters. Therefore, depending
on the strength of T-cell recruitment and the T-cell death parameter, the tumour grew
with stable and unstable oscillations and in some cases the tumour was completely
destroyed. However, due to the probabilistic nature of the model it was difficult to de-
termine exact parameter values at which the tumour becomes unstable. Additionally,
simulations showed (as expected) that increasing T-cell recruitment as well as increas-
ing the cytolytic ability of T-cells leads to greater reductions in tumour size.
In [74], Gerlee and Anderson developed a hybrid cellular automaton model which cap-
tures the growth dynamics of glycolytic tumours. The interactions between the cancer
cells and the ECM were taken into account. The authors investigated the impact of
the micro-environment on the growth and evolutionary dynamics of the tumour by
varying the oxygen concentration and matrix density in the tissue. In particular, they
focused on the emergence of the glycolytic phenotype, which is an important aspect of
carcinogenesis. The results showed that environmental conditions affect both the mor-
phology and the evolution of phenotypes in the tumour. While a low oxygen concen-
tration destabilises the growth and leads to a branched tumour morphology, a denser
matrix gives rise to a more compact tumour with less fingering. On the other hand,
the combined effect of both these environmental variables leads to the emergence of
the glycolytic phenotype, which is found to appear in a poorly oxygenated and dense
tissue.
In [191], Qutub and Popel used a 3-D rule-based lattice model for sprouting angiogen-
esis. In particular, the rules concerning the tip cell activation, and migration, stalk and
tip cell growth and proliferation, and persistence of sprout direction were depended on
VEGF (concentration and gradients) and Delta-like 4 (Dll4; a Notch ligand [91]). The
model explored the characterisation of persistence effects on vessel formation, differ-
entiation of tip cells (from stalk cells), and stalk cell branching. The model predicts it is
not until 48 hrs that branching has a significant effect on the total vessel length changes.
In Dll4 haploinsufficiency (Dll4+/-; when in diploid organisms one of the two copies of
a gene is mutated) the relative total vessel length changed and the number of tip cells
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in 24 hrs was increased compared to the control condition (Dll4+/+).
In [41], Das et al. also incorporated the effect of ECM and growth factors in a 3-D lattice
model to predict capillary formation. The deterministic component of the model in-
cludes the diffusion-convection-reaction equations that govern the growth factor con-
centrations. The model incorporates probabilities of an individual cell to transition into
one of four stages: quiescence, proliferation, migration and apoptosis. The transition of
each cell between states is a function of its current state, the condition of the surround-
ing matrix and external governing factors such as the presence or absence of flow, the
growth factors present in neighbouring matrix and initial matrix stiffness. All cell-cell
communication occur via the field (e.g. ECM), and direct cell-cell interactions were not
considered.
In [153], McDougall et al. developed a hybrid model with the aim to produce the whole
retinal vascular plexus (RVP) from proliferating ECs which migrate towards (poorly
oxygenated) astrocytes which secrete VEGFA and fibronectin. Once a perfused vascu-
lar network has formed, astrocytes gradually downregulate VEGFA expression. The
hybrid formulation allows for the tracking of individual cells (ECs, astrocytes) towards
the outer retinal boundary, and visualisation of blood vessel topology. Blood perfusion
is also included throughout plexus development. The resulting in silico RVP structures
are compared with whole-mounted retinal vasculatures at various stages of develop-
ment, and the agreement is found to be promising.
1.3.4.2 Cell-centre models
In cell-centre models, each cell is represented by the position (in R2 or R3) and move-
ment of its centre.
One of the first models using a discrete framework was that of Stokes and Lauffen-
burger [239]. The authors proposed a stochastic model for the random motility and
chemotaxis of single cells. Note that cells in this model are represented only by their
centres (they do not occupy a certain area). The cell velocity was described as a per-
sistent random walk. The resulting stochastic differential equation for cell velocity is
given by
dvi(t) = −βvi(t)dt+ αdWi(t) + κ∇c sin| φi2 |dt(
change in
velocity
)
=
(
resistance
to motion
)
+
(
random
f luctuations
)
+
(
chemotactic
bias
)
,
(1.3.11)
where, β is a ‘viscosity’ coefficient, W is the Wiener process1 (white noise), κ is the
1The Wiener process is a continuous-time stochastic process, which it is often called Brownian motion
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chemotactic resposiveness, c is the TAF concentration, φ is the angle between the direc-
tion the tip is moving and that towards the TAF source (see Figure 1.6), and subscript
i denotes the ith sprout [239]. The discrete framework used in the above model had
Figure 1.6: Geometry of the angiogenesis model in [239]. The primary vessel is rep-
resented by the horizontal line. The path of each capillary is determined
by the trajectory of an actively migrating cell located at its tip. This tip
migrates with velocity, v (as in equation (1.3.11)), towards the spherical
source of the chemoattractant. All other cells in the sprout follow directly
behind the tip cell [239].
the advantage of enabling the motion of individual ECs to be followed. Realistic cap-
illary network structures were generated by incorporating rules for sprout branching
and anastomosis. Although the model incorporated random motility and chemotaxis
as mechanisms for cell migration, no account was taken of the interactions between
the ECs and the ECM. The model did not include any rules to reproduce the observed
increase in branching frequency at the leading edge of the network as it approached
the tumour, but this would be straightforward to add.
In cell-centre models, cell movement can also be determined by a balance of forces act-
ing on a cell. Various approaches have been developed for calculating the forces acting
on a cell. These include modelling cell-cell connections with springs, and modelling
the cells as deformable elastic circles/spheres.
In [54], Drasdo and Loeffler developed a cell-centre based model concerned with the
buckling of a colorectal crypt. The authors developed a model for a 1-D chain of cells in
2-D space, where the cells were treated as deformable elastic circles. The force on each
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cell was composed of four parts: (i) the elastic deformation force between the cells, (ii)
a shear force holding the crypt in shape, (iii) a force from the stroma, and (iv) a force
restricting any bending of the epithelium. The model incorporated proliferation and
allowed for variation in the size of the cells through the cell cycle.
To represent the shapes of the cells (except as deformable elastic circles/spheres), a
Voronoi diagrammay be used (see Figure 1.7(b)). In [212], Schaller andMeyer-Hermann
studiedmulticellular tumour spheroids by introducing a 3-D Voronoi-Delaunay hybrid
model. The cell shape varied from spherical if cells were immersed in thin solution to
convex polyhedral in dense tissues. The cellular interactions included direct elastic
forces and cell-cell as well as cell-matrix adhesion. The spatiotemporal distribution of
two nutrients, oxygen and glucose, was described by reaction-diffusion equations. The
experimental growth curves were reproduced by considering the dynamics of both nu-
trient concentrations simultaneously.
A disadvantage of some centre-dynamics models is their reliance on Voronoi tessela-
tion. That is, the number of vertices and the shapes of the cells do not change smoothly.
Another disadvantage, is that these models can be computationally expensive, with a
new Voronoi diagram needing to be constructed at each time step.
1.3.4.3 Cell-vertex models
Cell-vertex models are a type of cell-level model that view the cells as polygons. The
size and shape of each cell is dictated by the movement of its vertices (see Figure 1.7(c)).
In cell-vertexmodels themotion of the cells evolves, either through considering the bal-
ance of forces at the vertices [259] or by rearranging cells to minimise total free energy
[94].
Briefly, the vertex model was first introduced by Kawasaki et al. in 1989 [112] for the
simulation of 2-D grain (crystallites) growth. The basic idea behind this model is that
the minimisation of the free energy can be achieved exclusively by the motion of the
vertices. The curvature of the grain boundaries was not considered, but introduced
later by Weygand [261] by the introduction of virtual vertices along the boundaries.
The 2-D model of Kawasaki was extended to three dimensions from Nagai et al. [165].
The main advantage of cell-vertex models is that they have no need for a Delaunay
triangulation or Voronoi diagram to be produced at each timestep. However, one of
the main disadvantages of vertex-based models is that it is not easy to include differ-
ential cell-substrate adhesion terms for different cells, as any change in drag terms on
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vertex movement would depend on all cells surrounding the vertex. Finally, as vertex-
based methods contain more information than centre-based methods they can be more
computationally expensive.
i 
(a)
i 
(b) (c)
Figure 1.7: (a) Cell-centre model where the movement of cell i is determined by inter-
actions with neighbouring cells. (b) A Voronoi diagram (shaded grey) is
constructed for the polygonal shape of cell, i. (c) Cell-vertex model, where
the cell shape is defined by the cell’s vertices. Vertex imoves in response to
size and the shapes of the surrounding cells 1,2 and 3, with areas A1, A2, A3
and lengths L1, L2, L3 from vertex i to vertices 1, 2, 3 respectively.
It is important to point out that, althoughmost of the above (cell-centre and cell-vertex)
models were proposed to describe the movement of cells in sheets, cells of different
types can sort out due to differing intrinsic properties, such as surface adhesivity. This
led to the theory of differential adhesion and energy minimisation [237] and has been
extended [78] into a Potts-type model.
1.3.4.4 Cellular Potts models
The Glazier-Graner-Hogeweg (GGH) model, also known as the Cellular Potts Model
(CPM) [78], is a lattice-based approach where each cell is represented by many lattice
sites, allowing physical characteristics including cell shape, surface area and volume to
be modelled directly, in contrast to cellular automata [51] where each cell is represented
by a single lattice site. The model configuration depends on an overall effective energy
(or Hamiltonian) that is minimised as the systems evolves. Further details on the CPM
approach are given in Chapters 4 and 5, and below we briefly present some examples
of CPM applications which are related to those two Chapters.
In [155], Merks et al. used a CPM to demonstrate that cell elongation, in conjunction
with autocrine secretion of a chemoattractant, suffices to form vascular-like morpholo-
gies and subsequent remodelling by ECs. The model results showed that reducing cell
elongation below a critical cell length results in elimination of the vascular-like shapes.
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Therefore, the authors concluded that an elongated cell shape is key for the spatiotem-
poral behaviour of the model, and they suggested that mechanism for in vitro vasculo-
genesis.
In [157], Merks et al. used a CPM to present the ‘contact-inhibited’ chemotaxis mecha-
nism which can produce networks (without incorporating cell-autonomous elongation
as in [155]) both from dispersed ECs and EC clusters without requiring long-range
guidance cues. That is, ECs secrete a chemoattractant and preferentially extend pseu-
dopods up gradients of the chemoattractant, unless contact-inhibition locally prevents
chemotactic pseudopod extension. They also investigated how sprouting depends on
the sensitivity of cell-ECM interaction. If that sensitivity is above a threshold the cords
become thinner and longer with cords consisting of only one cell (otherwise, vascular
cords are two cells wide).
In [14], Bauer et al. investigated the roles of EC-EC and EC-ECM interactions during the
onset of angiogenesis, when the newly formed sprouts consist of only a few cells. It was
the first cell-based model of tumour-induced angiogenesis to incorporate extracellular
and intercellular environments, by utilising the advantages of both discrete and con-
tinuous modelling. This model incorporates ECs, ECM, as well as VEGF dynamics. At
the extracellular level, a PDE describes diffusion, uptake, and half-life decay of tumour
secreted VEGF. At the cellular level, a CPM is used to simulate cell migration, growth,
proliferation, cellular adhesion, and ECM degradation. The extra and intercellular en-
vironments directly impact on each other. The resulting morphology of the capillary
sprout is determined by several mechanisms: tip cell migration up spatial gradients
of VEGF and adhesion gradients, cellular adhesion to the ECM, and competition for
space. Moreover, it was shown that interplay between haptotaxis and chemotaxis can
result in EC elongation, a characteristic shape for migrating cells, without needing a
rule to prescribe an elongated cell shape as in [155]. Finally, the authors assumed that
branch splitting resulted from ECM inhomogeneities.
In [241], Szabo et al. used a CPM to model the patterning processes relying on the
hypothesis that multicellular patterning is the result of elongated cell-guided motility,
with each cell having a measure of anisotropy (directionally dependent). Firstly, they
showed that close contact with elongated cells indeed enhances and guides cell motil-
ity. Secondly, that cell density determines the interconnectedness of the structure, and
it also influences the characteristic pattern size (e.g. at very low cell densities, no mul-
ticellular structures were present). The cell density was measured as volume fraction
- the ratio of the area covered by cells and the overall simulation area. For example,
at densities higher than 55%, the linear structures gradually disappear. At densities
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under 20%, there were not enough cells to form interconnecting clusters. Additionally,
the cell shape was found to be determined by the relative balance of surface tension
and anisotropic bias: if anisotropic bias dominates, individual cells become extremely
elongated. Note that if the cell is circular, then it is regarded as isotropic.
In [250], Turner and Sherratt used a CPM to simulate cancer cell invasion. The model
incorporated the effects of cell-cell and cell-ECM adhesion (factors which are known
to be very important in cell migration), as well as migration in response to haptotactic
gradients created by proteolysis. The results reproduced the finger-like protrusions
from the main cell mass that are observed in malignant tumours. Also consistent with
biological theory and observations, the most invasive phenotype was found to be low
cell-cell adhesion and high cell-ECM adhesion, combinedwith high proteolytic activity.
The effects of including cell proliferationwere also examined. Somewhat unexpectedly,
the addition of cell proliferation, for certain parameter values, decreased the invasion
rate. The authors suggested that this was because the increased number of cells made
it more difficult for the leading cells to completely detach from the main cell mass, as
happened in the case without proliferation.
In [227], Shirinifard et al. presented a 3-D CPM of tumour growth and tumour induced
angiogenesis with simulations focused on gettingmore insight in differences in tumour
growth with or without angiogenesis. The model was able to distinguish between sev-
eral cell types: normal, hypoxic, necrotic, vascular and neo-vascular cells. If VEGF
concentrations exceed a certain threshold, ECs are activated, proliferate and move to-
wards VEGF gradients. The neo-vascular cells were contact-inhibited if the common
surface area with other neo-vascular cells is above a threshold. If less, the cells grow
with a rate related to the VEGF concentration, and divide if double in volume. To al-
low the formation of vascular networks, the model used the autocrine chemotaxis as
described in [155].
1.3.4.5 Lattice and off-lattice multi-agent models
In [16], Bentley et al. used a 3-D multi-agent lattice model for the Notch-mediated tip
cell selection in angiogenic sprout initialisation without incorporating cell migration
and proliferation. Remark that the Notch signalling pathway is responsible for cell
fate decisions (e.g. transition between stalk and tip cells). The model identified both
VEGFA concentration and gradients, and filopodia extension as critical factors in de-
termining the robustness of tip-stalk (checkerboard-like) patterning. It was shown that
increased VEGFA levels as found in many diseases can cause the delayed response
from Notch signalling and result in abnormal oscillations of tip-stalk cell fates.
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In a subsequent model, Bentley et al. in [17] explored the system dynamics as Notch
signalling is integrated with tip cell migration and fusion, but again without incorpo-
rating cell proliferation. The fusing tip cells become inhibited and neighbouring stalk
cells flip fate. In pathological conditions, when VEGF is high (e.g. 10 times bigger than
the normal level) it leads to sheet formation of multiple tip cells. Regarding cell-cell
junction sizes on tip cell selection, results showed that if average junction size is in-
versely proportional to the VEGF level, then normal selection is possible, regardless of
the VEGF level.
1.3.4.6 Particle models
In this section we briefly refer to a different group of models where a cell is treated as
a particle or a group of particles in the absence of an underlying grid.
In [158], Milde et al. presented a 3-D hybrid model of sprouting angiogenesis, which
considered explicitly the effect of the ECM and of the soluble as well as matrix-bound
VEGF on capillary growth. Stalk cells and molecular species (VEGF, MMPs and fi-
bronectin) are described as densities (using PDEs), whereas tip cells are represented
as particles in a discrete, agent-based model. They have shown that the structure and
density of the ECM has a direct effect on the morphology, expansion speed and num-
ber of branches. That is, simulation results demonstrated an increase in the number
of observed branches for an increase in both the amount of distributed VEGF ‘pock-
ets’ (cavities) in the numerical domain, and the level of VEGF at pocket location. In
other words, the pockets of VEGF located in the ECM induced strong chemotactic cues
and, therefore, the probability of sprout tips hitting a pocket was increased for a higher
pocket density, leading consequently to an increase in branching.
In [166], Neuman introduced a 3-Dmodel of interactingmulticellular systems, inwhich
the fundamental objects were not cells, but subcellular elements. The main objective
was the assessment of cell shape as it emerges from cellular interactions. That was at-
tempted by subdividing each cell into a number of subcellular elements. Both the intra
and intercellular dynamics are written in terms of interactions between these elements.
The dynamics of the elements are described by stochastic differential equations. The
three dynamical contributions to a given element’s motion are: (i) a weak stochastic
component, (ii) local biomechanical interactions with other elements within the same
cell, and (iii) local biomechanical interactions with elements in nearby cells.
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1.3.4.7 Modelling environments
In the last decade, several groups tried to incorporate different types of models in a
modelling environment, and below we present only some of the most widely used
ones:
• CompuCell3D (CC3D) [78] is based on the Cellular Potts Model (CPM). The Potts
model was originally developed to study ferromagentic and crystalline systems,
but later it was extended to study the coarsening of foam and sorting of biological
cells. CC3D is being used for studying foam morphogenesis, biofilms, cancer, as
well as many other biological and physical systems. Tissue Simulation Toolkit is
a two-dimensional library for the CPMwhich is mainly used for tissue patterning
and developmental mechanisms.
• FLAME [92] is an agent-based modelling system which can be used to devel-
opment applications in many areas. Some of the projects that use FLAME are:
Epidermis, Sumo2 (bacteria modelling), Epitheliome. In particular, Epitheliome
[256] explores the development of structure and function in epithelial tissues. It
is also used in many other areas such as urothelial tissue, wound healing in skin
etc. Its rule-based structure is adopted from Stekel et al. [238] a work on epithelial
tissue, and it has been extended by including more detailed hierarchies of control
(e.g. intracellular signalling pathways involved in cell-cycle control).
• Chaste [186] is a cell-based framework which supports the simulation of cell pop-
ulations using cell-centre (with connectivity defined either by a Voronoi tessella-
tion or ‘overlapping spheres’), cell-vertex, or the CPM approach. Chaste has also
been used in various applications such as cancer, and heart modelling, crypt for-
mation, bacterial biofilm formation etc.
• Virtual Cell (VCell) [211] is a computational environment for modelling and sim-
ulation of cell biology. The VCell is an application that is used over the internet.
Users can build models with a web-based Java interface to specify compartmen-
tal topology and geometry, molecular characteristics, and relevant interaction pa-
rameters. The VCell automatically converts the biological description into a cor-
responding mathematical system.
• iDynamics [129] (biofilms), VirtualLeaf [156] (plant tissue morphogenesis), Cell-
SyS [90] (off-lattice simulation of growth and organization processes in multi-
cellular systems in 2D and 3D).
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Having provided an overview of the main types of mathematical modelling in tissue
growth and angiogenesis, below we provide a summary, and in the next Chapter, our
ODE model on the growth of the bovine CL will be presented.
1.3.5 Summary
A fundamental issue in modelling cell populations is that of scale. One is typically
interested in systems composed of a single cell to many millions of cells (e.g. tissue,
organ). At the most coarse-grained level one erases cell identity and uses continuous
cell densities. At the next finer scale, cells within the population are modeled as dis-
crete objects. The type of modelling approach (or combination thereof) that is used to
simulate tissue growth or a particular aspect of angiogenesis is usually selected based
on the question that the model seeks to address and the types of available data with
which to construct the model.
As discussed earlier, the corpus luteum is a heterogeneous tissue and its growth is
highly angiogenesis-dependent. In Chapter 2, we present an ODE model in an attempt
to understand the CL growth as a continuummedium rather than working at the reso-
lution of its individual cells.
In Chapter 4, we seek to assess the dynamics of interactions between the two main vas-
cular cell types (endothelial cells and pericytes), and in Chapter 5, wemodel angiogenic
sprout formation. Since both aspects (cell-cell interactions and sprouting) involve only
a few cells, cell-based models are more appropriate, as attention is focused on the level
of an individual cell. Particularly, the Potts framework is a good basis and appropriate
for these applications since it explicitly accounts for cell shape and more importantly
cell-cell adhesion.
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An ODE model for the early growth
of the bovine corpus luteum
2.1 Introduction
The corpus luteum (CL) is an ovarian tissue created by follicular ovulation, and pro-
duces the progesterone needed for pregnancy. Rapid growth of the CL requires angio-
genesis, the creation of new blood vessels from pre-existing ones, a process which is
regulated by proteins that include fibroblast growth factor 2 (FGF2). Inadequate angio-
genesis has been linked to infertility in cows.
In this Chapter we develop a time-dependent ordinary differential equation (ODE)
model for the CL growth. The dependent variables represent FGF2, endothelial cells
(ECs), luteal cells (LCs), and stromal cells (like pericytes (PCs)), by simply assuming
that the CL volume is a continuum of the three cell types.
We assume that if the CL volume exceeds a threshold value, then cell growth is inhib-
ited. We define the discontinuity boundary to be the surface at which the volume thresh-
old is attained. This threshold separates the model into two different cases; therefore,
the model is analysed as a Filippov (piecewise smooth) system.
To investigate the importance of angiogenesis on CL growth we determine how the
system dynamics change as ρ5, the maximal EC proliferation rate, is varied.
We found that a weak (low ρ5) or strong (high ρ5) angiogenic environment implies
a ‘pathological’ CL growth, since the loss of CL constituents (specifically, LCs which
produce progesterone) compromises pregnancy. However, for intermediate values of
ρ5, a normal CL growth (with all its cellular components being present) is maintained,
which is necessary to sustain a healthy pregnancy.
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LUTEUM
2.2 Biological background
As has been described in Chapter 1, the corpus luteum (CL) is the tissue which devel-
ops from an ovarian follicle during the luteal phase of the oestrous or menstrual cycle
(see Figure 1.2). The CL (mainly LCs [108]) secretes progesterone which regulates the
length of the oestrous cycle and is essential for maintenance of pregnancy. Inadequate
progesterone secretion is a major cause of early embryonic mortality [108]. Therefore,
‘impaired angiogenesis’ in the CL could result in poor embryonic development and
infertility.
It is now well established that angiogenesis plays a key role in the growth and function
of the CL [197, 199]. The extensive vascularisation of the CL enables it to receive one of
the highest blood flows per unit tissue mass and to supply the nutrients needed for its
high metabolic rate [65, 197]. The capillary network of the mature CL is so dense that
most LCs are adjacent to one or more capillaries. This is perhaps not surprising, since
in several mammals most (up to 85%) cells that proliferate during CL growth are ECs
[198]. This enables the CL to grow at a rapid rate (0.5 g to >5 g in 5 days [203]) that
is only surpassed by the fastest growing tumours. Such dramatic growth is essential if
sufficient progesterone is to be produced to support the developing embryo [201].
Angiogenesis in the CL is controlled by a plethora of angiogenic factors, including
vascular endothelial growth factor (VEGF), fibroblast growth factor 2 (FGF2) and the
platelet-derived growth factor (PDGF) family. In vitro results suggest that all three
growth factors are active regulators of CL angiogenesis [202]. These factors are thought
to have complementary rather than redundant actions in CL angiogenesis, since the ab-
sence of any one signal is sufficient to cause marked alterations in endothelial network
formation, and the remaining factors are unable to compensate for the loss of any other
factors [202]. These studies also demonstrate that the ECs in the CL are more sensi-
tive to FGF2 inhibition than any other growth factor. Furthermore, dynamic changes in
FGF2 concentration have been observed during the follicle-luteal transition (the point
before and after ovulation) in the cow, while VEGFA concentrations remained constant
[202]. Hence, in this study we focus on the role played by FGF2.
Although the mechanisms responsible for the development of the CL have been stud-
ied for several decades (for review, see [96]), no mathematical models of this process
have yet been developed. In the remainder of this section, we present data taken from
[145, 203] to motivate the model that we have developed.
Figure 2.1(a) shows how the FGF2 concentration in the CL changes in the 12 days that
follow oestrous. The surge in FGF2 that occurs during ovulation (days 1-2) [203] is fol-
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lowed by a rapid decrease until FGF2 levels settle to a steady value. The rapid change
in FGF2 levels during the first two days coincides with the initiation of angiogenesis in
the early CL.
Figure 2.1(b) shows how the CL increases rapidly in size during the early and mid-
luteal stages of the oestrous cycle [145]. In the absence of data for the LCs we anticipate
that their volume is proportional to that of the CL.
Figure 2.1(c) shows how the total area of von Willebrand factor (VWF; EC marker) in
CL changes over time [127], which is an indication of the changes on the EC numbers.
Additionally, in Figure 2.1(d) the presence of PCs and/or smooth muscle cells is indi-
cated by the total area of smooth-muscle actin (SMA; PC marker) in CL [127].
(a) (b)
(c) (d)
Figure 2.1: A series of plots showing the profiles of: (a) FGF2 concentration in the CL
[203], (b) CL size (diameter) [145], (c) total endothelial cell area in the CL
[127], and (d) total pericyte cell area during CL development (days 1 (ovu-
lation) to 12 (mature CL)) [127]. The data are mean + S.E.M.; significant dif-
ferences between groups are indicated with a<b<c; P<0.05. Key: the Von
Willebrand Factor (VWF) and Smooth Muscle Actin (SMA) are endothelial
and pericyte markers, respectively.
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The main objective of this work is to develop a model that reproduces existing experi-
mental data, and that can be used to explore the dependence of normal and pathologi-
cal behaviours on parameter values.
The remainder of the Chapter is organised as follows. We present the model overview
in section 2.3, the different types of steady states in section 2.4, and we proceed in
section 2.5 by identifying regions of parameter space in which the steady states are
physiologically realistic. We devote section 2.6 to describe how the evolution of the
CL is affected by varying the ‘angiogenic’ parameter along with the robustness of our
results to parameter values. The Chapter concludes in section 2.7 where we summarise
our results.
2.3 Model overview
2.3.1 The mathematical model
In this section, we develop an ordinary differential equation (ODE) model for the time
evolution of the CL in which the dependent variables represent the volumes of ECs,
LCs, and all other stromal cells (such as PCs). We denote by F(t) the concentration
of the growth factor, FGF2, and the volumes of the ECs, LCs, and stromal cells by
E(t), L(t) and R(t), respectively.
We postulate that CL growth is regulated by endothelial (E) and stromal cell (R) di-
vision, volumetric growth of LCs (L), and also by the FGF2 contribution as explained
below.
2.3.1.1 Growth factor FGF2, F(t)
Guided by the results described in section 2.2 and following [203], we assume that ECs
produce FGF2 at a constant rate, a1, and LCs produce it at a rate which peaks during
the two days that follow ovulation (see Figure 2.2).
As described in Chapter 1 (section 1.2.4), following the disassembly of the theca vascu-
lature after ovulation, there is extensive EC proliferation and migration to the granu-
losa region in order to re-establish connections with other endothelial and luteal cells.
The reconnection of ECs coincides with a decrease in FGF2 concentration [202]. There-
fore, we hypothesize that there should be some form of feedback mechanism between
ECs and LCs; that is, when ECs attach to LCs, the latter decrease their rate of FGF2
production. Hence, we assume that the rate at which individual LCs produce FGF2 is
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Figure 2.2: Schematic illustration of FGF2 production during CL development. Dis-
tinct localisation for ECs and LCs over time (as described in [215]), and
quantification for FGF2 as described in [203], where FGF2 concentration
was highest during early CL development, further suggesting that FGF2 is
a key mediator of the initiation of angiogenesis [203].
a decreasing function of E/L:(
rate at which individual
LCs produce FGF2
)
=
a2
REL +
E
L
, (2.3.1)
where the dimensionless parameter REL is the value of E/L at which FGF2 production
rate (from LCs) is half-maximal. Note that the dependence on E/L becomes problem-
atic when L = 0, which corresponds to some of the ‘pathological’ steady states later in
the chapter.
Combining the above processes, we conclude that the evolution of FGF2 is given by:
dF
dt
= a1E+
a2L
2
RELL+ E
− dFF, (2.3.2)
where a1, a2, REL and dF are positive constants, with dF representing natural decay rate
of FGF2.
The equations that describe the dynamics of the three cell types are of the following
general form:
d
dt
(
cell
volume
)
=


rate o f volume
increase due to
cell swelling or
proli f eration

−


rate o f volume
loss due to
competition
f or space

 . (2.3.3)
We postulate that the CL is contained within an elastic membrane. The ECs and stro-
mal cells proliferate and increase in number, whereas LCs increase in volume, until
eventually the CL volume (V = E+ L+ R) occupies the cavity (V∗) left by the mature
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ovarian follicle after its rupture during ovulation. The surroundingmembrane then be-
comes taut and exerts a restraining force on the cells which, if sufficiently large, leads
to competition for space. We assume that this is the dominant mechanism for volume
loss within the CL so that for each cell type the rate of cell death can be written as:
(
rate o f
volume loss
)
= kCVH(V −V∗), (2.3.4)
where, C = E, L,R and k is a measure of howmechano-sensitive cells are. The equation
(2.3.4) implies that all cells are equally sensitive to competition for space. H is the
Heaviside step function (H(x) = 1, x > 0 and H(x) = 0, otherwise), which explicitly
assumes no cells experience contact inhibition of growth until the CL volume threshold
(V∗) is reached.
2.3.1.2 Endothelial cells, E(t)
The EC proliferation rate is taken to be an increasing, saturating function of FGF2. Then
equation (2.3.3) supplies
dE
dt
= kE
F
Fh + F
E− kEVH(V −V∗), (2.3.5)
where the positive parameter kE represents the maximal rate of EC proliferation, and
Fh is the FGF2 concentration at which EC proliferation is half-maximal.
2.3.1.3 Luteal cells, L(t)
We account for the dependence of LC swelling on nutrient levels [199] by assuming
that the LC swelling rate is an increasing, saturating function of E, so that
dL
dt
= kL
E
Eh1 + E
L− kLVH(V −V∗). (2.3.6)
In equation (2.3.6) the positive parameter kL is the maximal swelling rate of the LCs,
and Eh1 is the volume of ECs at which the swelling rate is half-maximal.
2.3.1.4 Stromal cells, R(t)
We assume that the evolution of all stromal cells is similar to that of the ECs and the
LCs, with
dR
dt
= kR
E
Eh2 + E
R− kRVH(V −V∗). (2.3.7)
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In equation (2.3.7) the parameter kR represents the maximal proliferation rate of the
stromal cells, and Eh2 is the volume of ECs at which proliferation of the stromal cells is
half-maximal.
Having presented the ODE model given in equations (2.3.2),(2.3.5)-(2.3.7), in the next
section we provide the estimates for the parameter values.
2.3.2 Estimation of parameter values
The phenomenological nature of the model makes it difficult to determine many of the
parameter values directly from biophysical considerations or by adapting values from
the literature, and in these cases plausible estimates have been used.
Guided by estimates of the in vitro maximal bovine aorta EC proliferation rates of the
order of 1 day(d)−1 [137], we suppose initially that the maximal growth rate of all cell
types are identical so that kE = kL = kR, and later explore the consequences of relaxing
this assumption.
Regarding the decay rate of FGF2, we fixed dF = 3 d
−1 since the half-life of FGF2 in the
human body is ∼ 8 hrs [15]. Concerning Fh, the FGF2 concentration at which the EC
proliferation rate is half-maximal, we chose F∗ (the steady level of FGF2) to be a typical
late level of FGF2 (see Figure 2.1(a)), so that Fh = F
∗ ≃ 50 ng.(cm3)−1. We remark that
in Figure 2.1(a) FGF2 has units ng/g tissue, but since the majority of tissues are water
then 1 g corresponds to 1 cm3.
A value of V∗ was estimated for the maximum CL volume, where above this the cells
are constrained by the outer membrane. From Figure 2.1(b), the steady value for the
CL diameter is approximately 2.5 cm and, therefore, V∗ ≃ 43piR3 ≃ 8.2 cm3. In [263],
Wiltbank reviewed the morphological characteristics of the main cell types of the CL in
ruminants. In the mid-cycle bovine CL, small and large steroidogenic (luteal) cells con-
stitute approximately 68% of the CL volume, the ECs approximately 13%, and there-
fore, the other cell types account for the remaining 19% of the total volume. Therefore,
we assume that the volumes of ECs at which the swelling rate of LCs and stromal cells
is half-maximal are identical. That is, Eh1 = Eh2 ≃ 13%V∗ = 1.07 cm3.
The above statement further implies that the characteristic proportion of ECs and LCs is
ECs:LCs=13:68. Therefore, an estimate for the parameter REL, the value of E/L at which
FGF2 production rate (from LCs) is half-maximal was obtained. That is, REL = 0.19.
The methods for estimating the parameters a1 and a2, and the parameter k are enumer-
ated below as methods (Ia) and (Ib), respectively.
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(Ia). To estimate a1 and a2, we assume a steady state F˙=0, and solve for a1 when there
are no LCs, and solve for a2 when there are no ECs. Then, for a1, F˙ = a1E − dFF,
gives a1 = dF
F
E ≃ dF F
∗
E∗ ≃ dF F
∗
0.13V∗ ≃ 3∗501.1 ≃ 136. For a2, F˙ = a2 LREL − dFF, gives
a2 ≃ dFREL FL ≃ dFREL F
∗
L∗ ≃ dFREL F
∗
0.68V∗ =
3∗0.19∗50
5.6 ≃ 5.1.
(Ib). To estimate the parameter k, the strength of the tissue constraint to the cell growth
or proliferation, we assume a steady state E˙=0 by taking the limiting case where FGF2
is sufficiently high (F∗ ≫ Fh). Therefore, E˙ = 0⇒ kEE = kEV ⇒ k = kEV ≃ kEV∗ ≃ 0.12.
A list of the model parameters and their units are summarised in Table 2.1. Before
proceeding with our investigation of equations (2.3.2),(2.3.5)-(2.3.7), it is appropriate to
nondimensionalise and, in so doing, to reduce the number of system parameters.
Table 2.1: Dimensional parameter values used in equations (2.3.2),(2.3.5)-(2.3.7).
Parameter Value Unit Reference
a1 136 ng.(cm
3)−2.d−1 estimated
a2 5.1 ng.(cm
3)−2.d−1 estimated
k 0.12 (cm3)−1.d−1 estimated
dF 3 d
−1 [15]
kE 1 d
−1 [137]
kL 1 d
−1 [137]
kR 1 d
−1 [137]
Fh 50 ng.(cm
3)−1 estimated
Eh1 1.1 cm
3 estimated
Eh2 1.1 cm
3 estimated
V∗ 8.2 cm3 estimated
REL 0.2 - estimated
2.3.3 Nondimensional model
Wenondimensionalise equations (2.3.2),(2.3.5)-(2.3.7) by choosing F(t)=Fh Fˆ(tˆ), E(t)=V
∗Eˆ(tˆ),
L(t)=V∗ Lˆ(tˆ), R(t)=V∗Rˆ(tˆ) and t= tˆkV∗ , where, Fˆ, Eˆ, Lˆ, Rˆ are the dimensionless depen-
dent variables and tˆ is the dimensionless time. By substituting for F, E, L, R and t, in
(2.3.2),(2.3.5)-(2.3.7) we obtain the following dimensionless equations (hats have been
dropped for notational convenience):
dF
dt
= ρ1E+ ρ2
L2
ρ3L+ E
− ρ4F, (2.3.8)
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dE
dt
= ρ5
F
1+ F
E− EVH(V − 1), (2.3.9)
dL
dt
= ρ6
E
ρ7 + E
L− LVH(V − 1), (2.3.10)
dR
dt
= ρ8
E
ρ9 + E
R− RVH(V − 1), (2.3.11)
where V = E+ L+ R, and the dimensionless parameters are given by:
ρ1 =
a1
kFh
, ρ2 =
a2
kFhV∗
, ρ3 = REL, ρ4 =
dF
kV∗ , ρ5 =
kE
kV∗ ,
ρ6 =
kL
kV∗ , ρ7 =
Eh1
V∗ , ρ8 =
kR
kV∗ , and ρ9 =
Eh2
V∗ .
(2.3.12)
The dimensionless parameter values used to generate the numerical simulations in
section 2.3.5 were obtained by using equation (2.3.12) and the dimensional values from
Table 2.1:
ρ1 = 23, ρ2 = 0.1, ρ3 = 0.19, ρ4 = 3, ρ5 = 1,
ρ6 = 1, ρ7 = 0.13, ρ8 = 1, ρ9 = 0.13.
(2.3.13)
2.3.4 Initial conditions
As mentioned in section 2.3.2, in the mid-cycle CL, LCs comprise approximately 68%
of the bovine CL volume, the ECs approximately 13%, and the other cell types account
for the remaining 19% of the total volume [263].
In vivo, it can be difficult accurately to define the boundary of the CL immediately post
ovulation as the CL can have a similar ultrasonographic appearance to the rest of the
ovarian stroma. However, within 24 hrs the boundaries of the CL can be accurately
determined and based on this we have estimated the diameter of the CL to be 8 mm on
day 1, resulting in V(t = 1) ≃ 43piR3 = 0.27 cm3. We close equations (2.3.8)-(2.3.11) by
imposing the following initial conditions:
F(0) = 4.0, E(0) = 0.04, L(0) = 0.18, R(0) = 0.05, (2.3.14)
with F(0) estimated from Fig 2.1(a) and the value of Fh (as stated in Table 2.1) since
F(t)=Fh Fˆ(tˆ).
2.3.5 Typical numerical results
The Heaviside step function that appears in equations (2.3.9)-(2.3.11) introduces a dis-
continuity into the right-hand sides of equations (2.3.9)-(2.3.11) at V = 1 (the ‘disconti-
nuity boundary’ [20]), making the system piecewise-smooth (PWS) [20, 58].
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There is a wide variety of numerical methods for solving ODEs and many of them
are routinely used in established software (e.g. MATLAB), where most of these algo-
rithms require that the ODEs are smooth. However, in PWS systems constrained mo-
tion along a discontinuity boundary is possible and requires special treatment numeri-
cally. Furthermore, from a dynamical systems of view what characterises PWS systems
is that they can not only undergo standard bifurcations (e.g. Hopf bifurcations) but
also non-smooth transitions. We solve the system given in equations (2.3.8)-(2.3.11) us-
ing Piiroinen’s method [185], where the time and location of any non-smooth events
are resolved as accurately as possible.
In Figure 2.3 we plot the evolution of F, E, L,R and V for a typical simulation. These
results are in good qualitative agreement with the in vivo data presented in Figure 2.1.
In equations (2.3.9)-(2.3.11) the loss terms switch onwhenV increases above the thresh-
old V = 1. This transition occurs at time t∗ (Figure 2.3) where, in biological terms, t∗
delineates the shift from the early-mid to the mid-late CL developmental stage. For
t < t∗ and V < 1 the cells do not experience any growth constraints (Figure 2.3(b)). In
contrast, for t > t∗ CL volume remains constant (V = 1) and the volumes of the cells
evolve subject to this constraint (Figure 2.3(b)).
Figure 2.3: Profiles of (a) the FGF2 concentration, F(t), and (b) the CL volume, V(t) =
E(t) + L(t) + R(t). The numerical results were obtained by solving equa-
tions (2.3.8)-(2.3.11) subject to the initial conditions (2.3.14) and the param-
eter values in equation (2.3.13). Note that ρ5 = 1.
In Chapter 1 and also at the beginning of this Chapter we referred to the importance
of angiogenesis in the CL growth and, therefore, we proceed to check the evolution
of the CL under different angiogenic situations. In particular, we vary ρ5, the maxi-
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mal EC proliferation rate. Figures 2.4(a)-(b) show the evolution of E, L,R and V (as in
Figure 2.3(b)) in low and high ρ5 = 2, respectively. In Figure 2.4(a) (low ρ5 - weak an-
giogenesis) the system evolves to an avascular steady state with E = 0 and, therefore,
V ≃ L+ R = 1. In Figure 2.4(b) (high ρ5 - strong angiogenesis) both L and R diminish
and V ≃ E > 1. Both steady states (with low or high ρ5) are regarded as ‘pathological’
since at least one of the three cell types diminish and, thereby, compromise CL growth
and subsequently a healthy embryo development. However, the steady state in Figure
2.3 (with intermediate value of ρ5) is regarded as a ‘healthy’ situation since all of the
cell types exist.
(a) ρ5 = 0.5; E = 0,V = 1 (b) ρ5 = 2; L = R = 0,V > 1
Figure 2.4: Profiles of the CL volume, V(t) = E(t) + L(t) + R(t), with (a) low and (b)
high ρ5 (the maximal EC proliferation rate) or equivalently in low and high
angiogenic environment. In (a) the system evolves to an avascular steady
state (E = 0) withV = 1, whereas in (b) L = R = 0 andV > 1. The absence
of any of the cell types (E, L,R) within the CL tissue may compromise a
healthy embryo development and, therefore, both cases are regarded as
‘pathological’.
2.3.6 A simplified model
Equations (2.3.8)-(2.3.11) define a fourth order system of ODEs, whose trajectories are
difficult to visualise in phase space. Before proceeding to an analysis of the full model,
we consider the case for which L ≡ R ≡ 0, and, V ≈ E so that equations (2.3.8)-(2.3.11)
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reduce to the following pair of ODEs:
FGF2 :
dF
dt
= ρ1E− ρ4F,
CL volume :
dE
dt
= ρ5
F
1+ F
E− E2H(E− 1).

 (2.3.15)
The behaviour of equations (2.3.15) depends on whether E < 1 or E > 1, giving two
forms of behaviour separated by the boundary E = 1 as explained below.
2.3.6.1 Phase plane analysis and steady states
Simple insight into the dynamics of this model can be obtained by inspecting certain
nullclines. Figure 2.5 shows that the nullcline dFdt = 0 is a line N1 on which E =
ρ4
ρ1
F.
The second nullcline dEdt = 0 is a curve N2 on which E = ρ5
F
1+F (when E > 1), and it
consists of the coordinate axes F = 0 and E = 0 (when E < 1).
Interestingly, the discontinuity boundary E = 1 is shown to be attractive (see arrows in
Figure 2.5) from both sides (E < 1 or E > 1). That is, the trajectories evolve onto E = 1,
a behaviour called sliding [20]. We define sliding more fully in section 2.3.7.
Equations (2.3.15) admit two steady states (where dEdt =
dF
dt = 0): we denote by B0 the
trivial solution (F, E) = (0, 0) and by B1 the nontrivial solution (F, E) = (Γ,
ρ4
ρ1
Γ), where
Γ = ρ1ρ5ρ4 − 1. The state B1 exists when E > 1, or equivalently
ρ5 > ρ
∗
5 :=
ρ4
ρ1
+ 1. (2.3.16)
Figures 2.5(a)-(b) show that when ρ5 ≪ ρ∗5 or ρ5 < ρ∗5 sliding states are attracted to-
wards a point B1s at which (F, E) = (
ρ1
ρ4
, 1), where the competing flows from E > 1
and E < 1 are equal and opposite. This point is called a pseudo-steady state (or pseudo-
equilibrium [20]). As ρ5 increases through ρ5 = ρ∗5 , the steady B1s approaches the point
where N1 crosses E = 1 at (
1
ρ5−1 , 1), then B1s vanishes, and B1 appears at the same point
and detaches from E = 1 into the region E > 1 (Figure 2.5(c)).
2.3.6.2 Conclusions from the simplified model
In summary, for ρ5 > ρ
∗
5 equations (2.3.15) evolve to a steady state B1 for which E > 1
(Figure 2.5(c)), while for ρ5 < ρ
∗
5 the system evolves to a pseudo-steady state which is
not a zero of (2.3.15), but lies on the discontinuity boundary E = 1 (Figures 2.5(a)-(b)).
Biologically, high ρ5 (high EC proliferation) implies a large CL, bigger than the wound
space formed after ovulation. Smaller EC proliferation implies a minimum size of the
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(a) ρ5 ≪ ρ∗5 (b) ρ5 < ρ∗5 (c) ρ5 > ρ∗5
Figure 2.5: Phase plane schematic diagrams for the simplified model (2.3.15) for dif-
ferent values of ρ5, where ρ
∗
5 as in equation (2.3.16). The sliding behaviour
occurs along the discontinuity boundary E = 1 towards the pseudo-steady
state, B1s. Key: N1 and N2 are the nullclines (solid or dashed curve if they
exist or not), where E = ρ4ρ1 F and E = ρ5
F
1+F , respectively. The points F1
and F2 lie at the intersections of N1 and N2 and the discontinuity boundary,
E = 1.
CL (V = V∗). Similar behaviour is expected in the full model, except that the compo-
sition of the CL is unclear. In the next section we investigate the existence of steady
states of the full model in more detail.
2.3.7 The full model as a Filippov system
We now express equations (2.3.8)-(2.3.11) in the form that is typically used for PWS (or
Filippov) systems, namely
dx
dt
=
{
f+(x), Θ(x) > 0,
f−(x), Θ(x) < 0,
(2.3.17)
by letting x = (F, E, L,R) ∈ R4 and defining
f+ := f− − (E+ L+ R) ·


0
E
L
R

 , (2.3.18)
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and
f− :=


ρ1E+ ρ2
L2
ρ3L+E
− ρ4F
ρ5
F
1+FE
ρ6
E
ρ7+E
L
ρ8
E
ρ9+E
R


, (2.3.19)
with Θ(x) = E + L + R − 1 = V − 1. The region of state space, D ⊂ R4, in which
equations (2.3.17)-(2.3.19) govern the system dynamics, can be partitioned into two
subregions, G+ and G− (see Figure 2.6), where
G+ = {x ∈ R4, Θ(x) > 0} and G− = {x ∈ R4, Θ(x) < 0}. (2.3.20)
The discontinuity boundary is a smooth hypersurface, Σ, given by:
Σ = {x ∈ R4, Θ(x) = 0}. (2.3.21)
Σ separates trajectories for which the CL growth is constrained (G+) from regions in
which the cells that constitute the CL grow without restriction (G−). Thus the model
is a nonlinear system with an ‘on-off’ feedback controller specified by the CL volume
(V).
Let the subscript x denote differentiationwith respect to x = (F, E, L,R), so that Θx(x) =
(0, 1, 1, 1) is the normal vector to Σ, and let 〈., .〉 denote the scalar product. Then con-
sider the quantity
〈Θx(x), f−(x)〉 = EΩ, (2.3.22)
where
Ω :=
ρ5F
1+ F
+
ρ6L
ρ7 + E
+
ρ8R
ρ9 + E
. (2.3.23)
The scalar product is strictly non-negative since F, E, L,R are positive or zero (in a bi-
ologically realistic situation) and ρi > 0 for all i. This means that f
− always points
towards Θ = 0, so the discontinuity boundary V = 1 is attractive with respect to G−
(‘attractive from below’, as was the case for the 2D model in section 2.3.6).
Depending on whether f+ points towards or away from the discontinuity boundary,
two kinds of motion are now possible when Θ = 0. These are known as crossing or
sliding, and occur when the quantity
〈Θx(x), f+(x)〉 = EΩ− 1 (2.3.24)
is positive or negative respectively, as we now describe. If 〈Θx(x), f+(x)〉 > 0, then
the vector field f+ points away from Σ, implying that trajectories evolve from G− to
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G+ by crossing Σ. Otherwise, f+ points towards Σ, so that the discontinuity boundary
attracts trajectories from both G+ and G−, and solutions must slide along Σ. When
sliding occurs, the CL volume remains fixed at the threshold value, V∗ = 1. We denote
the sliding region by Σˆ (see Figure 2.6), where
Σˆ =
{
x ∈ Σ, 0 ≤ EΩ ≤ 1
}
. (2.3.25)
Its boundaries are given by
∂Σ+ :=
{
x ∈ Σ : EΩ = 1
}
and ∂Σ− :=
{
x ∈ Σ : EΩ = 0
}
. (2.3.26)
On these surfaces the flow is tangent to the discontinuity boundary: at ∂Σ+ the condi-
tion EΩ = 1 means f+(x) is tangent to Σ, while at ∂Σ− the condition EΩ = 0 means
f−(x) is tangent to Σ.
G+ 
G- 
ɇ ɇ 
Figure 2.6: The phase space topology of a system with discontinuous vector fields
(Filippov system). The discontinuity boundary, Σ, separates the phase
space into two regions (G+,G−), and each region is governed by a different
smooth vector field (f+(x), f−(x)). Solutions of equations (2.3.17)-(2.3.19)
attracted to the sliding region (dark grey) Σˆ follow a constrained motion
on Σ.
2.3.7.1 Regular and sliding solutions
Using the above decomposition, we construct solutions of system (2.3.17) by consider-
ing separately regular solutions in G± and sliding solutions on Σ. Following Filippov
[124], we introduce g(x), a convex combination of the two vectors f±(x),
g(x) = λ(x)f+(x) + (1− λ(x))f−(x), 0 ≤ λ ≤ 1, (2.3.27)
for each nonsingular point in the sliding region, e.g. x ∈ Σˆ such that
〈Θx(x), f−(x)− f+(x)〉 6= 0. The function λ is defined as
λ(x) =
〈Θx(x), f−(x)〉
〈Θx(x), f−(x)− f+(x)〉
= EΩ, (2.3.28)
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so that g(x) is everywhere tangent to Σˆ. We then add the equation
x˙ = g(x), x ∈ Σˆ, (2.3.29)
to the system (2.3.17), thus extending its definition to include the sliding region. So-
lutions of (2.3.29) are called sliding solutions, and g(x) is called the sliding vector field
[20]. For (2.3.29) we have:
g(x) =


ρ1E+ ρ2
L2
ρ3L+E
− ρ4F
ρ5
F
1+FE− E2Ω
ρ6
E
ρ7+E
L− ELΩ
ρ8
E
ρ9+E
R− ERΩ


. (2.3.30)
Solutions are then defined in the following way:
Definition 5.1. A regular orbit is a smooth trajectory of the system (2.3.17), which
does not cross the discontinuity boundary (Σ). A sliding orbit is a smooth trajectory
of (2.3.29), that lies on the discontinuity boundary. An orbit will generally refer to a
continuous curve x(t) that is a concatenation of regular and sliding orbits.
The crossing set x ∈ Σ\Σˆ is defined as the set of all points x ∈ Σ for which the two
vectors, f±(x) , have nontrivial transverse components to Σ. At these points a regular
orbit of (2.3.17) reaching x from G− concatenates with a regular orbit entering G+ from
x. At points in the sliding set, x ∈ Σˆ, a regular orbit of (2.3.17) reaching x from each
of G+ and G− concatenates with a sliding orbit inside Σˆ passing through x. All other
points on Σ belong to the sliding boundaries ∂Σ±, and can be treated as either sliding
or crossing points without ambiguity.
2.3.7.2 Different types of steady states
The different types of steady states that Filippov systems exhibit are summarised by
the following definitions.
Definition 5.2. A point x ∈ D is termed an admissible steady state of (2.3.17) if
f+(x) = 0 and Θ(x) > 0, or f−(x) = 0 and Θ(x) < 0. (2.3.31)
Alternatively, a point x ∈ G± is termed a virtual steady state of (2.3.17) if
f+(x) = 0 but Θ(x) < 0, or f−(x) = 0 but Θ(x) > 0. (2.3.32)
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An admissible steady state x ∈ G± is a steady state of the system (2.3.17), while a virtual
steady state is a mathematical solution to the equations f± = 0 that is not a solution of
(2.3.17), for example, a point x ∈ G− where f+(x) = 0.
Definition 5.3. A point x ∈ D is termed a pseudo steady state if
g(x) = 0 and Θ(x) = 0. (2.3.33)
As for Definition 5.2, there may exist solutions to g(x) = 0 which are invalid because
x ∈ Σ\Σˆ. We distinguish such solutions as follows:
Definition 5.4. A pseudo steady state is termed admissible if 0< λ <1 and virtual if
λ < 0 or λ > 1, with λ as defined in (2.3.28).
For some parameter values, a steady state may lie on the discontinuity boundary. Since
f+ or f− vanishes there, we find that g also vanishes by (2.3.29), so that a steady state on
Σ always coincides with a pseudo steady state. Furthermore this occurs on the sliding
boundary where λ = 0 or 1. We define this as follows.
Definition 5.5. A point x ∈ D is termed a boundary steady state of (2.3.17) if
f+(x) = 0 and Θ(x) = 0, or f−(x) = 0 and Θ(x) = 0. (2.3.34)
2.4 Analytical results
In this section, our aim is to present the steady states in vector fields f±(x), which
will be indicated by a superscript ±, and those in the sliding vector field g(x) by a
superscript s.
The steady states in the regions G+ and G−, and in the sliding region Σˆ, satisfy the
following relations:
region steady state expression admissibility condition
G+ : f+(x) = 0 V ≥ 1 (2.4.1)
G− : f−(x) = 0 V ≤ 1 (2.4.2)
Σˆ : g(x) = 0 0 ≤ EΩ ≤ 1 (2.4.3)
In addition to the admissibility condition (see Definitions 5.2 and 5.4 in section 2.3.7.2),
each model variable F, E, L,R, must be positive for the steady state to be physically
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realistic. Recall that V = E + L + R, that Ω is given by (2.3.23), and that the vector
fields f+, f− and g are given by (2.3.18), (2.3.19) and (2.3.30), respectively.
In the following, we list all steady states that satisfy these conditions and in section
2.5 we translate criteria for solutions to be admissible and physically realistic into con-
straints on the parameters ρi (i = 1, ..., 9).
2.4.1 Steady states in G+
There are four steady states A+i = (F, E, L,R), i = 1, ..., 4 in G
+,
A+1 := E1 (φ(E1), 1,ψ(E1), ν(E1)− ψ(E1)− 1) , (2.4.4)
A+2 := E2 (ρ1/ρ4, 1, 0, η(E2)− 1) , (2.4.5)
A+3 := E3 (φ(E3), 1, ν(E3)− 1, 0) , (2.4.6)
A+4 := E4 (ρ1/ρ4, 1, 0, 0) , (2.4.7)
ν(E) :=
ρ6
ρ7 + E
, η(E) :=
ρ8
ρ9 + E
, φ(E) :=
ρ6
ρ5ρ7 + (ρ5 − ρ6)E , (2.4.8)
ψ(E) :=
ρ3ω(E) +
√
(ρ3ω(E))2 + 4ρ2ω(E)
2ρ2
, (2.4.9)
ω(E) := ρ4φ(E)− ρ1, (2.4.10)
E1 :=
ρ6ρ9 − ρ7ρ8
ρ8 − ρ6 , E2 =
ρ4ρ8 − ρ1ρ5ρ9
ρ1(ρ5 − ρ8) , E4 = ρ5 −
ρ4
ρ1
. (2.4.11)
and E3 solves the following cubic polynomial
ρ2(ν(E3)− 1)2 − ρ3ω(E3)(ν(E3)− 1)−ω(E3) = 0. (2.4.12)
For a physically realistic and admissible solution, we require all components of A+n ,
(n = 1, 2, 3 or 4) to be positive and the corresponding volume to be such that V =
E+ L+ R > 1. These lead to conditions on the parameters ρi given in section 2.5 (see
equations (2.5.1)-(2.5.10)).
Note also that all of the steady states in the vector field f+(x) are vascular, that is, they
have E > 0. If f+(x) = 0 and E = 0 then the only possible steady state has x = 0,
and V = 0. This is not an admissible steady state in G+, since V > 1 is required for an
admissible solution.
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2.4.2 Steady states in Σˆ
For each steady state solution (2.4.4)-(2.4.7) in G+, there is a similar steady state Asi =
(F, E, L,R), i = 1, ..., 4 in Σˆ,
As1 := E1
(
φ(E1), 1,ψ(E1),
1
E1
− ψ(E1)− 1
)
, (2.4.13)
As2 := E2
(
ρ1
ρ4
, 1, 0,
1
E2
− 1
)
, (2.4.14)
As3 := E
s
3
(
φ(Es3), 1,
1
Es3
− 1, 0
)
, (2.4.15)
As4 :=
(
ρ1
ρ4
, 1, 0, 0
)
. (2.4.16)
The functions φ and ψ are given by (2.4.8) and (2.4.9), and the constants E1, E2 by
(2.4.11), while Es3 solves the following cubic polynomial
ρ2(E
s
3 − 1)2 − ρ3Es3ω(Es3)(1− Es3)− Es3ω(Es3) = 0. (2.4.17)
The admissibility conditions associated with the steady states in G+ and Σˆ are pre-
sented in section 2.5 (see equations (2.5.11)-(2.5.16)).
2.4.3 Steady states in G−
Any state of the form
A− =
(
ρ2
ρ3ρ4
u, 0, u, v
)
, (2.4.18)
satisfies the steady state expression (2.4.2), and is physical and admissible over the
range 0 ≤ v ≤ 1− u and 0 ≤ u < 1− v. By varying u and v over these ranges, A−
forms a set of steady states lying in a planar surface Π−, given by
Π− =
{
(F, E, L,R) ∈ G− : F = ρ2
ρ3ρ4
L, E = 0
}
. (2.4.19)
In section 2.4.4.1, a stability analysis of the plane Π− reveals that it is not a global
attractor.
2.4.4 The 5th steady state in Σˆ
Where the plane Π− intersects the discontinuity boundary V = 1 (see Figure 2.7), it
forms a family of steady states of the sliding vector field that does not coincide with
any of the steady states Asn above. Thus any state of the form
As5 =
(
ρ2
ρ3ρ4
u, 0, u, 1− u
)
, (2.4.20)
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satisfies the steady state expression (2.4.3), and is physical and admissible provided
that 0 ≤ u ≤ 1. Note that E = 0 implies EΩ = 0, therefore from (2.3.26) we have
As5 ∈ ∂Σ−. Thus the states As5 do not lie on the discontinuity boundary (Σ), but on its
boundary ∂Σ−. Since u is a variable, the set of states As5 belongs to a line given by
Πs =
{
(F, E, L,R) ∈ ∂Σ− : F = ρ2
ρ3ρ4
L, E = 0, V = 1
}
, (2.4.21)
as shown in Figure 2.7. We remark that there are two limiting cases of equation (2.4.20)
which we denote by As5a = (0, 0, 0, 1) and A
s
5b = (
ρ2
ρ3ρ4
, 0, 1, 0), respectively.
A4
+ 
A1
s 
V=1 
Ʌ- 
A4
s 
A2
s 
A3
s 
A1
+ A2
+ 
A3
+ 
V<1 
V>1 
A1
s 
ɇ 
Ʌs 
Figure 2.7: Schematic illustration showing the three-dimensional projections of four-
dimensional (F, E, L,R) phase portraits. Steady states are presented for the
two different regions of phase space (V > 1 and V < 1) and the discon-
tinuity boundary, Σ : V = 1. The steady state As5 defines a 1-D manifold
(Πs) in the discontinuity boundary. Key: V = E+ L+ R is the CL volume.
2.4.4.1 Stability of the plane Π−
The stability of the plane Π− (as defined in (2.4.19) is of some importance being a
distributed object in the regions G− and Σˆ. It is also rather more simple to express,
requiring the calculation of stability in only two directions orthogonal to each other
and to the plane.
To determine whether Π− is an attractor we first take coordinates u1 = E, u2 = F− ρ∗L,
u3 = ρ∗F+ L, u4 = R, where ρ∗ =
ρ2
ρ3ρ4
. The ui form an orthogonal coordinate system,
since ∇ui · ∇uj = 0 for all i 6= j ∈ (1, 2, 3, 4) with ∇ =
(
d
dF ,
d
dE ,
d
dL ,
d
dR
)
. The u1 and u2
coordinate axes lie perpendicular to Π− (so Π− is the plane u1 = u2 = 0), while u3 and
u4 form a coordinate system over the plane Π
−.
The Jacobian of the u1, u2 system at u1 = u2 = 0 expresses the derivative of the flow
through Π−. Using u˙1 = E˙ and u˙2 = F˙− ρ∗ L˙, this is given by
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JΠ− =
(
∂u˙1
∂u1
∂u˙1
∂u2
∂u˙2
∂u1
∂u˙2
∂u2
)
|u1=u2=0
=

 ρ5u3ρ∗u3ρ∗+1+ρ∗2 0
ρ1 − ρ∗ ρ4ρ3 −
ρ6ρ
∗u3
ρ71+ρ∗2
−ρ4

 ,
with eigenvalues µ1 = −ρ4 and µ2 = ρ5u3ρ
∗
u3ρ∗+1+ρ∗2
. Note that µ1 < 0 since ρ
∗ > 0. Also
u3 = ρ∗F+ L > 0 given that F, L > 0, and therefore µ2 > 0.
As a result, the plane Π− is of ‘saddle type’, having one stable and one unstable direction.
Π− is therefore not a global attractor.
2.5 Admissibility conditions for the steady states
The admissibility conditions for the steady states in G+ and Σˆ as defined in section 2.4
are given below.
2.5.1 Conditions for the steady states in G+
2.5.1.1 Conditions for A+1
From equation (2.4.11) we deduce that E1 ≥ 0 if either
ρ9
ρ7
≤ ρ8
ρ6
≤ 1 or 1 ≤ ρ8
ρ6
≤ ρ9
ρ7
, (2.5.1)
where,
ρ8
ρ6
is the ratio of maximal growth rate of the stromal over luteal cells, and
ρ9
ρ7
is the ratio of half-maximal EC value of the stromal over luteal cells. Similarly, the
concentration of FGF2, F = E1φ(E1), is physically realistic if φ(E1) ≥ 0. That is,
φ(E1) ≥ 0 ⇔ ρ5ρ7 + E1(ρ5 − ρ6) ≥ 0
⇔ ρ5
ρ6
≥ E1
ρ7 + E1
⇔ ρ5 ≥ ρ6
ρ9
ρ7
− ρ8ρ6
ρ9
ρ7
− 1 , (2.5.2)
which places a lower bound on ρ5. The value of L is physically realistic if ψ(E1) ≥ 0
(⇔ ω(E1) ≥ 0), which implies
ρ5 ≤ ρ6(ρ4 + ρ1E1)
ρ1(ρ7 + E1)
, (2.5.3)
an upper bound to ρ5 (since E1 ≥ 0).
The value of R is physically realistic if ν(E1) − ψ(E1) − 1 ≥ 0. Substituting in the
expression for ψ (as in equation (2.4.9)) in terms of ω, implies
ρ2 (ν(E1)− 1)2 − ρ3ω(E1) (ν(E1)− 1) ≥ ω(E1) ≥ 0. (2.5.4)
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The admissibility condition for A+1 is simply that the volume V = V
+
1 satisfies
V+1 = E1ν(E1) =
ρ6ρ9 − ρ7ρ8
ρ9 − ρ7 ≥ 1. (2.5.5)
2.5.1.2 Conditions for A+2
The components of A+2 are non-negative if
E2 =
ρ4ρ8 − ρ1ρ5ρ9
ρ1(ρ5 − ρ8) ≥ 0, and η(E2)− 1 =
ρ8
ρ6
1
ρ9 + E2
− 1 ≥ 0. (2.5.6)
In particular, E2 ≥ 0 in two cases:
(i) 1 ≤ ρ5
ρ8
≤ ρ4
ρ1ρ9
, or (ii)
ρ4
ρ1ρ9
≤ ρ5
ρ8
≤ 1,
and η(E2)− 1 ≥ 0, iff
ρ5 ≥ 1
ρ1
(ρ4 − ρ1ρ9) + ρ8.
The admissibility condition for A+2 is that the volume V = V
+
2 satisfies
V+2 = E2η(E2) =
ρ4ρ8 − ρ1ρ9ρ5
ρ4 − ρ1ρ9 ≥ 1, (2.5.7)
noting that V+2 ≥ 0 is guaranteed by both cases (i) and (ii) above.
2.5.1.3 Conditions for A+3
The steady state A+3 is physically realistic if E3, φ(E3), and (ν(E3)− 1) are positive. The
solution for E3 as a root of the cubic polynomial (2.4.12) is unilluminating so we do not
present it here. We note, however, that (2.4.12) has real coefficients, hence it always
has at least one real root (since complex roots appear in pairs), but the root may not be
positive for all values of the parameters.
The admissibility condition can be written as
V+3 = E3ν(E3) =
ρ6E3
ρ7 + E3
≥ 1. (2.5.8)
2.5.1.4 Conditions for A+4
The steady state solution A+4 is physically realistic if E4 ≥ 0, implying ρ5ρ6 −
ρ4
ρ1
≥ 0 or,
as a condition on ρ5,
ρ5 ≥ ρ4
ρ1
. (2.5.9)
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The admissibility condition is
V+4 = ρ5 −
ρ4
ρ1
≥ 1 ⇔ ρ5 ≥
(
1+
ρ4
ρ1
)
. (2.5.10)
We now establish conditions under which the steady states Asn are physically realistic
and satisfy (2.4.3).
2.5.2 Conditions for the steady states on Σˆ
2.5.2.1 Conditions for As1
Because the first three components of As1 are the same as A
+
1 , the conditions (2.5.1)-
(2.5.3) ensure that E1, φ(E1), and ψ(E1) are positive. However, the condition for R to be
physically realistic becomes 1E1 − ψ(E1)− 1 ≥ 0. Substituting in the expression for ψ in
terms of ω, a little manipulation gives the condition
ρ2
(
1
E1
− 1
)2
− ρ3ω(E1)
(
1
E1
− 1
)
≥ ω(E1) ≥ 0. (2.5.11)
Now consider the admissibility condition 0 ≤ E1Ω ≤ 1. Note that E1Ω can be obtained
from the third component (L) of g(As1) from (2.3.30),
E1Ω =
ρ6E1
ρ7 + E1
,
and by substituting in E1 from (2.4.11), after a little rearranging the admissibility con-
dition becomes
0 ≤ ρ6ρ9 − ρ7ρ8
ρ9 − ρ7 ≤ 1. (2.5.12)
2.5.2.2 Conditions for As2
Physical values of As2 require E2 ≥ 0 and 1E2 − 1 ≥ 0, implying 0 ≤ E2 ≤ 1, which yields
0 ≤ ρ4ρ8 − ρ1ρ5ρ9
ρ1(ρ5 − ρ8) ≤ 1. (2.5.13)
There are two cases to consider from equation (2.5.13),
(i) ρ8 ≤ ρ5 ≤ ρ4ρ8ρ1ρ9 and ρ5 ≥
ρ8(ρ4−ρ1)
ρ1(1+ρ9)
, and
(ii)
ρ4ρ8
ρ1ρ9
≤ ρ5 ≤ ρ8 and ρ5 ≥ ρ8(ρ4−ρ1)ρ1(1+ρ9) .
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Now consider the admissibility condition 0 ≤ E2Ω ≤ 1. Note that E2Ω can be obtained
from the fourth component (R) of g(As1) from (2.3.30),
E2Ω =
ρ8E2
ρ9 + E2
.
Substituting in E2 from (2.4.11), the admissibility condition becomes
0 ≤ ρ4ρ8 − ρ1ρ5ρ9
ρ4 − ρ1ρ9 ≤ 1. (2.5.14)
2.5.2.3 Conditions for As3
For the state As3 to be physically realistic requires that the three quantities E
s
3, φ(E
s
3),
and 1Es3
− 1, are positive. As for A+3 , the cubic root solution for Es3 is unilluminating, but
we note that (2.4.17) always has at least one real root which need not be positive for all
values of the parameters.
The third (L) component of g(As3) from (2.3.30), yields
Es3Ω =
ρ6E
s
3
ρ7 + Es3
,
with which the admissibility condition can be written as
0 ≤ ρ6E
s
3
ρ7 + Es3
≤ 1, (2.5.15)
in terms of the cubic root Es3.
2.5.2.4 Conditions for As4
The condition for As4 to be physically realistic is simply E4 > 0, which provides a lower
bound to ρ5 as in equation (2.5.9). For the admissibility condition, note that by using
the second component (E) of g(As4), yields
E4Ω =
ρ5F
1+ F
=
ρ1ρ5
ρ1 + ρ4
and, therefore, the admissibility requires
0 ≤ ρ5 ≤ 1+ ρ4
ρ1
. (2.5.16)
2.5.3 Summary of the admissibility conditions
The admissibility conditions for A+n and A
s
n are summarised in Table 2.2. It is shown
that the ranges of existence of any two steady states labelled by the same n are mutually
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exclusive, except at boundaries where A+n and A
s
n coalesce on the switching boundary.
For example, A+3 and A
s
3 coincide when ν(E3) = 1/E3 (compare (2.4.6) to (2.4.15)) or,
equivalently, when
E3 = E
s
3 =
ρ7
ρ6 − 1. (2.5.17)
Note that for n = 3, ρ3∗5 evolves by substituting E3 from equation (2.5.17) in equation
(2.4.12).
Table 2.2: Admissibility conditions for steady states
steady state condition in G+ in Σˆ boundary
n = 1 ρ6ρ9−ρ7ρ8ρ9−ρ7 ≥ 1 ≤ 1 ρ6 = ρ∗6 := 1−
ρ7
ρ9
(1− ρ8)
n = 2 ρ4ρ8−ρ1ρ5ρ9ρ4−ρ1ρ9 ≥ 1 ≤ 1 ρ5 = ρ2∗5 := 1−
ρ4
ρ1ρ9
(1− ρ8)
n = 3 ρ6E3ρ7+E3 ≥ 1 ≤ 1 ρ5 = ρ3∗5
:=
(
1+ ρ4(ρ6−1)(ρ7+ρ3µ)
ρ2µ2+ρ1ρ7(ρ7+ρ3µ)
)
,
µ = ρ6 − (1+ ρ7)
n = 4 ρ1ρ5ρ1+ρ4 ≥ 1 ≤ 1 ρ5 = ρ4∗5 := 1+
ρ4
ρ1
2.6 Sensitivity analysis
Numerical solutions of a mathematical model for particular values of the system pa-
rameters can give some understanding of the dynamics associated with the model.
However, a more complete understanding relies on determining parameter values at
which the qualitative behaviour of these solutions change, i.e. bifurcations. (For a dis-
cussion of how to define bifurcations in piecewise-smooth systems, see [20]). An im-
portant characteristic of any bifurcation is its codimension - this is the number of param-
eters that need to be varied in order for the bifurcation to occur. In this section only
codimension one bifurcations are considered.
2.6.1 Steady state bifurcations at the discontinuity boundary
The composition and volume (V) of the CL vary as ρ5, the maximal rate of EC pro-
liferation, change for steady states n = 2, 3, 4 in Table 2.2. The bounds in this table
are examples of a particular class of discontinuity-induced bifurcations known as bound-
ary equilibrium bifurcations [21, 38]. As ρ5 passes through a bifurcation value ρ
j∗
5 (where
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j = 2, 3, or 4), a steady state A+j hits the discontinuity boundary and disappears, while
a sliding (pseudo) steady state Asj is created on the discontinuity boundary (or vice
versa). Since one steady state always persists through the bifurcation, this scenario is
classified as persistence. As an example, the persistence of As4 to A
+
4 as ρ5 increases
through ρ4∗5 is shown in Figure 2.8.
V 
 
 
ʌ5 
 
1 
 
 
A4
+ 
A4
s 
ʌ54* 
 
Figure 2.8: Schematic bifurcation diagram for CL volume, V = E+ L+ R, over ρ5 (the
maximal EC proliferation rate). It shows the persistence scenario associated
with a boundary equilibrium bifurcation (BEB) occuring at ρ5 = ρ
4∗
5 . For
ρ5 < ρ
4∗
5 , A
+
4 is a virtual steady state, whereas A
s
4 is an admissible pseudo
steady state. For ρ5 > ρ
4∗
5 , A
+
4 is admissible and A
s
4 is virtual. Thus, there
is one admissible (pseudo-) steady state on either side of the bifurcation
point. Key: admissible (solid lines), virtual steady state (dashed). See defi-
nitions in section 2.3.7.2.
2.6.2 Perturbation of ρ5: the maximal EC proliferation rate
The parameter ρ5 represents the maximal rate of EC proliferation (see equation (2.3.9)),
and by varying it we can assess how the CL growth (volume), and its cellular compo-
sition (ECs, LCs, and stromal cells) is affected.
In Table 2.1 we fix kE = kL = kR (so that the maximum growth rate for all cell types
is identical) and Eh1 = Eh2 (so that LCs and stromal cells have the same demand for
nutrients to grow), and hence ρ6 = ρ8 and ρ7 = ρ9. These parameter values lead to
singular value for the steady states A±1 , since the denominator of E1 in equation (2.4.11)
vanish.
To consider values of ρ6, ρ7, ρ8, ρ9, close to, but not at, the singular value, we take the
parameters to lie on an ellipse: ρ8 = ρ6(1 + r cos θ) and ρ9 = ρ7(1 + r sin θ) (with
radius r and θ ∈ [0, 2pi]) centred at the singular point S at (ρ8, ρ9) = (ρ6, ρ7), and
these are shown in Figure 2.9(a). In Figure 2.9(a) (inset plots), as θ varies we observe
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four qualitatively different cases. In case (1), R growth rate exceeds that of L and we
expect steady states with R 6= 0, and in (2) L and R dominance exchanges. That is, in a
low nutrient (E) environment, L grow at a faster rate than R, however, as the nutrient
abundance increases the growth rate of R exceeds that of L. In case (3), L growth rate
exceeds that of R and we expect steady states with L 6= 0, and in (4) L and R dominance
exchanges, where the opposite of case (2) applies.
Figure 2.9(b) shows how E varies (diagrams for F,R, L, are omitted for brevity) as θ
varies, with numbers 1 to 4 representing the four cases of L-R dominance as described
in Figure 2.9(a).
In biological terms, since we are interested in healthy CL development (where all four
variables are non-zero), a value of θ := θs ∈ (θ∗ = pi4 , θ∗∗) is chosen, which gives
a point S
′
= (ρ∗8 , ρ
∗
9) on the ellipse, with ρ
∗
8 > ρ6, ρ
∗
9 > ρ7. For these values, the
steady state As1 6= 0 exists and is stable. Note that the stability of each steady state is
evaluated numerically. Any case other than (2) implies a pathological CL. In particular,
case (1) implies As5a := (0, 0, 0, 1), an avascular (E = 0) state, where only stromal cells
survive and dominate the whole CL (V = R = 1). More importantly, there are no
LCs, which implies no progesterone production to support embryo development. The
case (3) yields As3 := (F, E, L, 0). This is also regarded as a pathological condition
(since R= 0), although embryo development might be sustained due to the presence
of LCs. Choosing θ := θss = θs + pi ∈ (θ∗′ = 5pi4 , θ∗∗
′
) gives the symmetrical point
S
′′
= (ρ∗∗8 , ρ
∗∗
9 ) with ρ
∗∗
8 < ρ6, ρ
∗∗
9 < ρ7, which corresponds to case (4) and the system
evolves either to As5a or A
s
3.
Figure 2.10 shows the bifurcation diagram for the ECs obtained by varying ρ5 in the
case (2), corresponding to point S
′
. The diagram was generated using the explicit ex-
pressions of steady states given in section 2.4 by plotting only the segments of the
branches which give rise to physically realistic and admissible states (for details see
section 2.5) for all four variables. Different scenarios with different steady states arise
depending on the value of ρ5. For ρ5 ∈ (ρ∗5 , ρ∗∗5 ) (intermediate levels of angiogene-
sis), the system can evolve to the ‘healthy’ state As1. Outside this range, the system
evolves to a pathogenic state: As3(R = 0;V = 1) for ρ5 < ρ
∗
5 (weak angiogenesis), or
As2(L = 0;V = 1), A
+
2 (L = 0;V > 1), and A
+
4 (L = 0,R = 0;V > 1) for ρ5 > ρ
∗∗
5 (high
angiogenesis).
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Figure 2.9: Steady state CL cellular composition depends on four qualitatively differ-
ent cases regarding the growth rate of L and R. (a) In the parameter space
(ρ8, ρ9), we consider the ellipse: ρ8 = ρ6(1+ r cos θ), ρ9 = ρ7(1+ r sin θ)
(with r = 0.3 and θ ∈ [0,2pi]) around the singular point S = (ρ6, ρ7) at
which LCs and stromal cells have the same demand of nutrients (E) to
grow. Inset plots present the four different cases. That is, how the swelling
rate of L, given by ρ6
E
ρ7+E
(dashed curve) as in equation (2.3.10), and the
proliferation rate of R, given by ρ8
E
ρ9+E
(solid curve) as in equation (2.3.11),
change as the nutrients vary. (b) Bifurcation diagram showing how the
steady state solutions for the ECs vary as the angle θ varies. For concise-
ness we include only the steady states that are stable for some θ ∈ [0,2pi].
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Figure 2.10: Bifurcation diagram shows how the steady state solutions for the EC vol-
ume vary as ρ5 varies for case (2) as in Figure 2.9(a). The steady states
are labelled as given in the Legend, and are further described in the text.
The parameter values ρi (i = 1, ..., 7) are specified in equation (2.3.13),
ρ8 = ρ
∗
8 = 0.81 and ρ9 = ρ
∗
9 = 0.09 which correspond to the point S
′
(case
(2)) in Figure 2.9(a).
61
CHAPTER 2: AN ODE MODEL FOR THE EARLY GROWTH OF THE BOVINE CORPUS
LUTEUM
2.6.3 Perturbation of other parameters
In this section our aim is to check whether the system evolves to the healthy steady
state As1 (where none of its variables vanish) by varying parameters which are associ-
ated with a greater degree of uncertainty as estimated in section 2.3.2. In particular,
parameters a1, a2 (rates of FGF2 production, by ECs and LCs, respectively), and k (a
measure of how mechano-sensitive cells are to competition for space) were estimated
in limiting cases.
In section 2.3.2, we used cases, labelled (Ia), to estimate a1 and a2, and (Ib) to estimate
k, and in the following section we use two different cases (IIa), (IIb), for a1, a2, and
k, respectively. Briefly, (Ia) represents the limiting case where we assume no LCs (to
estimate a1) and no ECs (to estimate a2), while (IIa) assumes that FGF2 production
from LCs after the first two days of ovulation is minimal (as shown in Figure 2.2). (Ib)
assumes F∗ ≫ Fh, which implies faster EC proliferation, while (IIb) assumes F∗ = Fh.
2.6.3.1 Cases (IIa) and (IIb) for estimating a1, a2 and k
The parameter values for the dimensional model in equations (2.3.2),(2.3.5)-(2.3.7) were
estimated as accurately as possible. However, since there is less evidence with which
to determine a1, a2, and k, than the other parameters, we provide here an alternative
method to estimate them, as a test of robustness. These alternative methods are enu-
merated below as (IIa) and (IIb):
(IIa). Here we estimate a1 and a2 as follows. In Figure 2.2, a schematic is presented
which illustrates the high FGF2 production by LCs during the first two days, while
ECs are productive all over the cell cycle. Based on that, we assume that the FGF2
production from LCs after the first two days is minimal. That is, at steady state (F˙ = 0)
a2L
REL+
E
L
→ 0, or equivalently,
a1E
∗ ≫ a2L
∗
REL +
E∗
L∗
. (2.6.1)
In addition, at steady state,
F˙ = 0⇔ a1E∗
(
1+
1
γ
)
= dFF
∗, (2.6.2)
where,
γ =
a1E
∗
a2L∗
REL+
E∗
L∗
= 0.07
a1
a2
, (2.6.3)
is the ratio of FGF2 production by ECs to that by LCs. By considering this ratio to be of
the order of 10 (γ = 10), equation (2.6.3) implies
a1 ≃ 143 a2. (2.6.4)
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Equation (2.6.2) implies a1 =
dFF
∗
E∗(1+ 1γ )
≃ 124, and therefore, from equation (2.6.4), a2 ≃
0.9.
(IIb). Here we estimate k as follows. We assume a steady state E˙ = 0 and FGF2 steady
value being smaller than for (Ib), e.g. F∗ = Fh, and solving for k implies: k = FFh+F
kE
V ∼
F∗
Fh+F∗
kE
V∗ ≃ 12 kEV∗ = 0.06.
2.6.3.2 Summary of results
The results obtained by combining cases (Ia), (IIa), (Ib), (IIb) are summarised in Table
2.3. A combination of (Ia) and (IIb) leads to a change in the steady state from As1(V = 1)
to A+1 (V > 1). Case (IIb) gives a smaller value for k suggesting that this can lead to
a non-constant CL volume. Overall, the alternative case for estimating a1 and a2 does
not seem to lead to any change in the steady state.
Table 2.3: Table summarising how the estimates of a1, a2, k, and the associated stable
steady state depend on the cases used for their estimation.
case a1 a2 k steady state
(Ia) & (Ib) 136 5.1 0.12 As1
(Ia) & (IIb) 136 5.1 0.06 A+1
(IIa) & (Ib) 124 0.9 0.12 As1
(IIa) & (IIb) 124 0.9 0.06 As1
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2.7 Discussion
In this chapter, we have developed anODEmodel for the early developmental stages of
the bovine corpus luteum (CL). The CL is responsible for the progesterone production
needed for pregnancy. Angiogenesis, the process of new blood vessel growth from
existing ones, is crucial for the CL growth. Inadequate angiogenesis has been linked
to infertility in cows. Therefore, by studying the dynamic processes which regulate CL
growth and development in vivo, our aim has been to determine how CL growth (and
pregnancy in the cows) is influenced by changes in the CL vascular density.
The model describes the time evolution of four dependent variables representing the
concentration of FGF2, and the volume of the endothelial (ECs), luteal (LCs) and stro-
mal cells (R), such as pericytes (PCs), with ECs representing the vascular density in
the CL. The model is based on the assumption that the CL volume (V) can be approx-
imated by the sum of the volumes of the three cell types, and if V exceeds a threshold
value, then cell growth is inhibited. The surface (Σ) at which the volume threshold is
attained is called the discontinuity boundary, which separates the model into different
cases: above, below, or on Σ. For each of those cases, the trajectories of the system
emerge from a different vector field, and evolve to real (above or below Σ) or pseudo
steady states (lie on Σ).
To gain some intuition about themodel we firstly considered a reduced two-dimensional
model for which L ≡ R ≡ 0 and, therefore, V = E+ L+ R ≈ E. Given the importance
of angiogenesis in the CL, in both the reduced and full models, the key bifurcation
parameter taken to be the maximal rate of EC proliferation, ρ5. Interesting model be-
haviours have been observed in the reduced model by varying ρ5. In particular, if
ρ5 was below a threshold (see equation (2.3.16)) the CL volume remained constant
(V = 1), sliding on the discontinuity boundary, Σ : E = 1, and the system evolved
to a pseudo steady state. Sliding is a special case where trajectories starting from either
vector field (above or below Σ) are constrained on Σ. However, if ρ5 exceeded that
threshold, E was able to detach from Σ into the region E > 1 (see Figure 2.5).
These notable cases observed in the reduced model were the motivation for further in-
vestigation into the existence of pseudo steady states in the full model. Therefore, in the
full model, we analysed the real steady states for the two different vector fields, above
and below Σ : E + L + R = 1, and the pseudo steady states, by exploring parameter
constraints for which steady states in each region can be physically realistic (non zero)
and admissible (see definitions in section 2.3.7.2).
As in the reduced model, the impact of varying the ‘angiogenic parameter’, ρ5, was in-
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vestigated in the full model, which was able to distinguish between normal and patho-
logical cases of CL growth (see Figure 2.10). In a weak angiogenic environment (low
ρ5) two cases are distinguishable. If the growth rate of LCs exceeds that of the stro-
mal cells, then the stromal cells are not able to survive and the LCs dominate. In that
case, although progesterone production by LCs may be high, there are few blood ves-
sels (ECs) to transport progesterone to the uterus. Alternatively, if the stromal cells are
more proliferative, they dominate the CL, and progesterone production ceases (since
LCs vanish). In both cases, low progesterone compromises pregnancy. In a high an-
giogenic environment (high ρ5), the CL shifts from a constant to an increasing volume
(steady state A+4 : V > 1) for which the CL is predicted to contain only vessels (ECs),
which is biologically implausible. For intermediate values of ρ5, a healthy growth of the
CL (where none of its cellular components vanish) is maintained, which is necessary to
sustain a healthy pregnancy.
The resulting behaviour of the (full) model was emerged using parameter values from
independent data as estimated in section 2.3.2. In order to check if the system evolves
to the healthy steady state we varied other parameters (except from ρ5), which were
associated with a greater degree of uncertainty. These are, a1, a2 (rates of FGF2 produc-
tion, by ECs and LCs, respectively), and k (sensitivity of cells to competition for space).
In section 2.6.3, we provided an alternative way of estimating those parameters, and
results showed that the system continued to evolve to the healthy steady state.
We discuss possible extensions and improvements to the current model, later in Chap-
ter 6. In particular, a more systematic parameter sensitivity analysis by assessing the
role of all parameters if possible could be more advantageous and informative. That
is, by providing information on the cases of our system which might evolve to either a
pathological or a healthy CL growth.
However, we believe that the resulting model reproduces several features of CL devel-
opment. That is, a transient surge in FGF2, and CL growth to a steady state volume in
which the different cell types are present in proportions that are consistent with exper-
imental observations [145, 203] and, in addition, the model can predict for normal and
pathological cases of CL growth.
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In vitro corpus luteum data
In this Chapter, our intention is to motivate the work being done in Chapters 4 and
5, focusing on cell aggregation and endothelial sprout formation, respectively, by de-
scribing in vitro studies of the corpus luteum (CL).
Infertility and poor embryo development is a big problem in dairy cows, which is
mainly caused by a deficiency in the CL ability to produce progesterone [146]. The
rapid and extensive development of vascular bed is crucial for the CL to function. Mo-
tivated by this, Robinson et al. in [201] developed a culture system by incorporating
all the CL cell types (e.g. ECs, steroidogenic cells (small and large luteal cells), fibrob-
lasts and pericytes (PCs)) in an attempt to shed some light on the dynamics that drive
angiogenesis in the CL. In this in vitro system EC networks were promoted by extracel-
lular matrix (ECM) components (e.g. fibronectin). The development of EC networks
in vitro that resembled the vasculature was stimulated by treatment with the two main
angiogenic growth factors found in the CL, FGF2 and VEGFA. The system was two-
dimensional, however, future work is looking to develop this novel system into three
dimensions by using collagen gels.
The ECs were identified by the EC marker, von Willebrand factor (VWF), and started
to form clusters (‘islands’) on day 2 (Figure 3.1A), then on day 5 proliferated and de-
veloped thread-like structures (Figure 3.1B). After 9 days in culture (Figure 3.1(C-D)),
these structures lengthened, thickened and formed highly organised intricate networks
resembling a capillary bed. Under higher magnification, they had a definite tubule-like
appearance with more intense staining on the outer edge. Note that we define a cluster
(or island) to be any group of cells (more than two in number and independent of type),
which are in contact. Therefore, we have two main categories: the individual and the
clustered cells.
Results regarding the different ECM components on the formation of endothelial net-
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Figure 3.1: The development of endothelial tubule-like structures in vitro in luteal an-
giogenesis culture system [201]. All luteal cell types isolated from the
bovine CL and ECs are immunostained using the VWFmarker. (A) 2 Days:
ECs form clusters, (B) 5 Days: tip cell formation (arrow), (C) 9 Days: forma-
tion of intricate networks of endothelial tubule-like structures (indicated
by arrows) and are shown at higher magnification in (D). The scale bar
represents 50 µm.
work suggest that collagen (Figure 3.2B) had no benefit, while fibronectin (Figure 3.2C)
greatly enhanced the formation of the endothelial network.
The authors in [201] also studied the effect of FGF2 and VEGFA on the formation of
endothelial networks, and below we summarise the main results:
• No FGF2 or VEGFA: endothelial tubules are formed albeit to a very limited extent
(Figure 3.3A).
• FGF2 (Figure 3.3B) and VEGFA (Figure 3.3C) independently: stimulate the for-
mation of tubules.
• FGF2 and VEGFA (Figure 3.3D) result to the greatest endothelial cell network
development when they are added simultaneously.
• FGF2 rather than VEGFA increased the size of the clusters (but not their number).
• VEGFA rather than FGF2 increased the number of the clusters (but not their size).
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Figure 3.2: The effects of collagen and fibronectin coating on luteal angiogenesis in
vitro. ECs were immunostained with VWF and representative images
are shown for (A) plastic alone (control), (B) 20 µg/well collagen, (C) 10
µg/well fibronectin and (D) rabbit immunoglobulin control (n = 3 per
treatment).
Based on the above observations, it might be suggested that FGF2 enhances cell prolif-
eration (mitogenic), and VEGFA enhances cell aggregation (possibly via chemotaxis).
In conclusion, the successful development of endothelial cell networks in vitro provides
a new opportunity to elucidate the physiological control of the angiogenic process in
the developing CL.
Another study from Bagavandoss and Wilks in [11], characterised isolated microvas-
cular ECs from developing rabbit CL in order to distinguish the complex physiological
functions of the ECs. The isolated cells formed capillary-like tubules in collagen gel cul-
tures. They showed that the FGF2 was mitogenic for the ECs, but several other growth
factors had no effect on the EC proliferation in vitro. In fact, transforming growth factor-
β1, TGF-β1, and tumour necrosis factor-α, TNF-α, strongly inhibited the proliferation
of the ECs. Other factors (e.g. PDGF, EGF, IGF-1 etc.) were investigated but these had
a more modulatory role.
In another experimental system, Stouffer and Christenson in [34] established a method
for isolating a pure population of ECs from the primate (rhesus monkeys) corpora lutea
by showing that both fibronectin and VEGFA stimulated EC proliferation.
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Figure 3.3: The effect of FGF2 and VEGFA on luteal angiogenesis in vitro. Representa-
tive images of the endothelial tubule development of dispersed luteal cells
treated with either (A) control, (B) 1 ng/ml FGF2, (C) 1 ng/ml VEGFA or
(D) 1 ng/ml FGF2 with 1 ng/ml VEGFA are shown. The endothelial cells
were immunostained (brown) with VWF. The scale bar represents 50 µm.
3.1 New data acquisition
In this section we will briefly describe results from in vitro experiments being done
in Robinson’s Lab with the aim to determine the temporal changes in EC dynamics
during aggregation in the formation of EC islands. Additionally, the association of
ECs-PCs was investigated. In all experiments, all cell types from the bovine CL were
isolated by enzymatic treatment as described in [201] and cultured for up to 9 days.
Then cells were fixed every day and immunostained for VWF or SMA or dual stained.
Images of the EC and PC pattern were acquired using Leica light microscope (under a
10x objective lens) connected to a digital camera. For each time point (days 1, 2 and 3)
a single coverslip per experiment was analysed. Numbers of aggregated ECs and PCs
were recorded using Image Pro-Plus 5.0 (Media Cybernetics, Wokingham, UK). This
was repeated for as many fields of view as possible in order to cover the whole well
(in vitro domain). Experiments were performed by R.S. Robinson and K.J. Woad, and
image analysis/quantification that follows by S.A. Prokopiou. Although Image Pro-
Plus provides an automated way to count the number of cells, I chose to count them
manually (using the software), since the existence of other irrelevant cell types (not ECs
nor PCs) could provide wrong and misleading results.
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3.1.1 Endothelial cells
Figure 3.4 depicts representative snapshots showing the formation and progress of the
EC islands over time. ECs are stained with brown colour using VWF, also indicated
with red arrows. The green arrows show another cell type, likely to be PCs which
surround the EC islands, and are also integrated within them (see day 3). This suggests
that there is likely to be a cross-talk between ECs and PCs.
The data presented in Figure 3.5 show that both the total number of ECs and the num-
ber of EC islands decreased from day 1 to 2. Thereafter, the number of ECs increases
from day 2 to 3; however, the number of clusters remains constant. These together im-
ply that whole EC islands failed to establish themselves in culture or underwent cell
death. Then, in those islands that survive, there was proliferation of the ECs.
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(a) day 1
(b) day 2
(c) day 3
Figure 3.4: The time course for the development of EC ‘islands’ in vitro. All cell types
from a recently ovulated bovine CL were dispersed and then grown on
fibronectin in specialised EC medium. The ECs were immunostained by
VWF immunocytochemistry (brown; also marked with red arrows). A dif-
ferent cell type (indicated by green arrows) was observed to surround the
EC islands as well as integrating within them (see green arrow on day 3).
These cells are possibly pericytes (PCs). Blue arrows point to other cell
types from the CL (e.g. fibroblasts, immune cells).
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(a)
(b)
Figure 3.5: (a) Total number of ECs, and (b) total number of EC clusters on days 1,2,3.
The data are mean ± S.E.M. from 3 individual experiments.
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3.1.2 Pericytes
In [202], Robinson et al. noted that PCs proliferate intensively in vitro by forming a
dense network after 3 days of culturing (see Figure 3.6(a), and Figure 3.6(b)-(c) in higher
magnification).
At early time points (e.g. 3 hrs), SMA positive cells (PCs) tended to have a uniform
appearance (flat, broad cells) and these were distributed across the whole well (Figure
3.6(b)). By day 1, PCs were associated with EC islands (red dotted line in Figure 3.6(c)).
They were localised to the outer edge of the EC islands as well as forming an integral
component of the islands. These PCs had a broad, flat cell appearance but some of them
had developed slender projections which formed multiple connections with other PCs,
ECs and/or other unidentified cell types.
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(a)
(b) 3 hrs (c) 24 hrs
Figure 3.6: All cell types from a recently ovulated bovine CL were dispersed and
then grown on fibronectin. PCs are immunostained using SMA marker
(brown). (a) Time course of PC growth from 3 hrs to 5 days in culture
showing the intense PC proliferation. (b)-(c) Higher magnification of 3
and 24 hrs showing that a number of individual PCs were observed ar 3
hrs in culture (b), and in (c) PCs had taken on a more elongated shape with
the ability of being associated with EC clusters (red dotted line).
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3.1.3 Endothelial cells & pericytes (dual localisation)
Intrigued by the experimental snapshots on ECs, and PCs in Figures 3.4 and 3.6, respec-
tively, regarding the possible cross-talk between EC ‘islands’ and the other cell type
(which assumed to be PCs) we performed dual localisation with VWF and SMA for
ECs and PCs, respectively. Indeed, Figure 3.7 depicts representative snapshots show-
ing EC ‘islands’ in brown colour (and red arrows) being surrounded and integrated
with PCs shown in purple colour (and green arrows).
(a) 6 hrs (b) 12 hrs
(c) day 1 (d) day 2
(e) day 3 (f) day 4
Figure 3.7: All cell types from a recently ovulated bovine CL were dispersed and then
grown on fibronectin in specialised EC medium. ECs are immunostained
using VWF marker (brown; and red arrows) and PCs with SMA marker
(dark brown/purple; and green arrows).
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Figure 3.8 presents results on number of ECs and PCs, and number of EC and PC
clusters from one experiment only. The pattern of EC growth is different compared to
Figure 3.5. In particular, in this current experiment there was no decline of the number
of ECs, and the number of EC clusters. The exact reason for this is unknown, but it’s
likely to be due to different ability of ECs to establish in culture (e.g. lower viability of
ECs). From this experiment, what is clear is that there is a large increase (∼5 fold) of
the number of PCs, and the number of PC clusters over the time course.
(a)
(b)
Figure 3.8: (a) Total number of ECs and PCs, and (b) total number of EC and PC clus-
ters in days 1,2,3 from a single experiment.
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3.2 Discussion
In this Chapter we have shown for the first time that not all the EC clusters were able
to establish in culture, but once established they manage to grow rapidly. Preliminary
results have shown some exciting observations regarding the associations between PCs
and the EC clusters, namely, that the PCs form an integral part of them (see Figure 3.7),
and the number of PCs increase dramatically (see Figure 3.8).
To the best of our knowledge, there are no reports of EC clusters being lost during
multi-cell type culture systems. The exact mechanisms by which the EC clusters are not
able to survive are unknown. However, one possible explanation is that the survival
ability of ECs might have been reduced due to the numerous processing steps (e.g. en-
zymatic dispersion, centrifugation) involved from tissue to culture. Additionally, ECs
appear to be more sensitive to changes in their environment [personal communication
with R.S. Robinson]. An alternative explanation is that some apoptotic ECs within a
cluster adversely affected the other ECs leading to the loss of that cluster. Futhermore,
immune cells (e.g. macrophages) are stimulated by these apoptotic ECs and migrate
to the cluster and digest it as a whole. Note that macrophages are found in abundance
during the early CL growth stages [226]. Indeed, we observed apoptotic looking ECs
within our cultures.
The large increase in number of PCs has previously been reported [202] (see Figure 3.6),
but the current study has extended this to quantify this increase. Regarding the PC
recruitment to the EC clusters, the secretion of angiogenic factors (e.g. FGF2, VEGFA,
PDGF) are the main candidates for this EC-derived event. It was also noted that the
PCs have multiple phenotypes (e.g. myofibroblasts, fibroblasts, smooth muscle cells),
which is likely to represent the different roles during the angiogenic process.
The in vitro work from Robinson et al. [201] by using all of the CL cell types in the
same experimental system provides a closer approximation to the in vivo environment
compared to other in vitro experiments where only a single cell type (ECs) is used.
However, having all cell types together make it more difficult to distinguish the effect
of one cell type to the other which is the main focus of Chapter 4 with regard to EC-
PC interactions and, particularly, how PCs affect endothelial proliferation. In addition
to this, given that cell staining techniques (immunocytochemistry) are not efficient at
early time points (e.g. 6hrs, 12 hrs), we are not able to clearly distinguish the different
cell types between them. Therefore, quantitative work proved to be difficult, or other-
wise it could provide misleading results. For these reasons, in Chapter 4, we are using
results from EC-PC co-culture systems, mainly from Orlidge and D’Amore [173].
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4.1 Introduction
The corpus luteum (CL) is an excellent model to study angiogenesis. Intense neovascu-
lar processes begin after ovulation, accompanying and sustaining the development of
the CL. During CL development more than 50% of its proliferating cells are of vascular
origin (e.g. endothelial cells (ECs), pericytes (PCs)). PCs, the cells that surround cap-
illary ECs may play key roles in blood vessel formation, maturation and maintenance.
Interestingly, in vitro CL studies presented in Chapter 3 reveal possible cross-talk be-
tween PCs and EC clusters (see Figure 3.7).
Control of cell proliferation is a fundamental aspect of tissue physiology central to
morphogenesis, wound healing, and cancer. Notably, PCs have been proposed to play
a key role in regulating EC proliferation. By using mixed EC-PC co-cultures, Orlidge
and D’Amore [173] observed that (growth-arrested) PCs had an anti-proliferative effect
on ECs, and it has been proposed that transforming growth factor-β1 (TGF-β1) is a
crucial factor for this result.
Motivated by results in Chapter 3 and the experimental study [173], we developed an
in silico EC-PC co-culture system, using the Cellular Potts Model (CPM) framework.
Our aim is to gain insight into the role of PCs on the EC growth, by focusing on cluster
formation, the first step in the in vitro angiogenic process (see Figure 3.1). Our model
allows for heterocellular interactions between ECs and PCs (along with interactions be-
tween cells of the same type) in order to assess the PC-derived suppression mechanism
to EC growth.
To understand the reported empirical findings in the low density and sparse EC-PC
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populations in [173], we expand the widely used CPM to incorporate active cell motil-
ity in order to allow for cell-cell interactions. In doing this, we are able to assess the
effect of speed and directional persistence time of cell movement on cell clustering and
contact inhibition. ECs, in contrast to the growth-arrested PCs, are able to proliferate
based on a phase cell cycle model. Mechanical contact between cells and TGF-β1 se-
creted from both ECs and PCs at their contact area can adversely affect the progress of
the phase model. Simulation results are analysed and compared with experimental re-
sults in [173] wherever possible. Our model provides further support that the effective
range of TGF-β1 is of great importance to EC growth inhibition.
The remainder of this Chapter is organised as follows. Section 4.2 provides the biolog-
ical background on the two main vascular cell types (ECs and PCs). We present the
model overview in section 4.3, and the basic steps of the in silico model development
in section 4.4. Section 4.5 is devoted to the numerical results, and section 4.6 provides
some model alternatives. The Chapter concludes in section 4.7 where we summarise
our results.
4.2 Biological background
In this section, we present current knowledge on the in vivo role of ECs and PCs, the
cross-talk between them, and also, their in vitro behaviour.
4.2.1 Endothelial cells and pericytes in vivo
ECs form a single layer that lines the entire vascular system. This thin monolayer
regulates the exchange of nutrients and waste products between the blood stream and
the surrounding tissues. However, it takes two cell types to make blood vessels; ECs
and PCs. While the ECs are the better characterised of the two, PCs are now coming
into focus as important regulators of angiogenesis and blood vessel function.
PCs have an intermediate phenotype between vascular smooth muscle cells (vSMCs)
and fibroblasts and seem to have the capacity to differentiate also in the latter direc-
tion. The following list summarises briefly their most important functional properties:
their key role in regulation of different cellular processes in the vasculature, including
endothelial proliferation and differentiation ([8, 89],[2]), the stabilisation and control of
permeability of blood vessels under physiological and pathophysiological conditions
[254, 264], their participation in vasculogenesis and angiogenesis [18, 111, 194], and
their involvement in the regulation of contractility and tone of vascular smooth muscle
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and hence participation in organ blood flow regulation [110, 122].
PCs and vSMCs reside at the interface between the endothelium and the surrounding
tissue and are as such ideally positioned to take an active part in the angiogenic process
[70]. The PC coverage of the endothelial surface is only partial, and varies extensively
between the capillary beds of different tissues [230]. The reason coverage is as low
as 10% in some tissues and as high as 50% in other tissues is not known, but likely
reflects specific functional features of the microvessels in different organs. The highest
PC density has been described for neural tissues and is stated to be almost in parity
with ECs in brain and retina. For comparison, the PC to EC ratio is stated to be 1:100
in striated muscle [192]. In addition, the distribution of PCs in the vessel wall is not
random. They are more prevalent at capillary branching points, although this is not
obligatory. Typically, the part of a vessel engaged in the transport of gases and/or
nutrients is free of PC coverage [70].
Despite the several functions of PCs relevant to angiogenesis proposed above, our un-
derstanding of PCs is still limited compared to that of the ECs. For a deeper under-
standing of angiogenesis, it is important to shed light on the mechanisms controlling
EC-PC communication.
Vascular formation involves a complex interplay of signals from ECs, PCs/vSMCs,
and non-vascular cells required for proper vessel assembly and function. These inter-
actions are both temporally and spatially regulated. The exact mechanism(s) by which
ECs recruit PCs or vSMCs during vessel formation is unknown. Potential regulators
include soluble factors that act in an autocrine and/or paracrine manner, as well as ho-
motypic (EC-EC, PC-PC) and heterotypic (EC-PC) cell contacts [88]. ECs are a source
of diffusible factors which can impact PCs in terms of PC-precursor maturation, prolif-
eration and migration [88].
Accumulated evidence shows that plateled-derived growth factor-B (PDGF-B) plays a
critical role in the recruitment of PCs to newly formed vessels. During angiogenesis
PDGF-B is expressed by the sprouting endothelium and platelet-derived growth factor
receptor-β (PDGFR-β) is expressed by the PC/vSMCs progenitors [85, 138] suggesting
a paracrine mode of interaction between the two cell types (see Figure 4.1). Therefore,
an endothelial PDGF-B signal controls PC recruitment to angiogenic vessels. It is likely
that the amount of PDGF-B available determines the number of PCs recruited [252]. It
is of particular interest that only a subset of the ECs express PDGF-B in the angiogenic
situation [85]. That is, PDGF-B expression is mainly seen in the cells situated at the tip
of the sprouts.
In this way, Minakawa et al. [159] developed a chemotactic assay and showed that PCs
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 Recruitment PDGF-B 
Pericyte 
Tip cell 
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deposition 
Figure 4.1: Schematic diagram showing the PDGF-B/PDGFR-β interactions with
PDGF-B synthesised and secreted by the migratory endothelial tip cells.
Endothelial-derived PDGF-B acts to recruit pericytes, which express the
PDGFR-β, that then migrate and proliferate along newly formed blood
vessels.
are chemotactically attracted to capillary-like structures (CLSs). One feasible reason for
the observed association of PCs with CLSs could be the release of chemotactic products
secreted by ECs in CLS formation.
ECs have been reported to synthesize FGF2 and its release from the cell cytoplasmmay
occur during cell injury or death [164]. FGF2 is angiogenic, as well as mitogenic [40]
and chemotactic [208] for vSMCs. Thus, although its mechanism of release remains
unclear, it is also a candidate for involvement in vSMC or PC recruitment by EC.
PCs may well play a leading role in angiogenesis. In the CL, the PCs are the first
vascular cells to invade the granulosa folds of the ruptured follicle (during ovulation)
[5]. This supports the view that PCs are pioneers in CL angiogenesis due to their ability
to secrete ECM, which allows EC migration. This opposes the common view that PC
recruitment lags behind that of ECs in the angiogenic process.
4.2.2 Endothelial cells and pericytes in vitro
The in vitro formation of capillary-like tubes by ECs is a powerful method to screen for
various factors that promote or inhibit angiogenesis. However, isolation and culture of
microvascular ECs from a solid tissue (e.g. CL) remains a hard task.
81
CHAPTER 4: ENDOTHELIAL-PERICYTE INTERACTIONS IN ANGIOGENESIS
4.2.2.1 Isolated endothelial cells in vitro
ECs have been the target of in vitro studies with the aim to answer several fundamental
biological questions regarding the cellular architecture of tubes and how, for instance,
clusters of ECs can give branches and, therefore, network formation. However, the
process of EC self-organisation in vitro to form vascular-like patterns is a complex bio-
logical process, involving a large set of interacting elements. Angiogenic cells undergo
specific structural alterations regarding cell shape, cellular projections and cell surface
modifications, indicating changes in intercellular interactivity.
In 1973, Gimbrone et al. [76] and Jaffe et al. [102] were the first who managed to suc-
cessfully grow vascular ECs from human umbilical vein endothelial cells (HUVECs) in
vitro. Subsequently, numerous in vitro systems of angiogenesis have been proposed (for
a review, see Auerbach et al. [9]) with the aim to approximate as closely as possible the
in vivo situation. Since new blood vessels are comprised of vascular ECs, in vitromodels
of angiogenesis mainly focused on cultured ECs. In most models, a two-dimensional
arrangement of ECs is explored [183, 247, 248], whereas models with more cell types
are scarce and we will refer to some of them in section 4.2.2.3.
4.2.2.2 Isolated pericytes in vitro
Interesting information regarding the possible functions of PCs has been derived by
studying homogenous cultures of PCs [47, 50, 87, 143]. Cultured PCs appear as large,
spreading, stellate cells with highly irregular edges. They display numerous long fil-
amentous processes and are characterised by prominent intracellular fibers of actin.
Their morphology differentiates them from ECs (‘cobblestone-like’ morphology [109,
193]), fibroblasts (long, spindle-shaped, with extended filopodia), and smooth muscle
cells (‘hill and valley’ growth). It should also be noted that their growth is not contact-
inhibited [192] and, after reaching confluence, PCs start forming multilayers.
A major problem in PC research, recognised by Zimmermann already in 1923 and still
valid, is the general lack of unequivocal PC markers. The strong degree of uncertainty
experienced in attempts to grow PCs in vitro is caused mainly by their occasionally
claimed pluripotency (differentiate into either vSMC or fibroblast).
Several markers have been used to identify PCs, including smooth muscle α-actin
(SMA), desmin, NG-2, PDGFR-β, aminopeptidase A and N, RGS5, and XlacZ4. How-
ever, none of these markers is absolutely specific for PCs, and none of them recognises
all PCs; their expression varies between organs and developmental stages [8]. As a re-
sult, the heterogeneous morphology and marker expression make identification of PCs
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a challenge.
Since PCs exist in close association with microvascular ECs in vivo, their physiologic
functions are best examined in the context of their interactions with microvascular en-
dothelium. However, there have been a limited number of in vitro co-culture (EC-PC)
studies, which are discussed in the following section.
4.2.2.3 In vitro co-cultures of ECs and PCs
PCs have been proposed to play a significant role in regulating EC proliferation. Tis-
sues with the greatest number of associated PCs such as the brain and retina were
found to have the lowest microvascular EC turnover rate [234]. Studies on diabetic
retinopathy also support the suggestion that PCs inhibit EC growth; prior to the rapid
neovascularisation characteristic of this disease, there occurs a selective loss of PCs
associated with the retinal capillaries [234].
Orlidge and D’Amore [173] developed an in vitro co-culture system to mimic the in-
teractions between ECs (isolated from bovine adrenal cortex) and PCs/vSMCs (from
bovine retinas). They found that an activated form of TGF-β1 produced by these co-
cultures totally inhibited the growth of ECs (see Figure 4.2). TGF-β1 is a cytokine which
can be found in a latent form on the plasmamembranes of ECs and PCs and is activated
once the two cell types come into contact [173].
Figure 4.2: The effect of PCs on EC proliferation is depicted by comparing the nor-
malised number (N(t)/N(0)) of ECs grown alone to the one of ECs in co-
culture with PCs over time. Data redrawn from [173].
Yamagishi et al. [264] also studied interactions between retinal PCs andHUVECs. Close
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contact of the two cell types was found to partially inhibit growth of HUVECs, whereas
substitution of PCs with fibroblasts gave no inhibition.
Sato and Rifkin [209] confirmed that in a co-culture of bovine aortic ECs with bovine
PCs or SMCs the latent form of TGF-β1 was activated resulting in the inhibition of EC
movement.
Kondo et al. [118] showed that in co-culture with retinal PCs, the proliferation of retinal
capillary ECs was significantly inhibited. However, no such inhibition was observed
in a co-culture where contact between the two cell types was not allowed. Those re-
sults led to the hypothesis that the concentration of soluble growth factors emerged
from PCs is important for the suppression of EC growth. Results in a later report from
the same investigator [119] provided the first evidence that conditioned medium from
the cultivation of PCs alone can inhibit retinal neovascularisation, further suggesting
that the soluble growth factor is TGF-β1. The latter result is in contrast with the afore-
mentioned experiments [173, 209, 264] which suggest that inhibition of EC growth is a
result of TGF-β1 activated only when ECs and PCs come into contact.
Having provided the necessary biological background on endothelial and pericyte in-
teractions, in the next section we present our model overview.
4.3 Model overview
4.3.1 Contact-inhibition of cell proliferation rate
An increasing number of agents has been shown to either positively or negatively in-
fluence the growth of vascular ECs. Best known among the stimulators of EC growth
are acidic and basic FGF (aFGF; bFGF or FGF2) [39]. In vitro, it has been shown that ECs
produce FGF2 [190, 218], and that endogenous FGF2 modulates EC proliferation and
migration [208]. FGF2 is also expressed by other cultured cell types including fibrob-
lasts, SMCs, and glial cells [53]. In addition, Lee et al. [131] found that the distribution
of bovine pulmonary artery ECs (BPAE) division times showed a shift to shorter di-
vision times in the presence of FGF2, indicating the mitogenic effects of FGF2 on the
growth of BPAE.
FGF2 has a dual action. Firstly, chemotaxis enhances EC clustering (and also strength-
ens EC-EC aggregation), the initial stage of angiogenesis on which our model focuses,
and secondly, FGF2 promotes EC proliferation.
As we described earlier (see Figure 4.1), PC recruitment is mainly controlled through
the PDGF-B/PDGFR-β signalling pathway. However, FGF2 could also serve to main-
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tain PC recruitment to EC clusters and, thereby, enhance PC proliferation [88]. Other
growth factors which have been shown to bemitogenic for PCs include heparin-binding
epidermal growth factor and endothelin [88].
Despite the biological knowledge on the possible interactions between ECs and PCs
as described above, a biologically meaningful mathematical model is required to be
validated against biological measurements. Therefore, according to the available ex-
perimental data on co-culture systems described earlier in section 4.2.2.3, we decided
to model the experimental design adopted by Orlidge and D’Amore [173]. In that ex-
perimental system, ECs were co-cultured with growth-arrested PCs in order to assess
the negative effect of PCs on EC proliferation.
Therefore, our model is mainly based on the following assumptions which arise from
the above study [173]:
1. ECs and PCs are randomly seeded in a 1:1 ratio.
2. PCs are growth-arrested, and only ECs are able to divide.
3. There is no FGF2 secreted by the cells or externally added in the domain.
4. TGF-β1 is secreted by both ECs and PCs at their common contact area.
5. TGF-β1 inhibits the EC growth.
Figure 4.3(a) shows a network diagram with all possible EC-PC interactions, while
Figure 4.3(b) depicts the subset of interactions which we consider here as developed by
[173].
4.3.2 The Cellular Potts Model (CPM) approach
Cell-based computer simulations can be an effective tool to check biological hypothe-
ses and mechanisms. In our model, cell shape and cell-cell contacts play an important
role in cell communication. Therefore, to understand the basic mechanisms of inter-
actions between ECs and PCs, we adopted a two-dimensional Cellular Potts Model
(CPM) approach [78] where both variables can be explicitly represented. The CPM is a
discrete lattice model initially developed by Glazier and Graner to study the cell sort-
ing behaviour that had been observed experimentally in Hydra aggregates [78], and it is
based on an energyminimization principle. The CPMhas already been used tomodel a
multitude of biological phenomena including fruiting body formation of Dictyostelium
[105], avascular tumour growth [106], cancer invasion [250] and vasculogenesis [155].
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(a) (b)
Figure 4.3: Network diagrams present the EC-PC autocrine and paracrine interactions
explained with the given numbers on the arrows as known from literature
(a), and as developed by [173] (b). (1a) ECs secrete FGF2, which enhances
the proliferation rate of ECs (1b), and PCs (2). PCs may inhibit EC growth
by contact (3a), and by diffusive TGF-β1 (3b), which is activated once ECs
and PCs come in contact. There is also some evidence that ECs might sup-
press PCs proliferation (4) but in lesser extent [173]. Note that (3a,b) and
(4) is the heterotypic (EC-PC), whereas (5) and (6) is the homotypic (EC-EC
and PC-PC, respectively) contact inhibition.
In the CPM, each cell which is placed on a square numerical grid (in 2D) consists of
multiple lattice sites (pixels). Every single pixel in an individual cell is given the same
identity number, σ = 1, ...,N (also called ‘spin’ in the original Potts model), where N
is the total number of cells. In order to identify different cell types, cells are given
a second identity, τ = 1, ..., k, where k is the number of the different cell types. The
substrate (medium, e.g. extracellular matrix) is normally represented as a generalised
cell with τ = 0. The energy of a configuration of identities is determined by summing
the interaction energies (J) between pairs of neighbouring lattice sites. Therefore, J
describes the relative strength of cell-cell adhesion that occurs via e.g. transmembrane
cadherin proteins.
A description of all cell interactions are given through an effective energy function or
Hamiltonian (H),
H = ∑
(~x,~x′)
J
τ(σ(~x)),τ(σ(~x′))
(
1− δ
σ(~x),σ(~x′)
)
+ H′, (4.3.1)
where τ(σ) represents the type of the cell occupying a grid space σ, which in our model
can only be either an EC or a PC. The Kronecker delta function is δx,y = 1, if x = y; 0, if x 6= y,
and the term (1− δ
σ(~x),σ(~x′)) ensures that adhesive energy only accrues at cell surfaces
(see Figure 4.4). H′ can be any constraint on the cell behaviour (e.g. chemotaxis [210],
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haptotaxis [250], cell elongation [155]).
Jcell,cell 
cell 1 
cell 2 
Jcell,matrix 
matrix matrix 
Figure 4.4: Adhesion energies (J) at cell-cell and cell-matrix interfaces as implemented
at the CPM framework.
To mimic cytoskeletally driven, active surface fluctuations, a lattice site ~x and a neigh-
bouring target ~x′ is repeatedly and randomly selected, and we calculate how the ef-
fective energy would change if the initial site displaced the target. If the energy de-
creases H (∆H = Hnew − Hold < 0), the change is allowed to occur. However, if
H would increase (∆H > 0), the change will be accepted with Boltzmann probabil-
ity, p = exp(−∆H/T). T is the ‘temperature’ (like thermal fluctuations in statisti-
cal physics [22]) of the system, which influences the likelihood of energetically un-
favourable events taking place: the higher T, the more out-of-equilibrium the system
will be. Biologically, T indicates the amplitude of cell membrane fluctuations (and not
active cell movement), which is characterised by polarised membrane extension and
retraction. On a lattice with M sites, M site copy attempts represent our basic unit of
time, one Monte Carlo Step (MCS).
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4.3.2.1 Cell area constraint
The energy in (4.3.1) is minimised by typically incorporating a constraint on the cell
area,
H′area = λA ∑
σ>0
(ασ − Aσ)2 , (4.3.2)
with ασ being the current area of a cell. The cells are constrained to have an area close to
a fixed target area, Aσ, so that they do not grow or shrink. The factor, λA, is the strength
of the cell area constraint which corresponds to the elasticity of the cell membrane. The
growth constraint, H′area, delivers a penalty to the total energy for any deviation from
the target area and summation goes for all cells with the exception of the medium
(σ > 0).
4.3.2.2 Modelling of cell random motion
Mombach and Glazier in [161] claimed that the thermodynamic approach (regarding T:
‘temperature’) used in the CPM approach [78] is an appropriate way of modelling the
random component of cell movement, as experimental evidence indicates that individ-
ual cells in a cell mass exhibit Brownian motion in the absence of chemical or adhesion
gradients [161].
However, in order to achieve (random) motility of the cells in a more realistic way
(rather than only fluctuations of the cell membrane), we include an extra reduction in
energy for motion
H′motility = r(cosθ(t), sinθ(t)) · (~xCM − ~x′CM), (4.3.3)
with r representing the cell speed from its centre of mass (~xCM), and θ(t) ∈ [0, 2pi] the
rotation angle which updates every tper (the persistence time). The tper refers to the
average duration of locomotion in one direction before a random change of direction.
Active cell motility using the CPM framework was also attempted in some other mod-
elling studies. In modelling collective endothelial cell motion (where cells can be both
motile and adhere to one another), Szabo et al. in [242] incorporated active cell motility
in an attempt to understand streaming behaviours in high density cultures. The au-
thors modelled active cell motility by first assigning a cell polarity vector ~pi to each cell
i and then increase the probability of the motility steps that advance the cell centre in
the direction parallel to ~pi as
w(~x → ~x′) = m∑
i
∆~Xi(~x → ~x′) ~pi|~pi| , (4.3.4)
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where m sets the magnitude of the bias, and ∆~Xi represents the displacement of the
centre ~x of cell i. The cell polarity vector was an attempt to represent the localisation
and magnitude of the biochemical changes characterising the leading edge of a migra-
tory cell. Cell polarity vectors are updated by assuming a spontaneous decay k and a
positive feedback from cell displacements as
∆~pi = −k~pi + ∆~Xi. (4.3.5)
A characteristic memory length (persistence time) k′ of the polarisation vector is de-
fined as k′ = 1/k.
In another recent work, Szabo et al. in [243] studied the cell invasion from an aggregate
into a surrounding ECM. The authors modelled active cell motility according to their
previous work [242]. By exploring the interplay between haptotaxis, matrix degrada-
tion and active cell movement, the model showed that the cells are able to both invade
the ECM and follow the ECM tracks, and also that ECM can increase motion persis-
tence.
4.3.2.3 Modelling the EC cell cycle: contact-inhibition
Instead of explicitly modelling the cell cycle of the ECs by considering all the interme-
diate stages as in [251], we use a simple phase model as in [180] in which φj ∈ [0,1]
represents the phase of the cycle of EC j, with
dφ
j
EC
dt
=
1
1+ a4Pj
1
1+ a5TGFβ1
a1, (4.3.6)
and the reset condition that when φ
j
EC = 1 it is reset to zero (so that φ
j
EC = 0 represents
the start of the cell cycle, and φ
j
EC = 1 its completion). In equation (4.3.6) the right hand
side specifies the speed of progress through the cycle. The constant rate, a1, specifies
the speed of the phase in the presence of no additional factors. In section 4.4, we discuss
further on the value of a1.
The growth of vascular cells in vitro is characterised by cell-cell interactions, where
neighbouring cells touch one another. If during this growth process an EC becomes
surrounded by other cells, it will stop growing [130]. Therefore, only a fraction of cells
will continue to grow and divide. As wementioned earlier, Orlidge and D’Amore [173]
found that PCs co-cultured with ECs adversely affect the EC growth as a result of the
TGF-β1 being activated when the two cell types come into contact.
By considering the above statements and findings, we model EC growth inhibition by
assuming that the proliferation rate of ECs is inversely proportional to the ContactArea
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(Pj) with its neighbours. Pj is the ratio between (cell j)-neighbour (of either type) com-
mon perimeter and the total perimeter of cell j,
Pj =
∑(~x,~x′)
(
1− δ
σ(~x),σ(~x′)
) (
1− δσ(~x),0
)
δσ(~x),j
∑(~x,~x′)
(
1− δ
σ(~x),σ(~x′)
)
δσ(~x),j
, (4.3.7)
with ∑(~x,~x′) summing over all pairs of adjacent sites in the lattice. TGFβ1 in equation
(4.3.6) is the concentration of the growth factor secreted at the common perimeter, and
the constants a4, a5 are the strengths of contact inhibition by mechanical contact, and
the diffusive TGF-β1, which is described by the following PDE
∂TGBβ1
∂t
= D∇2TGFβ1+ s− δTGFβ1, (4.3.8)
with D being the diffusion constant, and s, δ represent the secretion and decay rate,
respectively. Table 4.1 summarises the behaviours of ECs and PCs as implemented in
our model based on the experimental system of Orlidge and D’Amore [173].
Overall, in reality not all cells in a cluster are exposed to the same amount of inhi-
bition [115], which is implied from equation (4.3.6); that is, the cells at the centre of a
cluster experience more contact and, therefore, their mitotic phase is delayed compared
to the cells located at the perimeter of a cluster and the individual cells.
Taking further the mitosis into account, division in our model applies in the middle of
and perpendicular to the longest cell axis. After mitosis, both daughter cells inherit half
of their mother’s target area. This assumption is in agreement with in vitro experiments
which have shown that the positioning of microtubule asters is such that the cell will
divide perpendicular to the longest axis [93]. However, Drasdo et al. in [68] assumed
that the orientation of cell division is determined by the direction of the total force
exerted on the dividing cell by all its neighbours.
Table 4.1: Rules for the various cell types based on the experimental system of Orlidge
and D’Amore [173].
Cell behaviour Endothelial cells Pericytes
growth X X
mitosis X (see equation (4.3.6)) X
secrete TGF-β1 only when in contact only when in contact
with pericytes with endothelial cells
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4.4 Methods
This section outlines the basic steps of the in silico model development along with the
experimental systems [40, 130, 173] used for validation. Our simulations use the open-
source simulation environment CompuCell3D (CC3D) and Python scripts specifically
developed by the author.
4.4.1 Model setup
4.4.1.1 Cell density
In co-cultureswith direct contact, Orlidge andD’Amore [173] plated the growth-arrested
PCs at a density of 20,000 cells per 16-mmwell. After overnight attachment equal num-
bers of capillary ECs were added into the wells.
Therefore, 40,000 cells (EC:PC=1:1) in total were plated in an Area≃ piR2 ≃ 2x108µm2.
If each cell is about 100 µm2 [263], that means the initial area coverage was ∼2%. Since
the numerical domain in the in silico model is 200x200 pixels2 and each pixel is 2µm
(see section 4.4.2), that implies N = 32 in silico cells (ECs and PCs).
4.4.1.2 Initial conditions
To simulate the cell interactions, 32 cells (both ECs and PCs) occupy randomly chosen
positions within the grid. At this point we should make clear that since ECs and PCs
are randomly distributed in our in silico domain, heterogeneities in the spatial distri-
bution of seed cells may affect the observed cell proliferation rates. In order to avoid
any biased allocation of the two cell types, each simulation starts with a different ini-
tial condition (seeding positions of the cells). Figure 4.5 shows a representative initial
condition, with ECs and PCs being in a ratio of EC:PC=1:1 as in [173].
Note that by using the existing plugins in CC3D to generate the initial conditions, dif-
ferent seed numbers produce different sequences of random numbers with the ratio of
EC:PC=1:1 not being exact. Since perturbation experiments in [173] with different cell
ratios showed to greatly impact the EC growth, we chose to generate random locations
of the cells in the numerical domain by using our scripts in MATLAB software package
in order to keep the ratio exact.
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Figure 4.5: A representative initial configuration of the simulation, with ECs (red)
and PCs (blue) randomly distributed in the numerical domain in a ratio
EC:PC=1:1.
4.4.2 Space & time conversions
The target area of each cell is 25 pixel2. The ECs in vitro have approximately 10 µm
diameter and 100 µm2 area [263]. This sets the space conversion as: 1 pixel = 2 µm.
Thus, each cell in the in silicomodel represents 1 cell in reality. We ran our simulations
on a 200x200 CPM lattice with periodic boundary conditions.
Based on experimental data [130], the speed of ECs without the existence of any ad-
ditional growth factor was ∼ 0.4− 0.5 µm/min. By considering the persistence time
(∼ 30min) in [130], we set the temporal conversion as 1 MCS ≃ 1 min so that cells can
move for several MCS before changing direction, a value similar to the one used in
other CPM studies [155, 227, 242].
4.4.3 The initial phase φ(0) and the quiescent period (tq)
In the experimental system [130], the authors found that the period between inocula-
tion (seeding of cells) and the first division varied widely among the ECs of a popu-
lation. Some divided between 12 and 18 hrs after inoculation, others required more
than 24 hrs. The wide variability of the first division time complicates the choice of the
initial conditions for our simulations. Therefore, for the first division of the cells, the
cell phase counters in equation (4.3.6) are loaded with a random number (φ(0): ‘initial’
phase) such that φ(0) ∈ (0, 1). If this is not done, the model will underestimate the
time interval required for the first division of each cell and will over-predict the cell
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population in the initial stages of proliferation [130]. Note that φ(0) can be close to 1
since some cells before being dissociated from a tissue, might be close to division, and
φ(t) is reset to zero when φ(t) = 1.
Another important issue regarding the choice of the initial conditions in our simula-
tions is about the quiescent period (tq: the time from the initial in vitro cell seeding up to
several hrs), during which cells adhere to the tissue culture surface, spread, and then
start migrating. In terms of implementation, the phase counter for each cell starts to
progress after ∼4 hrs [154]. That is, φ(0) for each cell remains fixed for the first 4 hrs.
4.4.4 Parameters
The default parameter values used for our simulations are summarised in Table 4.2,
unless otherwise stated. Below we provide a discussion on how some of those were
estimated.
4.4.4.1 Doubling time of ECs: estimation of parameters a1
The constant rate a1 as in equation (4.3.6) was estimated using data from D’Amore and
Smith [40]. In that experimental system, ECs and PCs were cultured independently in
varied concentrations of different growth factors (e.g. FGF2) in order to investigate the
contribution of each growth factor on the cells’ proliferation rate. Below we explain
how we estimated these rates for the ECs.
Initially, 10,000 ECs were seeded and in the absence of FGF2 (FGF2=0 ng/ml) the cell
number tripled in approximately 3 days. Therefore, by considering tq ∼ 4 hrs, the basic
EC cycle time is ∼36 hrs=2160 MCS, so a1 = 12160 MCS−1 = 0.00046 MCS−1.
4.4.4.2 Cell-cell adhesion: contact energies (J)
Contact communication is known to result in the initiation of different developmental
fates [80]. The differential adhesion hypothesis (DAH), advanced in the 1960s from
Steinberg [236], proposed that cell sorting dynamics arise from tissue surface tensions
that in turn arise from differences in intercellular adhesiveness, which served as a basis
for quantitative approaches on cell adhesion [161].
In the CPM, interactions between neighbouring pixels have an effective energy (J),
which characterises the strength of cell-cell and cell-matrix adhesion. Larger J means
more energy is associated with the interface between two cells, which is less energeti-
cally favorable, corresponding to weaker adhesivity.
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Our simulations used up to 3 generalised cell types: medium, ECs, and PCs. The con-
tact energies among them are shown in Table 4.2. Note that JEC,PC < JEC,EC ≪ JPC,PC
implies that: 1) the heterotypic (EC-PC) contacts are stronger than the homotypic (EC-
EC, PC-PC) ones, and that 2) ECs adhere more strongly between them (create zipper-
like structures along their borders through adherent junctions [45]) compared to the
loose contacts between PCs as shown in Figure 4.6.
Figure 4.6: Snapshot from EC-PC co-culture system [Courtesy of Dr. R.S. Robinson],
showing the loose contacts between PCs (green arrows) compared to the
strong ones between ECs (red arrows). Key: ECs (brown); PCs (dark pur-
ple).
It is worthy to mention that although it shows to be of great importance, there is very
limited experimental work on the evaluation of the strength of cell-cell adhesion (either
homotypic or heterotypic).
4.4.4.3 TGF-β1: diffusion, secretion and decay
TGF-β1 is a key regulator of cell growth and differentiation. It exists in a latent (inac-
tive) form, and is activated once cells (e.g. ECs, PCs, macrophages) come into contact
[173].
In our model, TGF-β1 is activated at the contact area between ECs and PCs, and is
secreted by both cell types. We used the same diffusion parameters as proposed by
Merks et al. in [155, 157] (see Table 4.2). We used these values to obtain steep gradients
by assuming that the diffusion of TGF-β1 is a local event and mainly affects the ECs in
close proximity, since its diffusion length (L =
√
D
δ = 30µm ∼ 3 cell length) is short.
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Table 4.2: Default parameter settings for simulations
Parameter Description CPM value Dim/nal value Reference
Cell features:
(for ECs and PCs)
A cell target area 25 pixels2 100 µm2 [263]
λA resistance to changes 10 / /
in size
T cell-membrane 10 / /
fluctuations
Adhesion:
(contact energies)
JEE EC-EC 15 / /
JPP PC-PC 100 / /
JEP EC-PC 5 / /
JcM cell-medium 20 / /
TGF-β1:
D diffusion constant 1.5 pixels2/MCS 10−13 m2/s [155, 157]
s secretion rate 0.006 nM/MCs 10−4 nM/s [155, 157]
δ decay constant 0.006 1/MCS 10−4 1/s [155, 157]
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4.5 Results
Having provided the basic biological background and our model overview based on
the experimental system of Orlidge and D’Amore [173], our aim is to proceed with the
following systematic approach: we start with single cell experiments in different motil-
ity scenarios (low, intermediate, high speed and persistence time). Then we proceed
with pure EC populations (without PCs) to assess cluster formation, with and without
mitosis, in the different motility scenarios. Finally, we present results from simulations
with both ECs and PCs in order to investigate the mechanisms for the total inhibition
of the EC growth.
4.5.1 Single cell experiments
In this section, in the absence of any external influence (e.g. FGF2), we present results
from single cell experiments with the aim to estimate the motility parameters: r (speed
of motility) and tper (directional persistence time), as presented in equation(4.3.3).
By considering the sparse cell populations in [173], we expect that the properties of
random cell motility (r and tper) may significantly affect the likelihood of cells making
contacts, which can lead to cell cycle delay.
Mathematically, a random walk is a series of steps, where each step is taken in a com-
pletely random direction from the one before. This kind of path was famously analysed
by Albert Einstein in a study of Brownian motion and he showed that the mean square
of the distance (msd) travelled by a particle following a random walk is given by
msd(t) = 〈∆i(t)2〉 = 〈(~xi(t)−~xi(0))2〉, (4.5.1)
where, ~xi denotes the centre of cell i and ~xi(t)−~xi(0) is the (vector) distance travelled
by the cell over some time interval of length t. The squared magnitude of this vector is
averaged (as indicated by the angle brackets) over many such time intervals.
If the cell encountered no other cells, travelling ballistically, then the distance it trav-
elled would be proportional to the time interval - distance equals velocity times time
- and the msd would increase quadratically with t. In denser phases, quadratic be-
haviour holds only for a very short time interval, of the order of the mean collision
time. Beyond this time the motion is better described as a random walk, for which the
msd increases only linearly with time (msd ∼ t). The rate of growth of the msd depends
on how often the cell suffers collisions. At higher density, it will take longer to diffuse
a given distance, as other cells continually impede its progress.
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The limiting slope of msd(t), considered for time intervals sufficiently long for it to be
in the linear regime, is related to the self-diffusion constant D,
lim
t→∞
d〈∆i(t)2〉
∆t
= 2nD (4.5.2)
where, n is the dimension of the space.
In Figure 4.7, results from simulation studies are shown, exploring the movement of
a single cell under various conditions (r = 10, 30, 90 and tper = 10, 30, 90 min). In
the left-hand column, cell positions (the centre of mass is calculated to determine the
(x, y) coordinate values) are plotted for 50 simulations. The central column shows the
corresponding displacement (d(t)=
√
~xCM(t+ ∆t)−~xCM(0), with ∆t = 1 min) for each
simulation in 24 hrs with the red thick line representing the average displacement of
all simulations. The bottom plot summarises the averages for each of the scenarios.
The right-hand column shows the instantaneous speed (S = ~xCM(t+ ∆t)−~xCM(t)) of
a cell for a single experiment. In the experimental system of Lee et al. [131], persistent
random walks were performed by bovine pulmonary artery ECs (without FGF2) with
tper ∼ 30 min and S ∼ 0.4− 0.5 µm/min. Therefore, by fixing tper = 30 min, we found
that r ≃ 30 is to be the value which gives the right estimation for speed.
In addition, since equation (4.5.2) implies 〈∆i(t)〉 ∼ 2
√
Dt (for n = 2), we approxi-
mated the diffusion of the random walk (for r = 30 and tper = 30 min) to be D =
0.625 µm2/min, which is consistent with various estimates (see supplementary mate-
rial in [180]). Figure 4.7 also reveals that speed depends only upon r and not on tper.
In modelling collective endothelial cell motion, Szabo et al. in [242] used tper = 1 hr,
and in [243] Szabo et al. in a study of cell invasion in an ECM environment used tper ∼ 2
hrs for unconstrainedmotion and∼10 hrs in a constrained ECM environment. In [135],
amoebae showed a persistence time ∼10 min beyond which they started to lose their
direction. Experimental studies from Stokes and Lauffenburger [239] on the locomo-
tion of microvessel ECs and fibroblasts have shown that these cells execute persistent
random walks in culture with calculated speed values in the range 0.1-1 µm/min and
tper in 0.1-5 hrs. In [258], Ware et al. studied the effect of epidermal growth factor (EGF)
treatment across a range of human matrix substratum (Amgel) levels on fibroblast mi-
gration speed and persistence time. Findings revealed that, in the absence of EGF,
cell migration speed and directional persistence are relatively independent of Amgel
level. The net effect of EGF is to increase the frequency of changes in the cell direction.
However, the mean persistence time with or without the effect of EGF was ∼30 min.
Taking the above measurements into consideration, we may deduce that speed and
persistence time of cell motion depend on the type of cells and the experimental sys-
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tem. As we mentioned above, with regard to our model, in the absence of any specific
data on EC motility in [173] we use tper = 30 min as described by Lee et al. [131], since
their model shares important similarities with ours (e.g. sparse EC population cultured
without any additional growth factors).
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Figure 4.7: Motion statistics from single cell experiments under various conditions
(r = 10, 30, 90 and tper = 10, 30, 90min) over 24 hrs. The three columns rep-
resent (left to right) cell positions, displacement (d), instantaneous speed.
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4.5.2 Simulations with only ECs
Having assessed the role of migration speed (r) and directional persistence time (tper)
with single cell experiments, in this section, our aim is to investigate the effects of
those on pure EC populations (without PCs) first, and how they affect cell aggregation
(cluster formation) and, therefore, contact inhibition.
4.5.2.1 Effects of migration speed (r) and persistence time (tper) on cluster formation
and contact inhibition
Cell aggregation could be governed by multiple factors, such as secreted molecules at-
tracting the cells toward each other (chemotaxis), by changes in the adhesive properties
of cells (cell-cell adhesion), cell proliferation (consecutive divisions of non-migrating
cells), random cell motility, haptokinetic motility (cell-matrix adhesion), and also cell
density.
Figure 4.8 shows results from simulations with only ECs without mitosis. Plots in
the first row show that in a low speed (r = 10; red line) environment, regardless of
the persistence time, the numbers of both individual (I) and clustered (C) ECs remain
approximately constant over 1.5 days. (Note that we define a cluster to be any group
of cells (more than two in number and independent of type), which are in contact.)
That implies little to no clustering, since cells are not able in such a case to move long
distances and contact other cells. On the other hand, in higher speeds (r = 30, 90; blue,
black curves) the likelihood of cell-cell collision increases. However, when r = 90 the
number of individual and clustered cells exhibit a ‘noisy’ behaviour (see last two plots
in the first row) which implies ‘impaired’ (not stable) clustering. The latter relies on
the fact that in high speed scenarios, two cells which collide during their movement
are more likely to detach from each other and return back to individual. This is in
contrast to lower speed scenarios, where cells remain clustered once they contact other
cells (stable clustering). Bar charts in the last three rows confirm results from above;
that is, when r = 30 and tper = 30, 90, the number of individual cells (categorised as
cluster size=1) decreases compared to the other cases, suggesting that mediummotility
(r = 30) enhances clustering.
Figure 4.9 shows results from simulations with only ECs with mitosis. Remark that
tq ∼ 4 hrs represents the quiescent period (see section 4.4.3), the time required from cells
to establish in culture before start moving, dividing etc. Therefore, for each motility
scenario we ran the model for t = 4 hrs and t = 3 days in order to assess clustering
before and after cell division. Results from the last three rows show that all the motility
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scenarios exhibit similar (clustering) results up to 4 hrs (before division). Similarly, no
obvious differences are observed at later time points (3 days), among results from low
motility scenarios (r = 10; tper = 10, 30, 90). However, in medium motility (r = 30)
by increasing tper we notice that the number of small clusters (cluster size=2) decreases
while the number of bigger clusters (cluster size=4) increases. This is a consequence
of the ability of cells to move for a longer time before they change direction, and that
increases the likelihood of making contact with other cells. In the high speed scenario
(r = 90) increased tper results in less clustering; that is, the number of individual cells
increases, while the number of bigger clusters drops. In addition, note that if r = 90
and persistence time is either medium or high (tper = 30, 90), the number of individual
cells in 3 days is greater than the one in 4 hrs. That results from the interchange of cells
from clustered to individual, and vice versa, as was described in Figure 4.8. Plots in
the first row (Figure 4.9) support the aforementioned results. In particular, if r = 90,
the number of individual cells, regardless of tper, does not reach zero as opposed to low
and intermediate cell speeds (r = 10, 30). Furthermore, the individual cells increase as
tper becomes larger; in fact, note that if tper = 30, 90 the number of individual cells (I)
overtakes the number of clustered cells (C).
In biological terms, increased cell speed implies more active and rapid membrane ex-
tensions. Concurrently, there are increased chances for the cell to change direction and,
thus, its persistence time should decrease [258].
Having provided results on EC aggregation from different motility scenarios, a first at-
tempt of our model is to estimate parameter values in equation (4.3.6) such that model
assumptions summarised in section 4.3.1 allow one to reproduce quantitative results
(see Figure 4.2) presented by Orlidge and D’Amore [173].
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Figure 4.8: Simulation results with only ECs (N=16 cells) without mitosis for the dif-
ferent motility scenarios for cell speed (r = 10, 30, 90) and persistence time
(tper = 10, 30, 90 min). First row of plots present the number of ECs over
time. Key: individual cells (I); clustered cells (C). Each curve represents
the mean of 10 simulations for 36 hrs. The plots below present the number
of clusters over size. Error bars show the mean of simulations ± S.E.M.
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Figure 4.9: Simulation results with only ECs (N(0)=16 cells) with mitosis for the dif-
ferent motility scenarios for cell speed (r = 10, 30, 90) and persistence time
(tper = 10, 30, 90 min). First row of plots present the number of ECs over
time. Key: individual cells (I); clustered cells (C). Each curve represents
the mean of 10 simulations. The plots below present the number of clus-
ters over size for both t = 4 hrs (blue bar) and t = 3 days (red bar). Error
bars show the mean of simulations ± S.E.M.
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4.5.2.2 Estimation of parameter a4: strength of contact inhibition
In this section, our aim is to estimate parameter a4, the strength of the mechanical
contact inhibition, in the absence of any other effects (e.g. TGF-β1). Therefore, we ran
simulations with ECs only (for the moment, excluding PCs) by retaining the same cell
density in the in silico domain as in the experimental system of Orlidge and D’Amore
[173]. In the absence of PCs there is no activated TGF-β1 and, therefore, the equation
(4.3.6) is reduced to
dφ
j
EC
dt
=
1
1+ a4 Pj
a1. (4.5.3)
Several scenarios of motility were tested in section 4.5.1. Due to the lack of data on cell
motility from the in vitro experiments in [173], we postulate that cells therein exhibited
medium motility, since they were not affected from any external signals (e.g. addition
of growth factors). Therefore, results that follow were executed in a medium motility
(r = 30) and persistence time (tper = 30) environment, unless otherwise specified.
Figure 4.10 presents the normalised number of ECs (N(t)/N(0)) over time showing the
value of parameter a4 which is closer to the data points. The sparse cell density results
in a step-like endothelial growth for the first∼6 days, however, in the following section
we show that the growth becomes more linear by increasing the number of cells in the
in silico domain.
Figure 4.10: Normalised number of ECs (N(t)/N(0)=16) over time by varying a4, the
strength of contact inhibition. Each curve represents the mean of 10 simu-
lations. The estimated value of a4 ∼ 11 is closer to the experimental data
from Orlidge and D’Amore [173] (represented by ‘◦’), where ECs were
cultured alone (without PCs). For the rest of the simulations a4 is taken to
be a4 = 11, unless otherwise specified.
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4.5.2.3 Vary initial cell density
By considering the step-like EC growth for the first∼6 days as shown in Figure 4.10, in
this section, our aim is to assess the impact of the initial cell density on the EC growth.
Figure 4.11 depicts theoretical predictions for two different endothelial seeding den-
sities (without FGF2). It is shown that if we increase the EC density (N=32 ECs), cell
growth becomes substantially linear. This is a consequence of the increased cell colli-
sions and the more intensive contact inhibition in a higher-density population. On the
other hand, cells in a lower-density population (N=16 ECs) are more synchronised; that
is, the first division times of the majority of cells (mainly individual) are similar which
results in the step-like EC growth.
Regarding the EC density, Szabo et al. [241] in a multicellular sprouting model men-
tioned that cell density determined the interconnectedness of the network structure,
and also influenced the characteristic pattern size. In particular, by measuring density
as the ratio of the area covered by cells and the overall simulation area, at densities
higher than 55%, the linear structures gradually disappeared, whereas at densities un-
der 20%, there were not enough cells to form interconnecting clusters.
Figure 4.11: Normalised number of ECs (N(t)/N(0)) over time by varying the seed-
ing number of ECs (N=16, 32). In a low-density population, we observe
a step-like EC growth. However, in a higher-density population, the
growth becomes more linear. Each group of curves with different colour
presents simulations from different cell density with the thick curves be-
ing the mean of each group of 10 simulations.
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4.5.2.4 Vary initial cell density & cell motility
Results in the previous section highlighted the importance of the initial cell density
on the EC growth. As cell density increases, contact inhibition starts to dominate and
restricts the migration of individual cells. More cells are in contact with others and,
therefore, they become less proliferative. Note that in cancer cells the mechanism of
contact inhibition is usually disrupted, resulting in uncontrolled cell movement and
sustained cell proliferation [245]. Furthermore, Lee et al. [130] using a cellular automa-
ton model for the proliferation of migrating ECs showed that the seeding (initial) cell
density, the cell speed, and the spatial distribution of the cells are crucial parameters in
determining the temporal evolution of cell proliferation rates.
Motivated by the cell behaviour in [245] and findings in [130], in this section, our aim
is to assess the concurrent variation of cell density and cell motility on the EC growth.
Figure 4.12 shows simulation results from three different cell densities (N=16, 32, 96)
and cell speeds (r = 10, 30, 90), while keeping persistence time constant (tper = 30).
It is clear that in a low cell density (N=16) and high motility (r = 90) environment
the proliferation increases. This is a result of the reduced cell collisions (in small N),
and also the detachment of cells from clusters resulting in more individual (and more
proliferative) cells (in large r).
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Figure 4.12: Normalised number of ECs (N(t)/N(0)) over time by varying the seeding
number of ECs (N(0)) along with the cell speed (r). Each group of curves
with different colour presents simulations from different cell density and
cell speed with the thick curves being the mean of each group of 10 sim-
ulations.
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4.5.3 Simulations with both ECs and PCs
The main goal of this study is to shed light on the pericyte-mediated inhibition mech-
anism on the EC growth. Therefore, in this section we extend our in silico model by
incorporating the second vascular cell type, the PCs.
Briefly, as mentioned in section 4.2.2.3, Kondo et al. in [119] suggest that the presence of
PCs is not necessary (rather than conditioned medium (CM) from PCs) to suppress the
EC growth. The latter appears to be in contrast to the results of Orlidge and D’Amore
[173], and Sato and Rifkin [209], who reported that CM from cultivation of PCs or
SMCs alone showed no significant impact on the EC growth. Results from [119] also
suggest that the most abundant anti-angiogenic growth factor in the CM was found to
be soluble TGF-β1, whereas results from [173, 209] suggest that TGF-β1 is secreted once
the ECs and PCs come into contact.
Motivated mainly by the experimental system of Orlidge and D’Amore [173], and also
by the above findings of EC-PC co-culture systems [119, 209], we ran simulations by
incorporating both cell types (N(0)=32 ECs and PCs in a 1:1 ratio as in [173]).
Figure 4.14 shows results on cluster formation over the different motility scenarios (r =
10, 30, 90 and tper = 10, 30, 90 min). Mitosis was not considered in an attempt to assess
which scenario(s) is more likely to result in a total inhibition of the EC growth. If cell
speed is low (r = 10; see plots in first row), it might be suggested that it would not
be possible to result in total inhibition since the number of endothelial individual cells
(cluster size=1) is considerably higher than the other cases (r = 30, 90). Therefore, the
motility scenarios with increased cell speed (and persistence time) are more plausible
candidates for total inhibition of the EC growth, since cell collisions are more frequent.
However, remark that results in section 4.5.2 showed that high cell speed (r = 90)
yields an increased number of individual cells, which eventually leads to higher cell
proliferation. Overall, we suggest that medium cell speed (r = 30) is more likely to
result in total inhibition of the EC growth.
Furthermore, having estimated parameter a4 as described earlier in section 4.5.2, we
aim next to estimate parameter a5, the strength of contact inhibition from the diffusive
TGF-β1 (being secreted when the two cell types make contact with each other) as de-
scribed in equation (4.3.6). Results in Figure 4.15 reveal that even large values of a5 are
not able to totally suppress EC growth, which could suggest that a different parame-
ter/factor should be responsible for the total inhibition.
Simulation results in Figure 4.16 support the last suggestion. It is shown that by in-
creasing the diffusion length
(
L =
√
D
δ
)
of the TGF-β1 (by decreasing the decay rate
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δ) it may lead to total inhibition of the EC growth.
In summary, our model suggests that medium cell speed (and persistence time) along
with an increased diffusion length of TGF-β1 might suffice to totally inhibit the EC
growth in an EC-PC co-culture system. In the aforementioned experimental systems
[119, 173, 209], there was no reference on the effective range of the anti-angiogenic
growth factor, and further experimental work might prove that.
Experimental imageswith ECs and PCs in the co-culture system of Orlidge andD’Amore
[173] (see a representative in Figure 4.13) showprotrusions of PCsmaking long-distance
contacts with ECs. Notably, diffusive TGF-β1 in our model might represent the role of
PC projections, and in the future, it would be interesting to check if long projections
(filopodia) could replace the role of the TGF-β1.
Figure 4.13: Phase-contrast micrograph in [173] depicting the morphology of ECs di-
rectly co-cultured with PCs. ECs and PCs at a 10:1 ratio, illustrating a
centrally located PC extending many processes (short arrows) that con-
tact multiple ECs (long arrows). Bar: 10 µm.
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Figure 4.14: Simulation results with both ECs and PCs (N(0)=32 cells; EC:PC=1:1) in
36 hrs present the number of clusters over size. The different motility sce-
narios for cell speed (r = 10, 30, 90) and persistence time (tper = 10, 30, 90
min) were tested without mitosis. Key: ECs (left bars); PCs (right bars).
Contact energies: JEP = 5 < JEE = 15 ≪ JPP = 100. Error bars show the
mean of 10 simulations ± S.E.M.
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Figure 4.15: Normalised number of ECs (N(t)/N(0)=16) co-cultured with growth-
arrested PCs in a 1:1 ratio over time. We vary a5, the strength of contact
inhibition by the diffusive TGF-β1. Each curve represents the mean of 10
simulations.
Figure 4.16: Normalised number of ECs (N(t)/N(0)) co-cultured with growth-arrested
PCs in a 1:1 ratio over time. We vary δ, the decay rate of TGF-β1
(δ = 0.005, 0.001, 0.0005 ≃ 3.5, 8, 11 cell length). Each curve represents
the mean of 10 simulations.
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4.5.4 Cell ratio studies
In Orlidge and D’Amore [173], to assess the influence of the ratio of ECs to PCs on the
modulation of EC growth, direct co-cultures were established for 10 days at EC:PC ra-
tios of 1:1, 2:1, 5:1, 10:1, and 20:1. In particular, the number of ECs was kept constant
(20,000 cells/well), while the number of PCs was varied. All other experimental condi-
tions remained unchanged. In terms of implementation in our model, the exact ratios
for the aforementioned ratios are 16:16, 16:8, 16:3, 16:2, 16:1, respectively.
Figure 4.17 (right column) shows cell ratio results from [173]. In particular, comparable
inhibition of EC growth was observed at all ratios by day 3 and was constant up to
day 10 in co-culture for the ratios up to and including 10:1. However, when ECs were
co-cultured with PCs at a 20:1 ratio, the inhibition of EC growth was similar to other
ratios at day 3, but steadily diminished over the remainder of the time course.
Figure 4.17 (left column) shows results from our in silicomodel with the different EC:PC
ratios. It is shown that our simulation results for ratios 1:1 and 2:1 are in qualitative
agreement with the experimental results in [173]. However, for the rest of the ratios
our model predicts EC growth in the first two days, whereas the experimental results
show no EC growth until day 3. The exact mechanism for that is unknown, but one
possible explanation could be that the long PC-protrusions (see Figure 4.13) might be
able to suppress multiple ECs being in close proximity.
It is important to note that decreased PC to EC ratios have been observed in several
diseases (e.g. multiple sclerosis [35], brain tumour [268], diabetic retinopathy [83]).
Overall, our model results showed that, indeed, a decreased PC to EC ratio is important
to disrupt the total inhibition of the EC growth.
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simulations experiments 
Figure 4.17: Cell ratio studies for ECs:PCs. Left column: Results from our in silico
model. Right column: Results from Orlidge and D’Amore [173]. Note
that for the simulations the exact ratios for 1:1, 2:1, 5:1, 10:1, 20:1 are 16:16,
16:8, 16:3, 16:2, 16:1, respectively. Each curve represents the mean of 10
simulations. Parameter values used: a4 = 11, a5 = 1000, δ = 0.0005,
r = 30, tper = 30. 113
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4.5.5 Sensitivity analysis
The parameters used in our model (summarised in Table 4.2) were selected so as to fit
data from the experimental system in [173]. However, a sensitivity analysis on some of
those parameters is performed in order to assess any possible variability in clustering
and inhibition of the EC growth.
4.5.5.1 Contact energies:
Contact energies, homotypic (EC-EC, PC-PC) and heterotypic (EC-PC), may play a cru-
cial role in clustering and, therefore, contact inhibition. As we mentioned in section
4.4, in our simulations, unless otherwise stated, we chose JEC,PC = 5 < JEC,EC = 15 ≪
JPC,PC = 100 by assuming that heterotypic contacts are stronger than homotypic. As a
consequence of the large JPC,PC, PCs exist more commonly as individuals rather than
clustered with other PCs and, thereby, more motile in order to search the domain and
make contacts with ECs.
Due to the lack of any experimental (quantitative) data on contact energies (forces), we
aim next to investigate results from different scenarios regarding the homotypic and
heterotypic affinity, in the following way:
1. JEC,PC = 5 < JEC,EC = 15 and vary JPC,PC,
2. JEC,EC = JPC,PC = 5 and vary JEC,PC.
In particular, we are interested in the case where heterotypic are stronger than the ho-
motypic contacts (case (1)), and the inverse via case (2). Figures 4.18 and 4.19 depict
results for the two cases. It is shown that, in terms of clustering, there is not any ob-
vious difference between the two. Regarding the effect of contact inhibition on the
EC growth it would be more informative to assess the effect of these cases on the EC
growth (N(t)/N(0)), as shown in Figure 4.20. In particular, case (1) (see Figure 4.20 (a))
results in total inhibition regardless of the affinity between PCs (JPC,PC). On the other
hand, in case (2) (see Figure 4.20 (b)) large JEC,PC results in increased EC growth, since
the low affinity between ECs and PCs yields less secretion of TGF-β1 and, therefore,
less inhibition.
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Figure 4.18: Simulation results with both ECs and PCs (N=32 cells; EC:PC=1:1)
present the number of clusters over size in 36 hrs. The different motil-
ity scenarios for cell speed (r = 10, 30, 90) and persistence time (tper =
10, 30, 90 min) were tested without mitosis when heterotypic contact en-
ergies are stronger than homotypic (e.g. JEP = 5 < JEE = JPP = 15).
Key: ECs (left bars); PCs (right bars). Error bars show the mean of 10
simulations ± S.E.M.
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Figure 4.19: Simulation results with both ECs and PCs (N=32 cells; EC:PC=1:1)
present the number of clusters over size in 36 hrs. The different motil-
ity scenarios for cell speed (r = 10, 30, 90) and persistence time (tper =
10, 30, 90 min) were tested without mitosis when homotypic contact ener-
gies are stronger than heterotypic (e.g. JEC,EC = JPC,PC = 5 < JEC,PC =
15). Key: ECs (left bars); PCs (right bars). Error bars show the mean of 10
simulations ± S.E.M.
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(a) (b)
Figure 4.20: Normalised number of ECs (N(t)/N(0)) co-cultured with growth-arrested
PCs in a 1:1 ratio by varying contact energies, (a) JPP, and (b) JEP. Each
point represents the mean of 10 simulations for 3 days. The data are mean
± S.E.M.
4.6 The role of FGF2 and model variants
4.6.1 The role of FGF2
As mentioned in section 4.3, our model assumptions are mainly based on the exper-
imental system of Orlidge and D’Amore [173]. In [173], all cultures were grown in
media containing 10% calf serum without any additional growth factors.
It is a fact that the variability in the purity of growth factor preparations and differ-
ing cell culture conditions make comparison among the results difficult. Therefore,
D’Amore and Smith in [40] developed homogeneous mono-cultures of several cell
types (including ECs and PCs) by adding external growth factors (e.g. FGF2) in or-
der to test their effect on cell proliferation.
By considering the mitogenic action of FGF2 and the model set up in [40] the network
diagram in Figure 4.3(b) can change to the one in Figure 4.21. Therefore, we extend our
model by assuming that ECs proliferate at a rate which depends on the concentration of
the FGF2 according to aMichaelis-Menten form and, therefore, equation (4.3.6) changes
to
dφ
j
EC
dt
=
1
1+ a4Pj
1
1+ a5TGFβ1
(
a1 + a2
FGF2
a3 + FGF2
)
. (4.6.1)
The right hand side of equation (4.6.1) specifies the speed of progress through the cycle
117
CHAPTER 4: ENDOTHELIAL-PERICYTE INTERACTIONS IN ANGIOGENESIS
as a function of FGF2. The new constant, a2, is the maximum rate which could be
retrieved in high FGF2 concentrations, while a3 is the FGF2 concentration at which a2
is half maximal.
Furthermore, in [40], ECs were cultured for 3 days in different external FGF2 concen-
trations and the EC number was half maximumwhen FGF2 was ∼1 ng/ml (see Figure
4.22; data). Therefore, the parameter a3 was chosen to be a3 = 1 ng/ml. Regarding
a2 and the FGF2 contribution to the EC proliferation rate, the addition of FGF2 (>4
ng/ml) [40] increased the number of ECs from 10,000 to 120,000 in 3 days. Therefore,
the EC cycle time decreases from ∼36 hrs (as it was in [173]) to ∼20 hrs=1200 MCS,
which implies a1 + a2 =
1
1200 = 0.00083⇒ a2 = 0.00037 MCS−1.
E P 
external 
FGF2 
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Figure 4.21: Network diagram presents the EC-PC autocrine and paracrine interac-
tions explained with the given numbers on the arrows as in Figure 4.3.
Note that in (1b) the FGF2 is not secreted from the ECs (as in Figure 4.3),
but is added externally (uniformly distributed in the domain) as in [40].
Notably, the set up of the two experimental systems [40, 173] was the same except from
the initial cell density (half cell density in [40]). For that reason, in this section we ran
the model with N(0)=8 ECs (instead of N(0)=16 ECs as in section 4.5.2).
Numerical results using equation (4.6.1) are depicted in Figure 4.22 showing the nor-
malised number of ECs (N(t)/N(0)) over uniform FGF2 concentration. It is shown that
in medium motility (r = 30), even by decreasing the strength of contact inhibition
(a4 = 11, 7, 3), our model is not able to fit the data from D’Amore and Smith [40]. Mo-
tivated by the results in Figures 4.8 and 4.9 (EC clustering without and with mitosis,
respectively), where we observed that increased motility (r = 90) can increase cell pro-
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liferation, interestingly, by increasing cell motility (r = 90) and a2, the model was able
to fit the data sufficiently well (see Figure 4.22; magenta curve).
In summary, we may conclude that in sparse cell populations increased cell speed can
relieve contact inhibition and, therefore, increase cell proliferation.
Figure 4.22: Normalised number of ECs (N(t)/N(0)) over uniform concentration of
FGF2 in 3 days, by varying a2, a4, and cell motility (r). The case repre-
sented by the magenta curve can give a good fit to the data redrawn from
[40]. Note that N(0)=8 ECs in order to be consistent with the initial den-
sity in [40]. Parameters: a2 is kept constant (a2 = 0.00037 as estimated in
section 4.4.4.1) for all cases, with the exception of the case represented by
the magenta curve in which a2 = 0.00085.
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4.6.2 Model variants
In this section we present twomodel alternatives bywhich the EC population can triple
in about 3 days as in D’Amore and Smith [40] (as shown in Figure 4.22; data). Firstly,
we consider a stronger affinity of ECs to the medium (ECM) and, secondly, a lower
affinity between the daughter cells for a certain period of time.
4.6.2.1 Strong affinity between ECs and the medium
ECs have been noted to prefer coatings with some matrix component [192], whereas
PCs, unlike ECs, generally grow at similar rates regardless of the substrates [192].
Therefore, the affinity between ECs and the medium (JEC,Medium) is another important
factor which could impact EC cycle, and it would probably be reasonable to consider
a strong affinity between ECs and the medium. Figure 4.23 shows results for the mor-
phology (clustering) and the quantified contact inhibition when JEC,Medium = 10 <
JEC,EC = 15 compared to the default model in which parameters used are as shown in
Table 4.2 (JEC,EC = 15 < JEC,Medium = 20). Figure 4.23(d) shows that smaller JEC,Medium
results in considerably increased cell proliferation compared to the default model, and
notably, the EC population can triple in approximately 3 days.
4.6.2.2 Low affinity between daughter cells
Lee et al. in [131] studied the in vitro EC locomotion and observed that immediately
after a cell division, the daughter cells moved away from each other. The distance
between daughter cells was about 20 µm.
Motivated by this finding, we extend our model by allowing daughter cells to repre-
sent a different cell type for a certain period of time (tdaughter) after detachment (with
Jdaughter,daughter = 100). Subsequently, they convert back into their initial type (EC).
Since daughter cells remain as individual cells (due to their low affinity), they are in
turn more motile and not contact inhibited. Therefore, the EC population is able to
triple in approximately 3 days if tdaughter is sufficiently large (see Figure 4.23 (d)), which
is comparable with the case in section 4.6.2.1.
Overall, both model alternatives as presented above can fit the experimental data from
D’Amore and Smith [40] (Figure 4.23 (d)). However, it is worthy to note that results in
Figure 4.23 (e) show that the the case in section 4.6.2.1 can result in slightly increased
area coverage of the domain compared to the case in section 4.6.2.2, because in the
former case cells are more well spread in the medium.
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(a) (b)
(c)
(d) (e)
Figure 4.23: Cluster formation in 3 days for (a) the default model (parameters used
as in Table 4.2), (b) strong affinity between ECs and the medium (section
4.6.2.1), with JEC,Medium = 10 < JEC,EC = 15, and (c) low affinity between
daughter cells (section 4.6.2.2), with tdaughter = 1300 MCS. Key: ECs (red);
EC daughter cells (blue). (d) Normalised number of ECs (N(t)/N(0)), and
(e) area coverage (%) for the different cases (a)-(c). Note that in the default
model, N(0)=16 ECs (as in [173]), and in the other two cases, N(0)=8 ECs
(as in [40]).
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4.7 Discussion
In this chapter, we have developed a 2-D Cellular Potts Model (CPM) with the aim
to understand the dynamics of interactions between two of the main vascular cell
types, the endothelial cells (ECs) and pericytes (PCs). In particular, we focused on
the main mechanisms responsible for the total inhibition of the EC growth in an EC-PC
co-culture system.
Vascular formation involves a complex interplay of signals from ECs, PCs, and non-
vascular cells required for proper vessel assembly and function. These interactions
are both temporally and spatially regulated. PCs play an important role in vascular
stability and are integral to injury responses.
The process of EC-PC interaction is a result of cell-cell adhesion, cell division, and
cell migration, that involves a complex interplay among different interaction and con-
trol mechanisms on the cellular (and subcellular) level. To gain insight into this well-
orchestrated interplay, in vitro EC-PC co-culture studies have been performed [40, 119,
173, 209], which revealed the pericyte-mediated suppression of the EC growth.
Our model assumptions and validation were mainly based on the experimental system
of Orlidge andD’Amore [173]. The authors suggest that the inhibition of the EC growth
depends on the co-existence and contact of the two cell types. In particular, a latent
form of the anti-angiogenic growth factor TGF-β1 is activated only when ECs and PCs
contact each other. However, the last assumption is in contrast to observations from
the experimental system of Kondo et al. [119]. The latter suggests that inhibition of
the EC growth in pure EC cultures is also possible in medium conditioned by soluble
TGF-β1 rather than by actual contact between the two cell types. In our model, we
allowed TGF-β1 to be secreted from both cell types at their contact area and diffuse in
the domain.
Motivated by the sparse cell population in [173], we incorporated actual cell motility
in the CPM framework (and not only the membrane fluctuations). This allowed cells
to move randomly in the domain and make contacts with other cells. We determined
two foundational parameters of motility, speed (r) and persistence time (tper), in order
to gain a better insight into the role of cell motility on cell aggregation and, therefore,
contact inhibition. When cells collide with each other with high speed they might de-
tach depending on their predefined direction. On the other hand, cells may not leave
each other and adhere tightly together if they have about the same direction.
Another advance of our model is that the proliferation of the ECs was implemented via
a phase cell cycle model. Once ECs become mature enough they divide and begin to
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form small clusters. Note that the PCs in [173] were growth-arrested, which was also
the case in our model.
Overall, cells in our model can proliferate, migrate, and aggregate with other cells.
When clusters become big enough they may enlarge even more by merging with ad-
jacent clusters. Aggregation could also be governed by several other factors, such as
secreted molecules attracting the cells toward each other or by changes in the adhesive
properties of cells. Growth factors might also increase the speed of the cells [131, 243],
and extracellular matrix (ECM) may enhance the persistence of cell motion [243]. In
the current study, cells divide and migrate randomly without the effect of any external
factor (e.g. FGF2, ECM). However, this would be an interesting extension to address in
future work.
In vitro experimental data from corpus luteum presented in Chapter 3, suggest that
cell or whole cluster death is an important factor which could impact the overall cell
population. However, in our model cell death mechanisms were not considered, since
results in [173] have not shown any indication on that.
All the aforementioned mechanisms (e.g. motility, division) incorporated in the in silico
model collectively act together to give the macroscopic result (clustering). Most of the
model parameters were estimated from the experimental studies [40, 131, 173] and sim-
ulated results resembled efficiently the experimental data in [173]. That was achieved
by following a systematic approach. That is, we started with single cell experiments,
and by fixing tper from [131], we estimated cell speed (r) as in [131]. Then by using
pure EC populations we estimated a4, the contact inhibition parameter, which fits the
growth data in [173]. Cluster formation with and without mitosis was also assessed in
three different motility scenarios (low, medium, and high motility). Simulation results
in sections 4.5.1 and 4.5.2 showed that motility plays a critical role on cell aggregation.
Particularly, in the first scenario (low motility), cells are not able to make contacts with
neighbours, unless they are initially attached or in close proximity with other cells. On
the other hand, medium and high motility scenarios can enhance cell collisions. How-
ever, in high motility clustered cells may separate from each other and return back to
their individual (and more motile) stage. Individual cells are not contact inhibited and,
therefore, this could eventually result in increased cell proliferation. By considering
the above findings, we may suggest that mediummotility is able to enhance clustering
and, thereby, increase contact inhibition.
Having assessed cell clustering in pure EC populations, we extended our model by
incorporating equal number of growth-arrested PCs and ECs in order to investigate
the mechanism(s) responsible for the total EC growth. Interestingly, our model results
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showed that increasing the diffusion length of the TGF-β1 may result in total inhibition
of the EC growth.
Furthermore, cell ratio (EC:PC) studies in [173] showed that the total inhibition is pos-
sible up to and including a ratio of EC:PC=10:1. However, a ratio of 20:1 results in
total inhibition through the first 3 days of co-culture, followed by resumed EC growth.
These observations suggest that the ability of the PCs to contact multiple ECs may al-
low for a constant degree of EC inhibition in the presence of increasing numbers of ECs.
Decreased PC to EC ratios have been observed following multiple sclerosis [35], brain
tumour [268], diabetic retinopathy [83], aging [64], and in a variety of angiopathies
[244]. However, increased PC coverage may also be an indicator of vascular dysfunc-
tion. Simulation results from our model with different cell ratios showed that, indeed,
a decreased PC to EC ratio is important to disrupt the total inhibition of the EC growth.
Cell-cell adhesion is crucial in cluster formation and, therefore, contact inhibition. For
this reason, sensitivity analysis in contact energies followed in our study in order to
assess the effect of the homotypic (EC-EC, PC-PC) and heterotypic (EC-PC) affinity on
the inhibition of the EC growth. Most importantly, simulation results revealed that if
heterotypic are stronger than the homotypic contacts, then by varying the homotypic
contacts between PCs, no considerable change is observed on the EC growth.
As we mentioned previously, our model assumptions were mainly based on the exper-
imental system in [173], in which cells were cultured without any additional growth
factor. However, D’Amore and Smith [40], in an experimental system with the same
set up as [173] (except from the initial cell density, which was half in [40]) assessed the
effect of FGF2 on the EC growth. Therefore, we extended our model by incorporat-
ing uniform FGF2 concentration in the whole domain. Results showed that higher cell
speed (relieving cells from contact inhibition) was the key factor to allow for the best
fit to the increased EC growth in [40]. Two alternative ways (without FGF2) were also
presented in which we were able to match the EC growth in [40]. Namely, allowing
strong affinity between ECs and the medium or lower affinity between the daughter
cells for a certain period of time. From the above results, it becomes clear that contact
energies may play a crucial role in cell proliferation.
The CPM framework has been proved very efficient to describe in detail all the pro-
cesses governing the growth of contact-inhibited cells. Despite the power of cellular
automata model (e.g. [130]) using thousands of seeding cells and describing efficiently
important cell behaviours (e.g. division, migration), it is not possible to assess the
change of cell shape, one of the main advantages of the CPM, and also the contact area
which is perhaps the only way to test the effect of contact inhibition.
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In conclusion, we believe that our model has the potential to become a predictive tool
since most of its parameters can be fitted from experimental data. A unique feature
of this model is the incorporation of a second vascular cell type, such as pericytes.
We found that the cell-specific parameters, and in particular the contact energies, the
speed of cells (and persistence time) along with the diffusion length of the TGF-β1 have
a significant impact on the inhibition of the EC growth and, therefore, we suggest in
vitro experiments to test our model predictions. However, different limitations of the
model could be noticed and these are discussed in Chapter 6. Overall, it seems probable
that the relationship between ECs and PCs in vitro will be the subject of future studies.
Further understanding of the pericyte behaviour may lead to better insights into the
angiogenic processes, and also, to novel targeted therapies for vascular diseases.
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Sprout formation in angiogenesis
5.1 Introduction
Vascular cell types (e.g. endothelial cells (ECs) and pericytes (PCs)) have the ability to
self-organise geometrically into vascular networks. In Chapter 4, we assessed the EC-
PC cluster formation initiated from randomly dispersed cells, which is the first step in
the in vitro angiogenic process (see Figure 3.1). In this Chapter, we build on this work,
concentrating on the role of two EC phenotypes (the stalk and tip cells) in endothelial
sprout formation.
In angiogenesis, new blood vessels headed by a migrating tip cell sprout from pre-
existing vessels in response to signals. This is known to be regulated by two signalling
pathways concurrently, vascular endothelial growth factor (VEGF) and Notch. VEGF
upregulates Delta-like 4 (Dll4; a Notch ligand) [142] in stalk cells of a nearby blood
vessel. The Notch signalling is responsible for cell fate decisions. In particular, for the
interchange from the stalk to the tip EC phenotype leading to checkerboard (‘salt and
pepper’) patterns along the vessel. Stalk cells selected to become tip cells are the ones
with higher levels of Dll4.
Novel retinal angiogenesis data from embryonic mouse [Courtesy of Dr. Luisa Iruela-
Arispe] suggest that VEGFAmight be secreted by macrophages (immune cells) located
in close proximity to tip cells. Motivated by existing experimental observations, in
vitro CL data on spout and network formation (see Figure 3.1), and novel results from
Arispe’s Lab, we developed a cell-based, multi-scale mathematical model based on
the cellular potts framework. Our aim is to investigate the sprout evolution initiated
from a parent blood vessel by integrating the two signalling pathways. The model
incorporates three level descriptions: 1) macrophage-mediated VEGFA activates Notch
signalling in a nearby blood vessel, 2) tip and stalk EC phenotypes positioned along
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the sprout (’salt and pepper’ pattern) are dynamically interchangeable depending on
their Dll4 level, and 3) sprout morphology and polarisation depend on chemotaxis
(cells move up VEGFA gradients) and the alignment of the extracellular matrix (ECM)
fibers. The model reproduces phenomena in sprouting angiogenesis, including sprout
morphology, tip competition, and explains and predicts perturbation experiments on
Notch signalling pathway.
5.2 Biological background
5.2.1 Angiogenesis
Angiogenesis, the formation of blood vessels from a pre-existing vasculature, is a pro-
cess whereby capillary sprouts are formed in response to externally supplied angio-
genic stimuli. The new sprouts provide tissues and organs with oxygen and nutrients,
and remove the metabolic waste. Angiogenesis takes place in physiological situations,
such as embryonic development, wound healing and reproduction (e.g. corpus lu-
teum development [197]). The healthy body controls angiogenesis through an intri-
cate balance between pro- and anti-angiogenic factors [28]. Over the years, numerous
growth factors and chemokines have been shown to influence the process. This bal-
ance, though, is sometimes disrupted and angiogenesis also appears in many patholo-
gies, like diabetes [150], rheumatoid arthritis [117], cardiovascular ischemic complica-
tions [25], proliferative retinopathy [63], and cancer [27]. In either case, however, the
well-ordered sequence of events characterising angiogenesis is the same involving sev-
eral sequential steps.
5.2.1.1 In vitro and in vivo models in angiogenesis
Numerous in vivo models for studying angiogenesis have been developed, including
the mouse retina (for review, see [69]) and hindbrain model [73], the corneal pocket
assay [114], the chick chorioallantoic membrane assay [3, 60]. The zebrafish is used as
a model for vertebrate development in many research fields, including vascular biol-
ogy, since blood vessel development in zebrafish follows a spatiotemporally conserved
pattern [101].
In addition, a number of in vitro assays have been developed (discussed in Chapter 4;
for review, see [9]), which have provided important insights into the cellular mecha-
nisms of angiogenesis.
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5.2.1.2 Sprouting angiogenesis
Sprouting angiogenesis is initiated by (e.g. hypoxic) tissues or cells (e.g. macrophages
[56], astrocytes [260]) which demand the formation of new blood vessels and, there-
fore, they secrete a number of chemicals (Figure 5.1). These are collectively known as
tumour angiogenic factors (e.g. vascular endothelial growth factor, VEGF) [59], which
bound to EC receptors of the nearest blood vessel. Subsequently, the extracellular ma-
trix (ECM) and basement membrane, surrounding the ECs, are degraded locally by
activated proteases (e.g. matrix metalloproteinases, MMPs).
How individual ECs adopt specific phenotypes and how they coordinate their behaviour during
sprouting (?)
Several experimental studies have revealed the heterogeneity of a growing vascular
sprout. It is composed of a tip cell at the leading front, followed by stalk cells. The
latter cells comprise the body of the sprout and are responsible for the elongation of the
new vascular branch (Figure 5.1). They also establish junctions with neighbouring cells
and produce basement membrane components to ensure the integrity of the sprout
[184]. Adding to the cellular heterogeneity of a vessel, recent work by Carmeliet and
colleagues describe phalanx cells as the more quiescent type of ECs [152], whereas the
tip and stalk cell phenotypes characterise the ‘activated endothelium’ [75].
Where, when and how the activated endothelium transits to quiescence is poorly un-
derstood. The distinct tip and stalk EC phenotypes display different gene expression
profiles, suggesting that their specification is determined genetically [46]. However, a
single unique gene or protein that can be used reliably and unambiguously as a molec-
ular marker for tip cells has not been identified.
A key pathway, though, regulating the specification of tip and stalk cells is the Notch
signalling pathway which is described next. This finding concurrently emerged from
several groups using three distinct experimental models of angiogenesis including
solid tumour in mice [169, 200], postnatal mouse retinas [86, 142, 240], and zebrafish
embryos [132, 229]. Our model is mainly based on retina angiogenesis, with the main
angiogenic developmental stages described in Figure 5.2.
5.2.2 Notch signalling
Notch signalling is the canonical signalling pathway between neighbouring cells. It
plays an important role in fine-grained patterning processes such as the formation of
checkerboard-like differentiation patterns and sharp boundaries between developing
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Figure 5.1: Schematic of processes involved in a growing vascular sprout. A growing
sprout is mainly composed of tip (red) and stalk (blue) cells, where each EC
phenotype responds differently to a VEGF source (macrophage (brown)).
As guidance posts, macrophages act as ‘bridge cells’ to assist tip cells and
provide precision in preparation for the fusion of these specialised ECs
[56].
tissues [224].
Notch signalling is mediated by the interaction between Notch receptors (Notch 1,
Notch 2, Notch 3, and Notch 4) and Delta/Serrate/LAG-2 (DSL) ligands [23]. Upon
interaction between a Notch receptor in one cell and a DSL ligand in a neighbouring
cell, the Notch intracellular domain (NICD) is cleaved, translocates to the nucleus and
co-activates downstream transcriptional targets.
Notch has a role in various processes such as lateral-inhibition [224], synchronising
cells during somitogenesis [48], asymmetric cell division [13, 205], and neuronal plas-
ticity [4, 136]. In this study, we are mostly interested in the lateral-inhibition mech-
anism, which is responsible for the interchange between stalk and tip EC phenotype
[86].
5.2.2.1 Lateral-inhibition
One of the classical Notch-dependent patterning processes is lateral-inhibition, which
is a general mechanism for the formation of alternating, checkerboard-like, differentia-
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Figure 5.2: Vascular morphogenesis in the mouse retina [91]. The schemes depict the
developmental stages of the mouse retinal vasculature during the first 15
post-natal days (P). Initiation of the primary vascular network begins at P0
when vessels sprout from the optic nerve head, and begin extending and
fusing to form a capillary plexus [52]. The more mature vessels near the
optic nerve head begin to remodel after P3 and develop into an alternating
radial pattern of arteries and veins, connected by capillary beds. As the
edge of the plexus reaches the perimeter of the retina (P7 and 8), vascular
sprouts grow downward and form a secondary vascular plexus. By P15,
the primary and secondary networks have matured and an intermediate
plexus develops between the two established vascular layers [52].
tion patterns.
Lateral-inhibition, mediated by Delta-Notch (D-N) signalling, is used throughout de-
velopment to limit the number of initially equivalent cells that adopt a particular fate. It
is one of the most studied developmental patterning processes. The concept of lateral-
inhibition was initially proposed by Wigglesworth [262] who noticed that new bristles
in the developing kissing bug emerged at positions, which are the most distant from
existing bristles.
Examples of lateral-inhibition include the anchor cell/ventral uterine precursor cell
differentiation in Caenorhabditis elegans [222], bristle patterning in flies [84], neuroge-
nesis in flies and vertebrates [7, 221], and inner ear patterning in vertebrates [79].
Notch signalling is also commonly used for defining boundaries between developing
tissues, for example the formation of wing veins [97] and margin boundaries [43] in the
developing fly and the rhombomere boundaries in vertebrate hindbrain [33].
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5.2.3 Dynamic lateral-inhibition in sprouting angiogenesis: shuffling be-
tween stalk and tip cells
Sprout formation requires the coordinated behaviour of all EC phenotypes. The tip
cell located at the leading edge of the growing vessel senses the environment for an-
giogenic factors through the presence of filopodia. In contrast, the stalk cells situated
behind the tip cells are highly proliferative cells and allow the vessel to elongate to-
wards angiogenic stimuli.
Endothelial tip cells are induced and guided by an extracellular gradient of VEGFA
(and/or VEGFC [75]). ECs express three different VEGF receptors (VEGFR). The ac-
tivity of VEGFR2 (Flk-1) regulates most of the EC responses to VEGFA, including in-
duction of tip cell filopodia and EC migration, proliferation, survival, and vascular
permeability.
What determines which cell eventually becomes a tip cell?
Recent in vivo and in vitro studies fromGerhard et al. in [103] on retina sprout angiogen-
esis revealed that ECs dynamically compete with each other for the tip cell position. In
particular, it was shown that VEGFR2 levels between two cells affect which of the cells
will become a tip cell, in a competitive manner. The authors suggested that the bal-
ance between VEGFR2 and VEGFR1 (Flt-1) expression in individual ECs affects their
potential to become tip cells during sprouting angiogenesis. That is, cells with higher
VEGFR2 levels stand a better chance to take and maintain the leading position.
The tip cell is dynamically challenged and replaced by migrating cells from the stalk
region. This dynamic competition between ECs for a tip or stalk phenotype depends
on the integration of the VEGFA-Dll4-Notch1 signalling pathway, the main focus of the
current work, which is discussed next.
5.2.4 VEGFA-Dll4-Notch1 signalling pathway
One of the hallmark achievements in the field in recent years has been the identification
of the D-N pathway as the instructive regulator of tip versus stalk cell fate [98]. Both the
receptor (Notch1) and ligand (Dll4) are cell bound and thus act only through cell-cell
contact.
The VEGFA-VEGFR2 signalling was shown to upregulate expression of Dll4 in tip cells
[142], allowing Dll4 to activate Notch1 in the adjacent stalk cells, causing suppression
of the tip cell phenotype. Hence, ECs exposed to the highest VEGFA concentration are
most likely to become tip cells. This coordinated regulation ensures the selection of a
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single cell as the leader (e.g. tip), while the adjacent cells become followers (stalk cells).
To form new blood vessels, the endothelial tip cells of two existing vessels come together by the
process of anastomosis. But how do they find each other?
Previous studies have mainly focused on understanding how tip cells initiate vessel
sprouting; so nearly nothing is known about how these cells fuse with neighbour-
ing sprouts to form a perfused vessel. Macrophages, phagocytic cells of the immune
system, seem to provide a bridge and mediate their union [27]. Figure 5.3(a) shows
macrophages (being collocated with VEGFA), which probably act as coordinators for
the angiogenic network formation.
5.2.5 Macrophages: their role in anastomosis
Recently, Fantin and co-workers in [56] reported that, precisely when tip cells are about
to fuse, a process referred to as anastomosis, tissue-resident macrophages are located
in the vicinity of vessel branches. Further, the absence of macrophages or blockade of
their function impairs vessel fusion. The latter highlights the growing evidence for a
link between macrophages and angiogenesis.
It should be noted that there are two types of macrophages. As their name (Greek for
‘big eater’) reflects, they can inhibit angiogenesis by initiating a cell-death program
in ECs and engulfing the dying cells [141]. The macrophages that carry out these
processes are of the type termed M1 [228]. Another type of macrophage, called M2,
promotes angiogenesis by releasing pro-angiogenic factors such as VEGFA [98] and
VEGFC [75] and, thereby, induces tip-cell formation [4,5]. The macrophages that Fantin
and colleagues describe are of type M2, and this is also the type that we are referring
to in our model.
5.2.6 The role of ECM in sprouting angiogenesis: haptotaxis
The ECM is a mesh-like network (see Figure 5.3(b)) with the main components being
proteoglycans, fibrous proteins such as collagen and elastin and adhesive proteins like
laminin and fibronectin.
The ECM has many roles in angiogenesis. It is essential for EC migration, proliferation
and survival, since it provides structural support and chemical cues for cell adhesion
and motility [99]. ECM components like collagen I and fibrin are capable of supporting
chemotactic migration [63]. The density and spatial distribution of ECM proteins such
as fibronectin and collagen can affect the speed and direction of cell migration [49].
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Furthermore, ECs are able to secrete and degrade ECM components.
ECs activated by VEGFA first degrade the basement membrane of the parent vessel
and then migrate into the ECM towards the VEGFA source (e.g. macrophage). The
(a) (b)
Figure 5.3: (a) VEGFA (green) identified by using a soluble Flt-1 probe in retinas at
P7, possibly shows the location of macrophages just behind the tip cells
[Courtesy of Dr. Luisa Iruela-Arispe], (b) Sprouting vasculature (red) is
shown to align over fibronectin network (green) in retinas at P7 [Courtesy
of Dr. Luisa Iruela-Arispe].
local degradation (e.g. via MMPs) and deposition of matrix proteins by ECs and the
heterogeneity of the ECM can all create local gradients of ECM components which can
drive EC migration, a process called haptotaxis. In vitro experiments have shown that
collagen [219] and fibronectin [232] gradients can guide EC migration. Note that in
this study we consider haptotaxis, however, ECM production and degradation are not
being considered.
5.2.7 Elongation & Cell-cell adhesion
A crucial characteristic of sprout formation is (stalk and tip) cell elongation. To elon-
gate the stalk region, stalk cells must also divide, maintain contact with the leading tip
cell, and form a lumen [44]. However, the mechanisms of how trailing cells remain in
contact with the leading front remain mostly unexplored. For instance, VE-cadherin
which clusters at EC interfaces is important to maintain cell-cell contacts, as its ab-
sence induces random non-directional migration of disconnected cells [253]. However,
it is also known that the junctional molecule VE-cadherin shifts the EC response to
VEGFA from proliferation and migration to survival and quiescence [257]. Therefore,
the strength of adhesion between ECs plays a critical role to the sprout formation.
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The junctions between ECs during sprouting are known to be highly contorted, irreg-
ular and indeed dynamic as cells stretch and move [17]. Cell-cell adhesions inhibit cell
migration and need to be broken down to allow cells to migrate. VEGFA can break
endothelial cell-cell contacts by disrupting the VE-cadherin/beta-catenin complex at
adherens junctions [128]. In addition, the adhesion molecule VE-cadherin regulates fu-
sion between ECs of vessel branches. Intriguingly, low levels of VE-cadherin are also
expressed in macrophages, raising the question of whether this molecule promotes the
‘zipping’ of tip cells with macrophage bridge cells.
Having provided the necessary biological background, we proceed to summarise some
relevant mathematical models.
5.3 Mathematical models in sprouting angiogenesis
Angiogenesis modelling is a useful tool for understanding the interplay between the
factors that affect it and for the design of experiments of a predictive nature. In Chapter
1 we discussed in detail a number of mathematical model systems for studying aspects
of angiogenesis. In Table 5.1 we summarise those that have delivered key insights as
models for angiogenic sprouting, and in the next section we present our model.
The aim of the current work is to expand our understanding of sprout evolution through
the VEGFA-Dll4-Notch1 signalling pathway along with the dynamic competition be-
tween stalk and tip cells for the tip cell position. We incorporate all of the mechanisms
in Table 5.1, and in doing so, we improve upon other sprouting angiogenesis models,
which used only some of these.
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Table 5.1: Main mechanisms incorporated in sprouting angiogenesis models
Model/Mechanism Type of model ECM Mitosis VEGF stalk/tip Delta/ D/N
phenotype Notch blockade
Bauer et al. [14] 2-D cellular non-uniform X X X X X
potts model (ECM fibers) secreted from
source
Milde et al. [158] 3-D particle model non-uniform X X X X X
(stalk cell density, (ECM fibers, bound- & soluble- (one leading
particle representation ECM proteolysis) VEGF isoforms tip cell)
of the tip cell)
Bentley et al. [16] 3-D (multi-agent) X X X X X X
lattice model static gradients (‘salt-pepper’
pattern)
Bentley et al. [17] 3-D (multi-agent) X X X X X X
lattice model static gradients (‘salt-pepper’
pattern)
Qutub et al. [191] 3-D lattice model uniform X X X X X
(collagen concentration) static gradients (one leading
tip cell)
Das et al. [41] 3-D lattice model uniform X X X X X
(collagen concentration, bound- & soluble-
ECM proteolysis) VEGF isoforms
McDougall et al. [153] 2-D hybrid uniform X X X X X
discrete-continuum (fibronectin concentration secreted by (one leading
model secreted by astrocytes, astrocytes tip cell)
ECM proteolysis)
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5.4 Model overview
Our multi-scale model consists of three levels. At the cellular level, a discrete lattice
Cellular Potts Model (CPM) considers cell growth, proliferation, elongation, and inter-
cellular adhesion. At the extracellular level, a parabolic partial differential equation
(PDE) describes secretion and diffusion of a chemical concentration (VEGFA) secreted
by the macrophage. At the subcellular level, an ordinary differential equation (ODE)
model is used to model the D-N activity in each cell coupled with the contribution of
VEGFA from the extracellular level. The three levels are closely integrated and their
interplay is depicted in Figure 5.4.
Extracellular level 
 VEGF gradients 
 ECM fibres 
Cellular level 
Cellular Potts Model 
 Adhesion 
 Mitosis 
 Elongation 
 Chemotaxis 
ODE model 
Subcellular level 
 Delta-Notch signalling  
 ? ?ƐĂůƚ-ƉĞƉƉĞƌ ?ƉĂƚƚĞƌŶ ? 
Figure 5.4: Flow chart of the multi-scale model, showing how the micro- and macro-
scales interact with each other.
5.4.1 Cellular level: CPM
The cellular model is based on the CPM [78] framework as described in Chapter 4, and
the cell interactions are characterised through a total energy (or Hamiltonian, H):
H = ∑
(~x,~x′)
J
τ(σ(~x)),τ(σ(~x′))
(
1− δ
σ(~x),σ(~x′)
)
+ λarea ∑
σ>0
(aσ − Aσ)2 + H′, (5.4.1)
where, J are the contact energies, aσ the cell area, Aσ the target cell area, and H
′ can
be any constraint on the cell behaviour. There are three cell types in our model, the
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macrophage, and the two EC phenotypes (stalk and tip cells). In Table 5.2 we sum-
marise the different behaviours of the stalk and tip cells, which are discussed in detail
in the following sections. For each model ingredient we discuss the biology, previous
approaches, and our approach. Note that in Table 5.2 we define target length as a func-
tion of area, which might not be consistent in terms of the units of the two measures.
However, in terms of implementation, we only consider the numerical value of the two
and not their units.
Table 5.2: Stalk and tip cell behaviours
Behaviour Stalk cells Tip cells
1. chemotaxis weak strong
2. growth if adjacent to tip cells X
3. mitosis if cell area(a) > 2a(0) and X
cell cycle time >17 hrs
4. elongation target length = a/2 target length = a/2
(if adjacent to tip cells)
5. switch phenotype become tip become stalk
if Delta>threshold if Delta<threshold
5.4.1.1 Mitosis
It is well accepted that in the absence of EC proliferation, angiogenesis is incomplete.
That is, the ECs fail to reach their target (e.g. the tumour [6]). Sprouting is possible
without proliferation of cells only up to a limited extension length. Proliferation is
necessary to sustain sprouting for a longer period and to grow a large enough sprout
that can reach its target [71].
After the tip cell activation from VEGFA, initially, small sprouts are formed by aggre-
gation and migration of ECs that are recruited from the parent vessel. The sprout will
further extend when some of the ECs in the sprout begin to divide [10, 62]. Tip cells
rarely proliferate [72], although division of the leading cell of intersegmental vessel
(ISV) sprouts in zebrafish has been observed [229]. By contrast, stalk cells are strongly
proliferative, and thus, support sustained elongation of the growing sprout [72]. How-
ever, experimental observations indicate that stalk cell proliferation does not push the
tip cell forward, but rather that the tip cells themselves interact with the surrounding
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substrate to pull the growing sprout further in the direction of the growth [184].
In [158], Milde et al., to account for the cell cycle, assumed that a capillary branches
when its tip cell divides into two daughter cells. After the branching event, there is a
threshold time span before which a tip cell cannot proliferate or branch.
In [17], Bentley et al. excluded cell growth and division in their study by claiming fo-
cus on the early stages of sprouting: migration, fusion and lateral-inhibition, and by
also declaring that cell division is not necessary for initial sprouting and fusion in early
plexus formation [10].
Location of cell division on the sprout
Although the general idea is that proliferation occurs behind the tip cell, there is no
clear view about the exact location of EC mitosis during angiogenesis. Experiments
have shown that proliferation can occur some distance behind the sprout tip [182], at
the base of a new sprout [113], and even at the tip of the sprout [207]. In addition, other
studies suggest that proliferation might occur when the connection between adjacent
cells has been disrupted [10].
Since experimental models have reported conflicting results regarding the precise re-
gion of proliferating cells during angiogenesis [113], Bauer et al. [14] tested different
proliferating regions (namely, only at the tip, immediately behind the tip, three cell
lengths behind the tip, and at the base of the sprout) with no marked differences in
sprout morphology. However, numerical results in [14] indicated that as the prolif-
eration region moves further away from the migrating tip, the average rate of sprout
extension towards the VEGF source increases.
In Qutub and Popel [191], the model assumption that tip cells may also proliferate
(although with a lower probability than stalk cells) has an impact on the total vessel
growth. In the same model, cell elongation had also a significant effect on the total
vessel extension, since tip cell elongation was the stimulus for cell proliferation and
migration; without it, the cell may migrate to an extent, but was not able to proliferate
until stimulated.
Role of VEGF in cell proliferation
In experimental studies, Gerhardt et al. [72] in a study of retinal angiogenesis, and
Geudens and Gerhardt [75] in a review on blood vessel formation, demonstrated that
VEGF independently regulates tip cell migration (via VEGF gradients) and prolifera-
tion of stalk cells (via VEGF concentration). In a review on vascular-specific growth
factors, Yancopoulos et al. [265] noted that VEGF does promote vascular EC prolifera-
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tion, and must work in concert with other factors.
In in silico studies, Qutub and Popel [191] considered VEGF concentration on stalk cell
proliferation, and Dll4 levels on tip cell proliferation, in a probabilistic way.
Mitosis in our model based on cell cycle time
In our cell level model, we postulate that only stalk cells adjacent to tip cells prolifer-
ate. In an attempt to avoid any predefined or probabilistic rules (as in [191]), each cell
carries a clock defined as
dφ
dt
= a1, (5.4.2)
which progresses only when the cell is a stalk cell that is adjacent to a tip cell, and a1
was chosen to be the time conversion between real time and MCS. That is, a1 = 0.01
hrs/MCS (e.g. 1 MCS = 0.01 hrs). A stalk cell can divide if two conditions apply: 1)
its clock (φ) reaches the cell cycle duration (17 hrs as evaluated in section 5.5, which is
very close to the one (18 hrs) used in [14, 30]), and 2) its cell area doubles, which grows
with a rate µ = 2a(0)−a(0)cell cycle =
25
1700 = 0.0147 pixels/MCS. Note that φ(0) ∈ [0, 17], and
when φ(t) = 17 it is reset to zero.
Cell division is simply reassigning half of the area to a new cell id (daughter cell), and
the daughter cells inherit all the properties of their parent.
As we mentioned above, VEGF might influence endothelial proliferation, however, we
simply postulate that the proliferation rate is independent from any external (growth)
factors, which could be considered as a future extension to our model.
5.4.1.2 Elongation
To elongate the stalk region, stalk cells must divide, but cell elongation also seems to
be important. Although the shape of stalk and tip cells is not clearly defined, tip cells
are more elongated and retain a more spindle shape (due to filopodia) during sprout
evolution. As can be observed from experimental images in [75], stalk cells which are
in close contact with tip cells also appeared to be elongated. We suppose that this is
an attempt from stalk cells to retain the integrity of the sprout. That is, if only tip cells
are the ones which are able to elongate it is likely that the head tip cell will eventually
detach from the following stalk cell presumably as a result of the chemotactic strength.
Therefore, in our model, the elongation of the tip cells and only those stalk cells which
are adjacent with tip cells can be incorporated in the model by including an extra re-
duction in the energy equation (5.4.1). That is,
H′length = λlength ∑ (lσ − Lσ(t)) , (5.4.3)
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where, lσ is the length of cell σ along its longest axis, Lσ(t) its target length, and λlength
the strength of the length constraint. Note that we do not assign a constant target length
as in [155], but instead, a dynamic constraint to the cell length
Lσ(t) = aσ(t)/2, (5.4.4)
where, aσ(t) is the current cell area at each MCS. One of the main reasons for imple-
menting tip and stalk cell elongation in the way as described above is to prevent cells
from elongating before tip cell activation. In addition, by dividing cell area by 2, and by
also considering that cells double in size before they divide, it allows the cells to have a
cell length in a range (from aσ(0)/2 to aσ(0)), which is in agreement with experimental
measurements [75].
5.4.2 Extracellular microenvironment
5.4.2.1 VEGFA: concentration and local gradients
VEGF is one of the main growth factors involved in angiogenesis. Experimental stud-
ies have predicted that the absolute VEGF concentration and the VEGF gradient play
separate roles in new blood vessel formation, in a microenvironment-dependent way.
Cells interact with their microenvironment, which is characterised by local concentra-
tion of macrophage-mediated VEGFA, described by the following equation:
∂VEGFA
∂t
= DV∇2VEGFA+ s− δVEGFA, (5.4.5)
where, VEGFA concentration diffuses in the domain (with zero flux boundary condi-
tions) with DV being the diffusion coefficient, s is the secretion rate and δ the linear
decay. Chemotaxis can be incorporated by including an additional reduction in the
total energy (equation (5.4.1)) for extensions and retractions towards higher concentra-
tions of VEGFA (as described in [210])
H′chem = λchem
(
VEGFA(~x)−VEGFA(~x′)) , (5.4.6)
where, ~x′ is the neighbour into which site ~x copies its id (σ), and λchem is the strength of
the chemotactic response up VEGF gradients.
In the in silico studies [16, 17, 191], VEGFA gradient and local VEGFA concentrations
were constant inputs. However, in our model VEGFA is dynamic, and as we will see in
the next section, its concentration leads to up-regulation of Delta [139], whereas local
gradients guide tip cell migration and, thereby, sprout polarisation.
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High VEGF concentrations (pathological conditions)
In Bentley et al. [17], high VEGF concentrations led to sheet formation of multiple tip
cells. This is due to all cells attempting to become tip cells. This emergent sheet-like
sprouting morphology is consistent with observations of developing mouse retinas in
conditions of excessive VEGF concentrations [72].
In Qutub and Popel [191], the model predicted little effect of VEGF concentration on
overall vessel growth within the range of 1-25 ng/ml. At 50 ng/ml VEGF, the average
increase in vessel length looks noticeably higher compared to 25 ng/ml VEGF. How-
ever, the degree of variation in vessel length changes is very high at this concentration,
and in some instances, vessel length change could be similar to those at lower concen-
trations.
There are also a number of other factors that influence VEGF gradients and a cell’s
response to them. ECs themselves may secrete VEGF as they form a sprout. This au-
tocrine behaviour of ECs (which is probably valid in the in vitro rather than the in vivo
case) was modelled previously by Serini et al. [220], and Merks et al. in [155, 157]. In
addition, cells such as pericytes, endothelial cell precursors, smooth muscle cells, and
astrocytes in retina [260] may influence VEGF levels by secretion. ECM heterogeneity
and the presence of different VEGF isoforms (soluble and matrix-bounded as mod-
elled by Milde et al. in [158]) and heparin binding groups on cells could also alter the
response to VEGF gradients.
5.4.2.2 ECM: haptotaxis
ECM is another important factor in the extracellular environment that cells interact
with and affects their behaviour. As mentioned in section 5.2.6, haptotaxis is the di-
rectional migration of cells up ECM gradients or the the sensitivity of cells to absolute
concentrations of ECM components. The latter can be incorporated in the model with
the following energy minimization equation
H′hapt = λECM
(
m(~x)−m(~x′)) , (5.4.7)
where, m(~x) is the ECM concentration at site ~x, and λECM is the strength of the pref-
erential attachment to ECM. Therefore, depending on the thickness of the ECM fibers,
cells will have more affinity to increase or decrease their surface resulting in increased
or decreased spreading, respectively. Further details regarding the ECM implementa-
tion within the CPM framework are provided in section 5.5.
Experimental studies showed that aligned fibers in the ECM can guide cell migration,
and these guiding structures can in turn be remodelled by EC tip cells [134]. Differences
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in ECM rigidity or stiffness can also direct migration. In addition, tip cells must break
through the basement membrane, proteolytically degrade and invade into the ECM in
order to form a new capillary [134]. However, note that remodelling of ECM by ECs,
stiffness of ECM, and ECM degradation are not considered in our model.
The effect of ECM in the sprout formation has been published previously by Bauer et
al. [14], and Milde et al. [158], who explicitly incorporated the role of the ECM. Briefly,
in [14], the authors assumed that branch splitting resulted from ECM inhomogeneities,
and in [158], the authors showed that the structure and density of the ECM has a direct
effect on the morphology, expansion speed and number of branches.
5.4.3 Subcellular level: modelling lateral-inhibition
At the subcellular level, the tip cell activation is regulated via the D-N pathway, which
is stimulated by the macrophage-mediated VEGFA. The contact lateral-inhibition effect
for the exchange of the EC (stalk-tip) phenotype is implemented using a modification
of a well established mathematical framework that has been proposed by Collier [37].
The model is defined by a set of coupled ODEs, which describe the dynamical pro-
cesses of Delta and Notch activation and inhibition in contacting cells. Motivated by
Lobov et al. [142], where the authors acknowledged the dynamical regulation of Delta
expression by VEGFA in the retinal vasculature, we extend Collier’s non-dimensional
model by incorporating the contribution of the VEGF (as defined in equation (5.4.5)) in
the following model,
Delta :
dDj
dt
= v
(
α
VEGF
VEGFh +VEGF
1
1+ bN2j
− Dj
)
,
Notch :
dNj
dt
=
D¯j
2
a+ D¯j
2
− Nj ,
trans− Delta : D¯j = ∑i
DiPij
Pj
,
(5.4.8)
where, Dj, Nj, are the levels of Delta and Notch activity in cell j, respectively. At this
point, it should be noted that Delta ligands and Notch receptors are assumed to be
uniformly distributed on the cell membranes. VEGFh is the sensitivity of Delta to VEGF
or otherwise is the VEGF level at which α, the maximum Delta production rate, is half.
For the trans-Delta, the sum is taken over the immediate (contacting) neighbours i of
cell j, Pj is the perimeter of cell j, and Pij is the common area of cell jwith its neighbour
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cells i, which is defined as
Pij = ∑
(~x,~x′)
(
1− δ
σ(~x),σ(~x′)
) (
1− δ
σ(~x′),0
)
δσ(~x),i, (5.4.9)
with ∑(~x,~x′) summing over all pairs of adjacent sites in the lattice.
Equations (5.4.8) describe (i) the activation of Notch production within each cell as a
function of the levels of (trans-) Delta expressed by neighbouring cells, (ii) the inhibi-
tion of Delta expression by Notch, and (iii) the total (trans-) Delta signal (D¯j) received
by cell j. The novelty in our model compared to Collier et al. [37] is (iv) the activation of
Delta production by extra-cellular VEGF secreted from the macrophage. In the absence
of VEGF signalling, there is no up-regulation of Delta and, therefore, no tip cell acti-
vation. In addition, regarding the VEGFA, we assume an even distribution of VEGFA
molecules and that the molecules are in sufficient abundance that stochastic effects can
be neglected.
The model of Collier et al. [37], and our model presented in equations (5.4.8) incorpo-
rate the implicit assumption that all interactions are non-delayed. However, in reality
the basic production mechanisms that regulate target genes (e.g. Hes [100]) expression
of Notch signalling are associated with time delays and this might be considered for
future work.
In the following we present mathematical analysis on perturbations of the homoge-
neous steady state of equations (5.4.8), and parameter ranges in which the ‘salt and
pepper’ pattern is maintained. In section 5.5 we provide the model set up, and in sec-
tion 5.6 we present results on sprout formation.
5.4.3.1 Analysis of perturbations of the homogeneous steady state
In this section we consider the non-dimensional model as given in equations (5.4.8),
which can be rewritten in the following simplified form
dDj
dt
= v
(
αh(V)g(Nj)− Dj
)
,
dNj
dt
= f (D¯j)− Nj ,
(5.4.10)
where, h(V) =
VEGF
VEGFh +VEGF
, g(Nj) =
1
1+ bN2j
, f (D¯j) =
D¯j
2
a+ D¯j
2
, and D¯j =
∑i
DiPij
Pj
. Note that f , g are continuously differentiable, with f monotonic increasing
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and g monotonic decreasing. Under these conditions there exists exactly one homoge-
neous steady state (HSS), (D∗j ,N
∗
j ) = (αh(V)g(N
∗
j ), f (D¯
∗
j )) =
(
αh(V)g(N∗j ), f
(
D∗j
σ
))
,
where σ = 1, if squares/hexagons; σ = 2, if strings. The analysis in this section applies
to a specific set up in which VEGF is uniform and constant, and that the cells are ar-
ranged into precise configurations (i.e. strings, squares, hexagons). The HSS is defined
as the steady state in which all cells have identical levels of Delta and Notch, and we
wish to determine the patterns that emerge from perturbations about this steady state.
Therefore, we assume that Dj = D
∗
j + D˜j, Nj = N
∗
j + N˜j for D˜j ≪ D∗, N˜j ≪ N∗, and
by also making the following ansatz
D˜(x, t) = Dˆ(t) expikx, (5.4.11)
which allows us to remove the spatial dependency x of D, we get
¯˜D = D˜
K
σ
, (5.4.12)
where K(k), the ‘nearest neighbour contributions’, is defined as
K(k) =


cos(k) (string),K ∈ [−1, 1],
cos(k1) + cos(k2)
2
(squares),K ∈ [−1, 1],
cos(k1) + |cos(k2)|+ cos(k1 + k2)
3
(hexagons),K ∈ [−1/2, 1],
(5.4.13)
with k being the wavenumber (or wave-vector, k = (k1, k2) in two space dimensions).
The system (5.4.10) can be linearised about the HSS to give
dD˜
dt
= v
(
αh(V)g′(N∗)N˜ − D˜) ,
dN˜
dt
= f ′(D
∗
σ )D˜
K
σ
− N˜ ,
(5.4.14)
where F = f ′(D
∗
σ ) =
2a D
∗
σ
(a+( D
∗
σ )
2)2
> 0, G = g′(N∗) = − 2bN∗
(1+bN∗2)2 < 0, and
′ denotes
differentiation. The linearised system (5.4.14) gives the following Jacobian matrix
J(K) =

 −v vαh(V)G
F
K
σ
−1

 . (5.4.15)
We note that the trace, tr(J(K)) = −v− 1, is always negative since v > 0, and
det(J(K)) = v
(
1− αh(V)FGK
σ
)
. (5.4.16)
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From stability analysis we know that if tr(J) < 0 and det(J) > 0 then we have a stable
HSS. As amodel for lateral-inhibition, we are most interested in the case where the HSS
is stable to homogeneous (k = 0), and unstable to heterogeneous (k 6= 0) perturbations.
That is when det(J(1)) > 0, and det(J(K)) < 0 for some K ∈ [−1, 1) or [−1/2, 1).
Remark that G is always negative and, therefore, we exclude the cases when K > 0 (for
which det(J) > 0). In strings/squares we consider the case where K = −1, and for
hexagons where K = −1/2 (when the ℜ(λ) is maximal, with λ the eigenvalue of J(K);
for instance, see Figure 5.5 for strings/squares) and, therefore, if
strings: det(J(−1)) < 0⇔ Φ′
(
K
σ
)
= Φ
′
(−1
2
)
= αh(V)FG < −2,
squares: det(J(−1)) < 0⇔ Φ′′
(
K
σ
)
= Φ
′′
(−1
1
)
= αh(V)FG < −1,
hexagons: det(J(−1/2)) < 0⇔ Φ′′
(
K
σ
)
= Φ
′′
(−1/2
1
)
= αh(V)FG < −2.
(5.4.17)
Figure 5.5: The ℜ(λ1,2) of the eigenvalues λ1,2 (denoted with different colour), eval-
uated from the Jacobian as in (5.4.15), is maximal when K = −1 (for
strings/squares as in (5.4.13)). The parameter values used in the model
(5.4.10): a = 0.01, b = 100, v = 1, VEGFh = 1, VEGF = 1, α = 1.
In Figure 5.6(a)-(b) we explore for which values of α the det(J) in equation (5.4.16)
becomes negative. That is, (a) for strings, when Φ
′
< −2, and (b) for squares and
hexagons, when Φ
′′
< −1,−2, respectively. In Figure 5.6(c) we show that for α ∈
[0.13, 38.7] for strings, for α ∈ [0.07, 19.3] for squares, and for α ∈ [0.16, 4.5] for hexagons,
the HSS is unstable (det(J) < 0) and we get the ‘salt and pepper’ (checkerboard) pat-
tern, otherwise the HSS is stable (det(J) > 0) and no patterning is observed.
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(a)
(b)
strings: 
ɲ ɲ ?с ? ?07 ɲ ?с19.4 0.065 0.075 5.0 19.0 19.3 19.5 
squares: 
ɲ ?с ? ?16 ɲ2 = 4.5 ɲ 0.14 0.18 3.0 4.3 4.7 
hexagons: 
ɲ ?с0.13 ɲ2 = 38.7 ɲ 38 38.4 39 10 0.16 
(c)
Figure 5.6: (a)-(b) Φ
′
and Φ
′′
as in equation (5.4.17) over α (the maximum Delta pro-
duction rate) showing the ranges of α for which we get the checkerboard
pattern. That is, (a) for strings, when Φ
′
< −2, and (b) for squares and
hexagons, when Φ
′′
< −1,−2, respectively. (c) Simulation results for
strings, squares, and hexagons for different values of α as in (a) and (b).
The parameter values as in Figure 5.5. Colourbar: high (red) and low (blue)
Delta levels at 1000 MCS.
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5.5 Methods
This section outlines the basic steps of the in silicomodel development. Our simulations
use the open-source simulation environment CompuCell3D (CC3D) and Python scripts
specifically developed by the author.
5.5.1 Model setup
Our model is considered on a square spatial domain (size 200µm x 200µm; representing
a square of corneal tissue) as depicted in Figure 5.7(a) with the parent vessel located
along one side and the macrophage located at distance L=60 µm from the blood vessel.
Figure 5.7(b) shows the case where the VEGF is uniform in the whole domain and
macrophage is not considered.
L 
(a) (b)
Figure 5.7: Model setup on the numerical domain, (a) with, or (b) withoutmacrophage
(VEGFA source). Key: stalk cells (red); macrophage (blue).
5.5.1.1 ECM
In CC3D, the substrate (e.g. medium) is normally represented as a fixed cell covering
the whole numerical domain. In order to be able to model a non-uniform structure of
the ECM, we used our scripts in MATLAB software package to produce ECM fibers
randomly distributed in the numerical domain as shown in Figure 5.8. We consider
ECM fibers comparable to the cell size, and we assume that the ECM is rigid (fixed
in space). That is, cells do not produce or degrade ECM. Each pixel in the numerical
domain occupied by an ECM fiber is given a non zero (=1) value (and zero elsewhere),
so that the cells can preferentially adhere to the fibers depending on the strength of
ECM attachment (λECM) as in equation (5.4.7).
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1.0
0.5
0.0
Figure 5.8: Extracellular matrix (ECM) structure as implemented in the CPM frame-
work with the colorbar showing the ECM levels.
5.5.2 Space & time conversions
By equating the initial cell volume in the model to the real cell size (e.g. 5x5 pixels2
= 10x10 µm2 [263]), we can convert the lattice spacing to microns (1 pixel = 2 µm). In
addition, we set the time conversion to be 1 MCS = 0.01 hrs, which is slightly different
to the one (1 MCS = 0.016 hrs = 1 min) chosen in Chapter 4 in order to allow for further
investigation of the stalk-tip cell exchange during sprout evolution.
5.5.3 Parameters
The default parameter values used for our simulations are summarised in Table 5.4,
unless otherwise stated. Below we provide a discussion on how some of those were
estimated.
5.5.3.1 Cell cycle time
Remark that in our cell level model (see section 5.4.1.1), stalk cells adjacent to tip cells
can divide based on their cell cycle time (tcycle). This is estimated from available data
on EC numbers from retina at different post-natal time points as given in Table 5.3
[Courtesy of Luisa-Iruela Arispe]. As we mentioned (see Figure 5.2), EC sprouting
from the ophthalmic vein begins around the day of birth, and a dense plexus arrives
at the retinal periphery by post-natal day 7 (P7). For this reason we are interested in
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sprout behaviour around P7 and, therefore, we calculate tcycle as follows,
N7 = N62
24/tcycle
tcycle = 24 log2
(
N7
N6
)
tcycle ≃ 17 hrs, (5.5.1)
where, Nj is the number of ECs in retina at day j.
Table 5.3: Number of ECs in the retina over time (post-natal days)
day 1 2 3 4 5 6 7 9 11
ECs 208 312 998 3891 10903 40934 109896 509348 1183084
5.5.3.2 VEGFA: diffusion, secretion and decay
Our simulations use parameters for VEGFA as in Table 5.4. To isolate the effects of ECM
topology on sprout morphology, we assume that D is constant. This is a simplification,
however, because the ECM is not homogeneous and the growth factors can be bound
to and stored in the ECM.
5.5.3.3 Tip cell activation
In Qutub and Popel [191], a tip cell can be activated if VEGF concentration, [VEGF]>0.5
ng/ml. Without VEGF or with local VEGF levels below this threshold, the cells do not
get activated.
However, in ourmodel, a tip cell is activated if its Delta level is above a non-dimensional
threshold value (D∗ = 0.27). We admit that this threshold has not been evaluated from
any experimental measurements, but this may be evaluated in future experiments.
5.5.3.4 Cell-cell adhesion: contact energies (J)
In all the simulation results that follow in section 5.6, we use the following set of contact
energies: Js,t = 3, Js,s = 3, Jt,t = 10, where s, t stand for stalk and tip cell, respectively. In
doing so, we assume strong adhesion between stalk and tip cells, and weaker adhesion
between tip cells. Therefore, fusion of two tip cells will emerge dynamically (from
the chemotactic direction and/or ECM alignment), and not from preferential adhesion
between tip cells.
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Table 5.4: Default parameter settings for simulations
Parameter Description Value Reference
Cell features:
A cell target area 100 µm2 [263]
T cell-membrane fluctuations 10 /
λarea resistance to changes in size/area 10 /
λlength resistance to changes in length 15 /
λchem(stalk) chemotaxis strength for stalk cells 50 /
λchem(tip) chemotaxis strength for tip cells 200 estimated
λECM strength of preferential attachment to ECM 20 estimated
Adhesion:
Js,t stalk-tip contact energy 3 /
Js,s stalk-stalk contact energy 3 /
Jt,t tip-tip contact energy 10 /
VEGFA:
D diffusion constant VEGFA 10−11 m2/s [180]
s secretion rate VEGFA 10−4 nM/s [180]
δ decay rate VEGFA 10−4 1/s [180]
D∗ Delta threshold for tip cell activation 0.27 /
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5.6 Results
In this section we provide the main results from our model by considering first the
influence of cell shape on D-N (‘salt and pepper’) patterning, and then different sce-
narios (see Table 5.5) regarding VEGF and ECM profiles. Cell shape, sprout width and
sprout polarisation is predominantly determined by the interplay between chemotaxis,
cell-cell (homotypic and heterotypic) adhesion, and the ECM environment. Figure 5.10
shows representative snapshots for each scenario at different time points, and below
we provide results in greater detail.
Table 5.5: Different scenarios regarding VEGF and ECM profiles
Scenarios
1. homogeneous VEGF & homogeneous ECM
2. homogeneous VEGF & heterogeneous ECM
3. static VEGF gradients & homogeneous ECM
4. static VEGF gradients & heterogeneous ECM
5. heterogeneous VEGF & homogeneous ECM
6. heterogeneous VEGF & heterogeneous ECM
5.6.1 Influence of cell shape on D-N patterning
Equation (5.4.17) shows that string (‘salt and pepper’) patterning occurs when Φ
′
<
−2. In Figure 5.9(a) we see that this condition is satisfied for VEGF above a threshold
(VEGF> 0.07). In fixed cell geometries (without cell movement, fluctuations, elonga-
tion etc.) we observe no patterning for VEGF below this threshold, as expected (see
Figure 5.9(b)). However, if cells are allowed to move, this condition does not neces-
sarily hold, and we are able to generate patterning for VEGF< 0.07 (see Figure 5.9(c)).
This happens because if cells are not fixed, D¯j as in equation (5.4.8) changes since Pij
(the contact areas between cell j and its neighbours) change. Note that in Figure 5.9(b),
the cells at the edges of the string have larger Delta levels compared to the others, since
these two cells have only one neighbour, which implies a smaller value of D¯j for them,
which results in increased Delta.
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(a)
0.0473 
0.0237 
0.000 
(b) fixed cells; no patterning
0.0476 
0.0238 
0.000 
(c) not fixed cells; patterning
Figure 5.9: (a) Φ
′
as in equation (5.4.17) over uniform VEGF, (b)-(c) Delta profile with
and without fixing cell geometries, respectively, in 1000 MCS. Parameters
for the model (5.4.10): VEGF= 0.05, α = 1.
In the following, for scenarios 1 and 2 with uniform VEGF, we choose sufficiently large
VEGF (= 1) so that patterning is allowed. In addition, in scenarios 1 to 6 (except from
D-N patterning as in section 5.6.1) we allow for cell movement (cells are not arranged
into precise configurations) and all the other cell behaviours as summarised in Table
5.2.
5.6.2 Scenarios 1 & 2
In scenarios 1 and 2, there is no VEGF gradient, which implies no sprout polarisation.
Figure 5.10 shows that cell proliferation and elongation are undirected and, therefore,
stalk and tip cells evenly fill the space giving a checkerboard-like pattern. This cell
behaviour results in a reduced extent of EC migration (as shown later in Figure 5.11).
That was also found experimentally in [72, 160], where VEGF gradient was removed
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in the retina, via an increased expression of VEGFA in transgenic mouse models. In
scenario 2, it can be observed that the addition of a non-uniform ECM has a weak
effect. A parameter which could potentially have an effect on that is the λECM (the
preferential attachment of cells to the ECM). That is, if λECM is large, the cells are more
attractive onto the ECM fibers. However, we will see later in section 5.7 that this could
adversely affect (decrease) the sprout extension.
5.6.3 Scenarios 3 & 4
In these scenarios we incorporate static VEGF gradients, which eventually lead to
swollen sprout formation either with or without ECM.
Note that results in scenarios 1 to 4 approximately up to day 1 look quite similar. That
is, sprouts are dominated by single elongated tip cells. However, there are distinct dif-
ferences on days 2 and 3. Particularly, in scenarios 3 and 4, cell proliferation is focused
on single sprouts as a result of the steep VEGF gradients.
5.6.4 Scenarios 5 & 6
Here, a fixed macrophage (VEGF source) is responsible for the VEGF gradients. The
resulting morphology of the capillary sprout is determined by two main mechanisms:
the macrophage-mediated VEGFA, which activates the Delta activity in each cell (ac-
cording to equations (5.4.8)), and the D-N signalling pathway which yields the ‘salt
and pepper’ pattern with tip cells migrating up VEGFA gradients.
Figure 5.10 (scenarios 5 and 6) demonstrates the model’s ability to reproduce realistic
capillary sprout morphologies (up to ∼18 hrs). Scenario 5 (with homogeneous ECM)
can give a polarised sprout, but scenario 6 with heterogeneous ECM gives narrower
sprouts in 12-18 hrs.
Therefore, we suggest that scenario 6 provides a close approximation to a growing
vascular sprout as depicted in the schematic in Figure 5.1, and henceforth, all results
shown are derived under scenario 6, unless otherwise stated. However, since the
macrophage is fixed it does not allow for a longer sprout formation, because at late time
points (days 2-3) we observe a mass of cells surrounding the macrophage. Therefore,
in section 5.8 we extend our model by incorporating macrophage motility, a condition
which can allow for longer sprout formation over 3 days.
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1. 
2. 
3. 
4. 
5. 
6. 
Day 1 VEGF ECM Day 2 6 hrs 12 hrs Day 3 18 hrs 
Figure 5.10: Representative snapshots at different time points (up to 3 days) from the
six scenarios regarding different VEGF and ECM profiles as summarised
in Table 5.5. Key: stalk cells (red), tip cells (yellow), fixed macrophage
(blue).
5.6.5 Sprout length & extension speed
Sprout length is determined by measuring the distance from the parent blood vessel
(located at the one side of the domain; see Figure 5.7) to the leading tip cell’s centre
of mass. Average sprout extension speed is then calculated as the final sprout length
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over time. Figure 5.11 shows the average speed of the sprout for the six scenarios (as
in Table 5.5) up to 18 hrs, the time needed from the sprout to reach the macrophage in
scenario 6. Scenarios 5 and 6 are the ones with the highest speed, since cell prolifera-
tion is focused on a single sprout. The results from those two scenarios are in a good
agreement with retinal experimental data [speed ∼3.3 µm/hr between day 5-7; speed
∼4.8 µm/hr between day 7-9] provided by Dr. Luisa-Iruela Arispe.
Figure 5.11: Average speed of sprout in 18 hrs for the six scenarios given in Table 5.5.
Speed in scenarios 5 and 6 give a good approximation to experimental
data. Results are mean ± S.E.M. from 10 simulations for each scenario.
5.6.5.1 Sprout anastomosis (fusion)
When the head tip cell of a growing sprout contacts another sprout (other head tip cell),
new cell-cell junctions are established and the sprouts become connected (anastomosis,
see Figure 5.12). The establishment of new contacts between tip cells is not yet fully
understood. Recent descriptions of macrophage-tip cell interactions, in particular at
sites where two tip cells make contact via their filopodia, raised the hypothesis that
macrophages might act as ‘bridge cells’ that facilitate the contact and possibly stabilise
nascent connections [206, 216].
It is important to note, however, that anastomosis in the complete absence ofmacrophages
is normal, albeit less frequent [206]. Possible receptor-ligand candidates that medi-
ate this interaction are Notch1-Dll4, Tie2-Ang2 or chemokine receptor CXCR4-stromal
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cell-derived factor-1 (SDF1). Interestingly, the Notch1, Tie2 and CXCR4 receptors are
expressed in macrophages [56], whereas their respective ligands Dll4, Ang2 and SDF1
are expressed in tip cells [86].
(a) 8 hrs (b) 12 hrs
(c) 13 hrs (d) 18 hrs
Figure 5.12: Representative simulation snapshots (different realisation of scenario 6
from Figure 5.10) at different time points showing the model’s ability to
reproduce anastomosis. (a)-(b) tip cell fusion (two adjacent tip cells), (c)
one of the two tip cells becomes a stalk cell (lateral-inhibition effect from
Notch signalling), and (d) the leading tip cell moves up the macrophage-
mediated VEGFA gradients. Key: stalk cells (red), tip cells (yellow),
macrophage (blue).
5.6.5.2 No elongation
Here we investigate the effect of cell elongation on the sprout formation in scenario
6. Figure 5.13(a) shows that if stalk cells adjacent to tip cells are not able to elongate,
then the sprout splits. Similarly, Figure 5.13(b) shows that if both stalk and tip cells
are not able to elongate, the same is true. Together this suggests that cell elongation
is necessary for sprouting. It should be noted, however, that if cell proliferation was
increased that could sometimes prevent cell detachment, but the sprout width would
increase which is not desirable (results not shown in this case).
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0.5 hr 1 hr 5 hrs 10 hrs 15 hrs 20 hrs 24 hrs 
a. 
b. 
Figure 5.13: Representative simulation snapshots (derived from scenario 6) with no
cell elongation, a) from the stalk cells (adjacent to tip cells), and b) from
both stalk and tip cells. It can be observed that in (a) from 5 to 10 hrs
a tip cell detaches from the sprout and surrounds the macrophage and,
similarly, in (b) at 5 hrs the macrophage is surrounded by a tip cell. At
later time points more cells follow to end up with a mass of cells around
the macrophage.
5.6.6 Perturbation experiments: D-N knockouts
The VEGFA-Dll4-Notch1 signalling appears to be critical to vascular development. In
this section we summarise published experimental results on VEGFA-Dll4-Notch1 sig-
nalling, and aim to address its importance in sprout growth in in silico knockout exper-
iments.
5.6.6.1 In vitro knockout experiments of Notch signalling
The dynamic interaction between VEGF and Notch signalling was unravelled inde-
pendently by several groups while studying the process of angiogenic sprouting in the
postnatal mouse retina [86, 142, 240]. They all observed Dll4 expression in ECs at the
leading front of the vascular plexus and found that inhibition of D-N signalling results
in increased vascular density due to excessive sprouting.
Similar findings were described in the zebrafish ISV sprouting model. Inhibition of the
Notch pathway induced hyperbranching of the ISVs and led to an increased number of
ECs in the ISVs [132, 229]. By contrast, overexpression of the activated Notch receptor
blocks sprouting of the ISVs [229].
In addition, haploinsufficiency (when in diploid organisms one of the two copies of a
gene is mutated) of the Dll4 gene was embryonically lethal in many mouse strains as a
result of extensive vascular defects [67, 121].
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5.6.6.2 Published in silico knockout experiments
Below we briefly discuss results obtained from two in silicomodels which attempted to
address the effects of D-N knockout experiments on vessel development.
In [191], Qutub and Popel studied the effects of VEGF protein concentrations and Dll4
haploinsufficiency (Dll4+/-) on capillary network formation. Without VEGF or with
local VEGF levels less than 0.6 ng/ml, the cells in the model were not activated. Re-
garding the effect of haploinsufficiency of Dll4 on blood vessel sprouting, it was found
that in Dll4+/- condition, the relative total vessel length and the number of tip cells
in 24 hrs increased compared to control conditions. Note that the Dll4’s activity (and
haploinsufficiency) in [191] is ingrained in the model in a rule-based way, e.g. tip cell
proliferation, the maximum number of tip cells, and the rules in branching are different
in Dll4+/- and Dll4+/+ conditions.
In [16], Bentley et al. implemented the Dll4+/- in silico experiments by varying a param-
eter δ, which controls the expression level of Dll4 in response to VEGF (equivalent to
parameter α in our model (5.4.17)). In particular, by setting δ to 1 which is equivalent to
a Dll4+/- heterozygous knockout genotype (as δ was set to 2 in normal case (Dll4+/+))
showed that the model is unable to give the ‘salt and pepper’ pattern. The lowered
inhibition level causes all cells to be classified as tip cells. The authors suggested that a
Dll4+/- mutant would perform normal patterning at twice the VEGF level. However,
in the following, results from our in silico knockout experiments suggest that the latter
may not always be true.
5.6.6.3 New knockout experiments in our in silico model
In Figure 5.14 we present results from our in silico model in a Dll4+/- condition. We
follow a similar approach as in [16]; that is, vary α (the maximum Delta production
rate). Our parameter choice (e.g. uniform VEGF=1 (as in scenarios 1 and 2), and α = 1)
in the parameter space (α, VEGF) sets our case to be at point A (see Figure 5.14(a)). If
we move from A to B, or B to C, or C to D by halving α each time (see Figures 5.14(b)-
(d)), then we get patterning for all cases since we are in the white region of Figure
5.14(a), where Φ
′
< −2 as in equation (5.4.17). However, if we move from D to E,
we lose patterning (high Delta in all cells). As we mentioned above, Bentley et al. in
[16] suggested that if we double the VEGF level, patterning could be recovered. We
show here an example where if we move from E to F (by doubling VEGF from 1 to 2)
patterning is not recovered (see Figures 5.14(e)-(f)). Therefore, our results suggest that
if α → 0, recovery is not necessarily possible.
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(a)
0.250 
0.125 
0.00 
(b) A→ B; α = 0.5; VEGF = 1
0.00 
0.062 
0.125 
(c) B→ C; α = 0.25; VEGF = 1
0.00 
0.029 
0.059 
(d) C → D; α = 0.12; VEGF = 1
0.00 
0.015 
0.029 
(e) D → E; α = 0.06; VEGF = 1
0.00 
0.016 
0.033 
(f) E→ F; α = 0.06; VEGF = 2
Figure 5.14: (a) VEGF over α (the maximum Delta production) shows the ranges of
patterning when Φ
′
< −2 as in equation (5.4.17). See text (section 5.6.6.3)
regarding the movement from point A to F. (b)-(f) Delta levels in different
combinations of VEGF and α where patterning does or does not occur.
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5.7 Sensitivity analysis
Dynamic rather than strictly rule-based models (e.g. [191]) are necessary for under-
standing the mechanisms of how sprout formation generates robust properties to cell-
cell adhesion, lateral-inhibition (interchange between stalk and tip cell phenotypes),
and environmental changes (e.g. chemotaxis, haptotaxis).
By considering the difficulty to get the exact parameter values either from in vitro or in
vivo experiments, sensitivity analysis allows the link to the robustness of results. In our
model, simulations were performed in which parameters were varied independently
from their reference values presented in Table 5.4.
5.7.1 VEGF decay rate
The spatial distribution of VEGF has several influences on angiogenesis. Firstly, we
varied the VEGF gradient, via the decay rate of VEGF (δ) as in equation (5.4.5).
Figure 5.15(c) shows that in normal decay rates there is directed sprouting and po-
larised proliferation. However, in small decay rates (Figure 5.15(a)-(b)) the sprout mor-
phology dramatically changes. The sprout splits off resulting in a mass of cells sur-
rounding the fixed macrophage, as a consequence of strong chemotaxis induced by
steep VEGF gradients (Figure 5.15(e)). On the other hand, a large decay rate may in-
duce shallow VEGF gradients and low VEGF levels, which in turn do not allow for tip
cell activation (Figure 5.15(d)).
It is also worthy to note that by increasing the VEGF decay rate it could potentially be
regarded as equivalent to an anti-VEGF therapy characterised by the administration of
e.g. a VEGF aptamer, a molecule which binds to VEGF with high affinity so that the
free VEGF available to ECs is reduced [267]. It is important to note though that anti-
VEGF therapy depends on the day that we are referred to and, therefore, on the pericyte
coverage of a sprout. Noteworthy, in retina at day 10 all vessels are fully covered by
pericytes and are resistant to anti-VEGF therapy [107]. Pericytes are crucial to vessel
stabilisation (maturation process). Our model does not currently incorporate pericytes,
but it could be considered for future implementation. Taking the above statements
and findings into account, care should be taken when suggesting any anti-angiogenic
treatments at present.
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(a) δ = 0.0025 (b) δ = 0.005
(c) δ = 0.01 (d) δ = 0.02
(e)
Figure 5.15: The markedly different capillary sprout morphologies (after ∼5 hrs) that
result from small (a)-(b), normal (c), and large (d) VEGF decay rate δ
(1/min). (e) Cross section of VEGF gradients for the four different cases
of δ. Cells of the parent blood vessel are located within 0-10 µm, and the
macrophage at x = 70µm. See Figure 5.7 for the model set up. Key: stalk
cells (red), tip cells (yellow), macrophage (blue).
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5.7.2 Strength of chemotaxis
Chemotaxis promotes migration up the macrophage-mediated VEGFA gradients, and
in this section, we investigate how sprouting depends on the chemotactic strength,
λchem. The value of λchem might depends on the amount of receptors for the chemoat-
tractant expressed by the cells [225], and obviously, is hard to get values in measurable
units. Therefore, a range of values was tested to find a close approximation to a grow-
ing vascular sprout, as depicted in the schematic in Figure 5.1.
In Figure 5.16 we showmorphological results of sprout formation from three examples:
(a) low, (b) intermediate, and (c)-(d) high λchem. Figure 5.16(a) shows that if strength
of chemotaxis from tip cells is low that will eventually prevent sprouting (sprout will
not reach the macrophage). However, if it is large (Figure 5.16(c)-(d)), the sprout splits
off, which is comparable with low VEGF decay rate as it is shown in Figures 5.15(a)-
(b). Strong chemotaxis can increase the extension speed and promote cell elongation,
but the stronger the chemotaxis, the stronger the cell-cell adhesion is needed to keep
cells in contact and avoid cell detachment. Therefore, a better chemotactic response is
achieved at intermediate chemotactic forces (Figure 5.16(b)), where there is a balance
between cell-cell adhesion and chemotactic migration.
(a) λchem = 10 (b) λchem = 200
(c) λchem = 500 (d) λchem = 500
Figure 5.16: Snapshots of growing sprouts after 5 hrs (except (c) 1 hr) by varying the
strength of chemotaxis (λchem) in three different cases, (a) low, (b) inter-
mediate, and (c)-(d) high λchem.
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5.7.3 Strength of preferential attachment to ECM
Next we investigate the role of haptotaxis on the speed and morphology of the sprout
formation by varying the strength of preferential attachment to ECM, λECM (see equa-
tion (5.4.7)), as shown in Figure 5.17. We found, as might be expected, that if λECM
is large (e.g. λECM = 100) the speed decreases and the sprout is not able to reach the
macrophage since cells strongly adhere to the ECM. However, intermediate values (e.g.
λECM = 20) give a good speed approximation to experimental data [speed∼3.3 µm/hr
between day 5-7; speed ∼4.8 µm/hr between day 7-9] provided by Dr. Luisa-Iruela
Arispe. Morphological results are not shown in this case.
Our simulation results are in line with experimental results from DiMilla et al. in [49],
where they showed that the migration behaviour of human smooth muscle cells on
fibronectin and collagen IV varied with the concentration of each matrix protein. In
particular, cells had maximal migration speed at small and intermediate levels of ad-
hesiveness, since at low ECM densities, a cell cannot form strong stable adhesions to
generate traction forces, and at high densities a cell cannot detach adhesions from the
substrate.
Figure 5.17: Average speed of the sprout over λECM (strength of preferential attach-
ment to ECM) in 18 hrs. Intermediate rather than high values of λECM
give a better speed approximation to experimental data. Results are mean
± S.E.M. from 10 simulations for each value of λECM.
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5.8 Model variants
5.8.1 Scenario 6 + Moving macrophage
As we described in section 5.6, scenario 6 provides a close approximation to a grow-
ing vascular sprout as depicted in the schematic in Figure 5.1. However, the fixed
macrophage does not allow for a longer sprout formation, since a mass of cells even-
tually surrounds the macrophage. To tackle this problem, in this section we extend
our model (in scenario 6) by allowing cell (macrophage) motility, as implemented in
Chapter 4 (see equation (4.3.3)),
H′motility = r(cosθ(t), sinθ(t)) · (~x− ~x′), (5.8.1)
with r representing the cell speed, and θ the rotation angle. Two important questions
arise at this point: first, regarding the speed of the macrophage, and second, the time
point that the macrophage should start moving. A reasonable answer to start with
would be to allow the macrophage to start moving from the beginning of each simu-
lation. The speed of the macrophage must still be determined - the optimal would be
to get the same speed (or at least a good approximation) for both the sprout and the
macrophage. However, that would be difficult since the sprout extension speed varies
at different time points depending on the steepness of the VEGF gradient.
5.8.1.1 Macrophage moves from the beginning
In this section we allow the macrophage to move from the beginning of each simula-
tion, and with θ = 0 so that it moves parallel to the x-axis and only to the right-hand
side (away from the blood vessel). Since r represents the speed, it would be appropri-
ate to assess the sprout behaviour at various values of r. In doing this, we found that
for low/medium values (below 3.5 µm/hr as in Figure 5.11), the sprout can reach the
macrophage, and henceforth, the motility and direction of the macrophage depends
only on the dynamics of the sprout. Reassuringly, when r lies within low/medium
ranges we are able to get a sprout up to a certain time point. However, the sprout even-
tually splits, presumably at the point where the VEGF gradients become less steep. In
Figure 5.18 we observe that after 42 hrs the detached section of the sprout continues to
‘push’ (chemotacting towards) the macrophage. On the other hand, if r is large (greater
than 3.5 µm/hr), the sprout is no longer able to reach the macrophage, and eventually
all the cells in the blood vessel become or remain as stalk. Therefore, in this case we get
no sprout formation. Morphological results are not shown in this case.
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Overall, we can conclude that there are two problems: the cell detachment (splitting),
and finding the best match of the speeds between sprout and macrophage. In order to
tackle these problems, in the next section we introduce a different scenario regarding
the macrophage motility.
6 hrs 12 hrs 18 hrs 
24 hrs 30 hrs 36 hrs 
42 hrs 48 hrs 54 hrs 
Figure 5.18: Representative snapshots showing sprout evolution at different time
points with a moving macrophage at low/medium speed (as described
in section 5.8.1.1). The sprout splits after 42 hrs, and the detached section
of the sprout continues to ‘push’ the macrophage. Key: stalk cells (red),
tip cells (yellow), macrophage (blue).
5.8.1.2 Macrophage moves only when in contact with the sprout
In McDougall et al. [153] the authors are referred to the spatio-temporal formation
of the retinal vascular plexus in wild-type mice. In particular, prior to birth, astro-
cytes migrate from the optic nerve over the surface of the inner retina in response to a
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chemotactic gradient of PDGFA. Astrocytes (which could be regarded as the equivalent
to the macrophage in our model), as a respond to PDGFA, express a variety of chemo-
tactic and haptotactic proteins, including VEGFA and fibronectin, which subsequently
induce EC sprouting. Finally, the formation of blood vessels and delivery of oxygen
inhibits further astrocyte activity.
Taking into consideration the (negative) feedback between the astrocytes and the blood
vessels (oxygen), in this section we present an alternative way of macrophage motility.
That is, the macrophage canmove only when it comes in contact with the sprout (either
stalk or tip cell). In doing this, the macrophage gives the appropriate amount of time
to the sprout to reach it (either by elongation due to chemotaxis or cell proliferation
or both). Therefore, the two speeds (sprout and macrophage) become more synchro-
nised and, as a result, we get a straight sprout without cell detachment (see Figure
5.19). However, the problem with cell detachment reappears when we incorporate two
moving macrophages, probably because cell proliferation focuses now on two sprouts
instead of one (see Figure 5.20(a)). By increasing (doubling) cell proliferation rate (a1
in equation (5.4.2)), we found that this could alleviate somehow the problem (see Fig-
ure 5.20(b)), but not always, and also other problems might arise (e.g. splitting of the
parent blood vessel).
In conclusion, we suggest that the ‘macrophage movement in contact idea’ might pro-
vide a balance to the speeds of the sprout and the macrophage, however, the problem
with the cell detachment exists in both motility scenarios, and it remains an open ques-
tion for future work.
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Figure 5.19: Representative snapshots showing sprout evolution at different time
points (up to 3 days) with a moving macrophage (as in section 5.8.1.2)
exhibiting a long sprout formation. Key: stalk cells (red), tip cells (yel-
low), macrophage (blue).
(a) (b)
Figure 5.20: Representative snapshots showing sprout evolution in (a) normal, and
(b) increased stalk cell proliferation rate, by incorporating two moving
macrophages as in section 5.8.1.2. The former case is more likely to result
in sprout splitting.
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5.8.2 Cis-inhibition: mutual inactivation of Notch and Delta
Notch signalling is often used for determining the cell fate between neighbouring cells.
Delta in one cell can bind to and trans-activate Notch in a neighbouring cell. However,
Delta may have a second role, inhibiting Notch activity in its own cell, a process called
cis-inhibition [224] (see Figure 5.21).
Figure 5.21: Schematic taken from [224] shows the double role of Delta in the Notch
signalling pathway: transactivation (Delta from neighbouring cells) has
a positive feedback on Notch, and cis-inhibition (Delta within the same
cell) has a negative feedback on Notch.
Sprinzak et al. [235], by using a mathematical model showed that cis-inhibition could
be explained if Notch and Delta in the same cell bind and mutually inactivate each
other. In this case, the relative levels of Notch and Delta determine the cell’s signalling
state: if a cell has more Notch than Delta it becomes a ‘receiver’ (the cell can receive but
not send). Conversely, if a cell has more Delta than Notch then it becomes a ‘sender’
cell (the cell can send but not receive). For strong cis-interactions the transition be-
tween these two states is extremely sharp which accounts for switch-like behaviours
(e.g. sharp boundaries in wing disc in drosophila [97]).
Motivated by Sprinzak et al. [235], our aim is to investigate any different behaviours
on sprout formation by incorporating cis-inhibition in our model (5.4.8). Therefore, we
suggest the following model
Delta :
dDj
dt
= v
(
α
VEGF
VEGFh +VEGF
1
1+ bN2j
− Dj
)
,
Notch :
dNj
dt
=
D¯j
2
a+ D¯j
2
+ γDj
2
− Nj ,
trans− Delta : D¯j = ∑i
DiPij
Pj
.
(5.8.2)
The difference from the model (5.4.8) is the incorporation of the cis-Delta term (γDj
2:
Delta within the same cell and not from the neighbour cells) in a competitive way with
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the trans-Delta (Delta received from neighbour cells), with γ being the strength of the
cis-inhibition.
In the following we present mathematical analysis on perturbations of the homoge-
neous steady state (HSS) in model (5.8.2), and parameter ranges in which the ‘salt and
pepper’ (checkerboard) pattern does or does not occur.
5.8.2.1 Analysis of perturbations of the homogeneous steady state in the cis-inhibition
model
In this section we use the same model analysis approach as in section (5.4.3.1) by con-
sidering the non-dimensional model as given in equations (5.8.2), which can be rewrit-
ten in the following simplified form
dDj
dt
= v
(
αh(V)g(Nj)− Dj
)
,
dNj
dt
= f (D¯j,Dj)− Nj ,
(5.8.3)
where f (D¯j,Dj) =
D¯j
2
a+ D¯j
2
+ γDj
2
, and h(V), g(Nj), and D¯j as defined in the model
(5.4.10). By linearising about the HSS and removing subscript j (for each cell j), the
model in (5.8.3) changes to
dD˜
dt
= v
(
αh(V)GN˜ − D˜) ,
dN˜
dt
= FD¯(D¯,D)D˜
K
σ
+ FD(D¯,D)D˜− N˜ ,
(5.8.4)
where,
G = g′(N∗),
FD = − 2γDD¯
2
(a+ D¯2 + γD2)2
= − 2γD
∗(D
∗
σ )
2
(a+ (D
∗
σ )
2 + γD∗2)2
,
FD¯ =
2D¯(a+ γD2)
(a+ D¯2 + γD2)2
=
2(D
∗
σ )(a+ γD
∗2)
(a+ (D
∗
σ )
2 + γD∗2)2
,
with subscripts D, D¯ denoting differentiation, K as defined in equation (5.4.13) and
σ = 1, if squares/hexagons; σ = 2, if strings. The linearised system (5.8.4) gives the
following Jacobian matrix
J(K) =

 −v vαh(V)G
FD¯
K
σ
+ FD −1

 . (5.8.5)
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The tr(J) = −v− 1 remains the same as in model (5.4.10), whereas the determinant in
(5.4.16) changes to
det(J(K)) = v
(
1− αh(V)FD¯G
(
K
σ
−Ω
))
, (5.8.6)
where Ω =
γD∗2
a+ γD∗2
, and FD = − 1
σ
ΩFD¯. For instance, by considering the case for
squares (where K = −1; σ = 1), we get
det(J(−1)) = v (1+ αh(V)FD¯G(1+ Ω)) , (5.8.7)
and, therefore, the HSS becomes unstable if
det(J(−1)) < 0⇔ Φ = αh(V)FD¯G(1+ Ω) < −1. (5.8.8)
Figure 5.22(a) shows that for small γ (e.g. γ = 1), Φ < −1 for α > 0.07. However,
for large γ (e.g. γ = 30), Φ > −1 always holds (for any value of α) and, therefore, we
expect no ‘salt and pepper’ patterning. Simulation results in Figure 5.22(b) show that
they are in agreement with the analytical results in Figure 5.22(a).
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Figure 5.22: (a) Φ = αh(V)FD¯G(1+ Ω) (as in equation (5.8.8)) over α (the maximum
Delta production rate). It is shown that if the strength of cis-inhibition is
low (e.g. γ = 1), Φ < −1 for α > 0.07, whereas in large γ (e.g. γ = 30),
Φ > −1 for any value of α. (b) Simulation results for squares for different
values of α as in (a) for which we get patterning or not. The parameter
values as in Figure 5.5. Colourbar: high (red) and low (blue) Delta levels
at 1000 MCS.
5.8.2.2 Role of cis-inhibition on sprout formation
Figure 5.23 depicts representative snapshots of sprout evolution for different values of
α (the maximumDelta production rate) and γ (the strength of cis-inhibition), prompted
by results from Figure 5.22. That is, for small α we chose α = 0.05 < 0.07 and for γ we
chose γ = 1 and γ = 30. Results in Figure 5.23 show that: 1) α is small and, therefore,
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there is no tip cell activation (all cells remain as stalk cells), 2) normal stalk/tip cell
selection and sprouting, 3) tip cells can stay next to each other for longer before some
of them convert into stalks, as a consequence of the increased α, 4) further increment
of α allows tip cells to stay next to each other for even longer, which leads to sprout
splitting (in approximately 5 hrs), and in 5) all cells try to become tip cells due to the
strong cis-inhibition (large γ), which also causes the sprout to split.
 
1). ɶс ?  
   ɲс ? ? ? ? 
 
 
 
2). ɶс ? 
     ɲс ? 
 
 
 
3). ɶс ? 
     ɲс ?0 
 
 
 
4). ɶс ? 
     ɲс30 
 
 
 
5). ɶс ? ?  
     ɲс ? 
1 hr 2.5 hrs 5 hrs 10 hrs 15 hrs 20 hrs 24 hrs 
Figure 5.23: Representative snapshots showing sprout evolution at different time
points by varying α (the maximum Delta production rate) and γ (the
strength of cis-inhibition) in the cis-model (5.8.2) as described in section
5.8.2.2.
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5.9 Discussion
In this chapter, we have developed a 2-D Cellular Potts Model (CPM) with the aim
to understand the dynamic interaction between stalk and tip cells (two endothelial
cell (EC) phenotypes) during sprout formation integrated via the VEGFA-Delta-Notch
signalling pathway.
Sprouting angiogenesis, the initiation of microvessel growth, plays an essential role
in development, reproduction (e.g. corpus luteum development; see Figure 3.1), re-
pair, and is also a prominent feature in tumour formation as well as in a variety of
diseases. It requires activation of normally quiescent ECs in pre-existing blood ves-
sels, breakdown of existing basement membranes, migration of activated cells led by
one or more endothelial tip cells and proliferation of a subset of activated ECs (stalk
cells). The complex biological processes leading to sprout formation are a consequence
of cell-level decisions that are based on global signals (e.g. VEGF signalling) and near-
neighbour communication (e.g. Delta-Notch (D-N) signalling). Cell shape and cell-cell
(homotypic and heterotypic) contacts are two significant variables in such processes (as
was the case in Chapter 4) and, therefore, we chose the CPM framework for the model
implementation.
In our model we assessed six different scenarios regarding homogeneous and hetero-
geneous VEGF and extracellular matrix (ECM) profiles on sprout morphology. In par-
ticular, two with homogeneous/uniform VEGF (no gradients), two with static VEGF
gradients, and two with VEGF gradients emerged from a fixed macrophage. In each
pair of scenarios we alternated between uniform and non-uniform ECM. For the non-
uniform structure of the ECM, we used ECM fibers randomly distributed in the do-
main. In the last two scenarios, we started our simulations with a parent blood ves-
sel located at the one side of the numerical domain and the macrophage (the VEGFA
source) at some distance away from the vessel (for the model set up, see Figure 5.7).
Initially, the vessel is quiescent, only composed of stalk cells, and it becomes activated
once the first tip cell appears. Experimental studies have revealed a dynamic shuffling
of tip and stalk cells at the leading front of growing sprouts challenging the idea of
stable tip and stalk cell selection [75]. This dynamic behaviour was incorporated in
our model (compared to other mathematical models using fixed cell positions) in the
following way. A stalk cell may become a tip cell if its Delta level, which is upreg-
ulated from the macrophage-mediated VEGFA, exceeds a threshold value. In turn, a
fine-tuned feedback loop between VEGFA and D-N signalling establishes a ‘salt and
pepper’ distribution (checkerboard pattern) of stalk and tip cells within the activated
endothelium. Cells constantly have to re-evaluate the VEGFA-Delta-Notch signalling
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loop when they meet new neighbours, and the lateral-inhibition effect via the Notch
signalling defines the (interchangeable) fate of the (stalk and tip) cells in the parent
vessel and the new sprout. Stalk cells adjacent to tip cells may proliferate and elongate
to support sprout elongation. The proliferation of stalk cells was based on the cell cycle
time estimated from available retinal experimental data [Courtesy of Dr. Luisa-Iruela
Arispe]. Tip cells are allowed to elongate, but not to proliferate [72]. The ‘head’ tip
cell leads the sprout forward distinguishing it from other tip cells in the sprout having
the maximum VEGFA level compared to any other cell. As the stalk and tip cells mi-
grate through the ECM following up the chemotactic (moving up VEGFA gradients)
and haptotactic cues (moving preferably along ECM fibers if in a scenario with non-
uniform ECM), they define the morphology of the outgrowing sprout, with tip cells
leading the sprout polarisation. Tip cells contact other tip cells (anastomosis) to add
new vessel circuits to the existing network, a result which is also dynamically captured
in our model.
Briefly, the no gradient scenarios (1 and 2) resulted in a mass of elongated but undi-
rected cells, which evenly fill the space with a checkerboard-like pattern of stalk and tip
cells (see Figure 5.10). However, the scenarios (3 and 4) with static gradients resulted in
big swollen sprouts. Our aimwas to reproduce the sprout formation as depicted in Fig-
ure 5.1. That was achieved with the last two scenarios (5 and 6) with the macrophage.
In particular, there was narrower sprout formation in non-uniform ECM (scenario 6)
compared to the uniform ECM (scenario 5). The latter case resulted in slightly swollen
sprouts since cells have the same attachment preference to the ECM everywhere in the
domain.
By considering the above results, we may conclude that narrow sprout formation (as
in Figure 5.1) can be closely approximated under the scenario 6 with heterogeneous
VEGF (with macrophage) and heterogeneous (non-uniform) ECM in ∼18 hrs. How-
ever, at later time points cells start surrounding the fixed macrophage without being
able to produce a longer sprout formation (see Figure 5.10). To tackle this problem,
we extended our model by incorporating macrophage motility (moving away from
the blood vessel), so that the sprout can prolong further. Interesting questions which
arise at this point concern the time that the macrophage should start moving, and its
speed. To begin with, we simply allowed the macrophage to start moving from the
beginning of a simulation. Regarding its speed, since it is difficult to achieve equality
between the speeds of the sprout and the macrophage, we assessed various speeds of
the macrophage. We found that low or medium macrophage speeds could result in
sprout formation of a limited length because of sprout splitting. On the other hand,
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high speed resulted in no sprouting because the macrophage moves too fast and VEGF
gradients do not allow for tip cell activation. Therefore, all of the cells in the blood
vessel remained as stalks. In order to alleviate the problems with the speed of the
macrophage and the sprout splitting, we presented an alternative way of macrophage
motility. That is, the macrophage can move only when it comes in contact with the
sprout implying that there exists some form of feedbackmechanism between the sprout
and the macrophage. In that way, we achieved a better balance between the speeds of
the sprout and the macrophage, resulting in a straight and long sprout along the whole
numerical domain without splitting (see Figure 5.19). However, in an attempt to get
multiple sprouts or network development we further extended the model by intro-
ducing two moving macrophages. In that case, the splitting problem was once again
evident, since cell proliferation was not able to sustain two long sprouts. By increas-
ing cell proliferation rate, we found that this could partially solve the problem, but not
always. Therefore, the problem with sprout splitting remains as an open question for
future work.
Sensitivity analysis was performed for key parameters, such as the VEGF decay rate
(δ), the strength of chemotaxis (λchem), and the strength of the attachment to the ECM
(λECM). In particular, in basal decay rates there is directed sprouting and polarised
proliferation. However, in small δ the sprout eventually splits, whereas in large δ there
is no tip cell activation and, therefore, no sprout formation. Regarding λchem, if it is
small, the sprout is not able to reach the macrophage, whereas in large λchem the sprout
splits. It was also shown that the value of λECM affects the speed of the sprout. As
might be expected, if λECM is large the speed of the sprout falls below the available
experimental measurements since cells strongly adhere to the ECM.
Overall, our model has reproduced many experimentally observed aspects of sprout
formation including tip cell selection and a realistic sprout formation. A nice feature
of this model is its ability to form sprouts as a result of natural dynamics from the
VEGFA-Delta-Notch signalling and tip cell competition without emerging from prede-
fined probabilistic rules (e.g. [41, 191]). Various studies [157, 220] hypothesized that
autocrine regulation of the chemoattractant VEGF (playing the role of ECM) is respon-
sible for the formation of vascular networks in vitro. However, in vivo this might not
be true. Therefore, we explicitly incorporated the role of ECM instead of using a short
diffusive (and unrealistic) VEGF secreted from cells. In reality, active tip cells produce
matrix metalloproteinases (MMPs) which allow them to invade the ECM. However, in
this study MMP secretion and proteolysis were not considered.
In conclusion, although there are limitations in the current model, we believe that it in-
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corporates several biological assumptions allowing them to emerge dynamically lead-
ing to realistic sprouting morphology and extension speed.
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Conclusions & Future work
The corpus luteum (CL) is a tissue which develops in the ovary, in the wound space
created by follicular ovulation, and produces the progesterone needed for pregnancy.
The CL consists of several vascular (e.g. endothelial cells (ECs), pericytes (PCs)), and
avascular (e.g. luteal cells (LCs), immune cells) cell types. LCs are the main cell type
responsible for the progesterone production. The rapid growth of the CL has been
compared with the most malignant vascular tumours [197]. It requires angiogenesis,
the creation of new blood vessels from pre-existing ones, a process which is regulated
by several growth factors, e.g. fibroblast growth factor 2 (FGF2). Inadequate vascu-
larisation is likely to result in poor CL function, which is linked to infertility in cows
[146].
Motivated by the importance of angiogenesis on CL growth and its possible impact on
fertility, our focus throughout has been placed upon the interplay among the different
scale levels to tackle such a biological problem, e.g. tissue, cellular, subcellular, and
exracellular level.
Firstly, in Chapter 2, we started with a coarse-grained level (the tissue) with the de-
velopment of a time-dependent ordinary differential equation (ODE) model for the CL
growth. The four model variables are the volumes of the ECs, LCs, and stromal cells
(such as PCs), and the concentration of FGF2. We assumed that the CL volume is a
continuum of the volumes of the three cell types. The ECs (which represent the vascu-
lar density in the CL) enhance the proliferation rate of the other two cell types, and the
FGF2 (produced by ECs and LCs) enhances the EC proliferation rate. We postulated
that if the CL volume exceeds a threshold value, then cell growth is inhibited. We de-
fined the discontinuity boundary (Σ) to be the surface at which the volume threshold is
attained. This threshold separates the model into different cases: above, below, or on
Σ. Therefore, the model was analysed as a Filippov (piece-wise smooth) system. We
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applied stability analysis and bifurcation theory for the standard (when the CL volume
is above or below the threshold value), and sliding (when the CL volume is on the dis-
continuity) solutions. To investigate the importance of angiogenesis on CL growth we
determined how the system dynamics change as ρ5, the maximal EC proliferation rate,
is varied. In a weak angiogenic environment (low ρ5), the CL volume remains constant
(sliding on the discontinuity boundary), and the system evolves to one of two solutions.
If the growth rate of LCs exceeds that of the stromal cells, then the LCs grow at the ex-
pense of the stromal cells with the latter eventually not being able to survive. In that
case, LCs produce high amounts of progesterone acquired for embryo development.
However, low ρ5, implies few blood vessel (ECs) development, which is probably not
adequate for progesterone transportation to the uterus. Alternatively, if the stromal
cells are more proliferative, they dominate the CL, and progesterone production ceases
(since LCs vanish). In both cases, low progesterone compromises pregnancy. In a high
angiogenic environment (high ρ5), the system leaves the discontinuity boundary and
evolves to a steady state for which the CL contains only blood vessels, which is bio-
logically implausible. For intermediate values of ρ5, a healthy growth of the CL (with
all its cellular components being present) is maintained, which is necessary to sustain
a healthy pregnancy.
Motivated by in vitro CL (morphological and quantitative) data provided in Chapter 3,
an important question arises about the role of cell communication in cell aggregation
and sprout formation. In particular, in Chapter 3 we summarised published results
[11, 34, 201, 202], including novel ones from Robinson’s Lab focusing on the endothelial
and pericyte temporal growth and cluster formation. Interesting observations emerged
from preliminary results. Notably, some EC clusters vanish during the multi-cell type
(incorporating all the CL cell types) system, probably due to reduced survivability of
ECs or some apoptotic cells within a cluster attract immune cells which in turn digest
thewhole cluster. Another notable observation is the cross-talk between individual PCs
and endothelial clusters. Double localisation (cell staining) of ECs and PCs showed
that PCs are possibly attracted by EC clusters, and also revealed that they may form
an integral part of them (see Figure 3.7). Immunocytochemistry techniques, however,
proved to be difficult at the early time points (e.g. 6hrs, 12 hrs) and image analysis
and quantification of results was not possible. In addition, the experimental systems
in Robinson’s Lab use all the CL cell types in the same in vitro culture providing a
closer approximation to the in vivo environment compared to other in vitro cultures
which use only a single cell type (mainly ECs). However, this complicates matters in
terms of distinguishing cell behaviours and factors which contribute to the overall cell
dynamics. Therefore, in the next Chapter which deals with cell aggregation we used
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data from literature, mainly from Orlidge and D’Amore [173].
In Chapter 4, we looked at the next finer scale (the cell level) in order to model the
EC-PC interactions. While the ECs are the better characterised of the two, PCs are
now coming into focus as important regulators of angiogenesis and blood vessel func-
tion. In an attempt to understand the main angiogenic processes, several experimental
systems to date have been developed in vitro by incorporating homogeneous EC popu-
lations. Very few of them, however, have studied heterogeneous co-cultures with both
cell types. Orlidge and D’Amore published some intriguing results in their study [173].
They found that the presence of PCs could totally inhibit the EC growth, by suggest-
ing that this could be a result of the transforming growth factor-β (TGF-β), activated
once the two cell types come into contact. Contact inhibition plays a significant role
in developmental angiogenesis and tissue/tumour growth, and so our aim was to in-
vestigate the possible mechanisms which can lead to total inhibition of the EC growth.
Contact between cells implies that contact area (therefore, cell shape) and cell-cell con-
tact energies (forces) would be important variables. As a consequence, we decided to
use a cellular potts model (CPM) within which these variables can be explicitly incor-
porated. The main assumptions in our model were adopted from [173]. In particular,
ECs and growth arrested PCs were cultured in a 1:1 ratio, with no addition of any
external growth factor in the culture. In [173], the low and sparse initial seeding cell
density imply little to no contact between the cells. For that reason, in our model we
used random (since cells are unbiased from any growth factor) cell motility in order to
allow for cell-cell interaction, with both cell types being able to move randomly in the
numerical domain. The motility of cells was governed by the speed (r), and the persis-
tence time (tper; time of movement without change of direction). EC division was also
considered in our CPM and that was implemented via a phase cell cycle. Mechanical
contact between cells and diffusive TGF-β secreted from both ECs and PCs at their con-
tact area are two factors which contributed to delayed EC cell cycle. This implies that
ECs in an aggregate (especially in the presence of PCs) have a more delayed cell cycle
compared to individual ECs (which are not contact inhibited). The parameters used
for motility and division were estimated as those giving the best fit to the experimen-
tal growth data in [173]. Data on cell motility are not provided in [173], so we began
our simulations with single EC experiments in order to estimate r (by fixing tper as in
[131]) which resulted in a cell speed similar to that found in [131]. In doing this, we
proceeded with pure EC populations in order to assess clustering in different motility
scenarios (low, medium, and high speed). Results showed that in low speed, there was
no clustering in contrast to medium speed where the number of clusters increased. In
higher speed, clustering decreased and that was a result of the detachment of clustered
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cells due to their high motility. Further in silico experiments showed that by increas-
ing cell density the growth of the EC population becomes more linear compared to
the step-like behaviour in lower density. This is a result of the increased contact be-
tween cells in higher cell density, which implies that few cells remain as individuals
and, therefore, the whole cell population becomes less synchronised (cells divide at
different time points). By varying cell density concurrently with cell motility, we found
that there is increased EC proliferation in a lower density and higher motility environ-
ment. Furthermore, results from co-culture (EC-PC) in silico experiments showed that
medium and high speed scenarios are more likely to result in total inhibition of the
EC growth. Interestingly, in such cases, results suggest that the effective range of the
diffusive TGF-β is a crucial determinant of the degree of EC growth inhibition. Mo-
tivated by studies in [173], we also investigated the effect of different initial seeding
EC:PC ratios on the inhibition of the EC growth. Altered ratios have been observed in
several diseases (e.g. multiple sclerosis [35], brain tumour [268], diabetic retinopathy
[83]). Experimental results from [173], and our in silico results showed that a decreased
PC to EC ratio is able to disrupt the total inhibition of the EC growth.
In Chapter 5, we developed a CPM to study the evolution of the sprout formation. Both
vascular cell types (ECs and PCs) have a distinct role in this process, but we chose to
focus on one cell type, the ECs, and particularly, on its two phenotypes: stalk and tip
cells. We are mainly interested on how a sprout develops initiated from a parent blood
vessel towards a pro-angiogenic growth factor (e.g. VEGFA). There are two signalling
pathways which are regarded as the main controllers of this process: Delta-Notch (D-
N), which is responsible for cell phenotype (e.g. stalk, tip) decisions, and VEGFA.
In our model we explore six different scenarios regarding the VEGF and extracellular
matrix (ECM) profiles, by considering either homogeneous (no gradients) or hetero-
geneous (with static gradients or gradients produced by a fixed macrophage) VEGFA,
and uniform or non-uniform ECM environment.
The macrophage-mediated VEGFA generates gradients in the domain, and D-N sig-
nalling controls the tip cell activation. A stalk cell becomes a tip cell if its Delta levels
(which are upregulated from the macrophage-mediated VEGFA) exceed a threshold
value. After the tip cell activation, the D-N signalling regulates the stalk-tip distribu-
tion along the parent blood vessel and the new sprout, the so called ‘salt and pepper’
(checkerboard) pattern which prohibits tip cells being next to each other. Stalk cells
adjacent to tip cells were allowed to grow and divide based on a cell cycle time esti-
mated from available retina experimental data [Courtesy of Dr. Luisa-Iruela Arispe].
Those stalk cells and the tip cells were able to elongate. Non-uniform ECM was also
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incorporated in our model and was represented by randomly distributed ECM fibers.
ECM and chemotaxis (towards up VEGFA gradients) can greatly impact the sprout
polarisation. It has been suggested that the macrophage acts as a ‘bridge’ cell which
can bring two tip cells (from two different sprouts) together [56]. This is called sprout
anastomosis (or fusion). Our model reproduces phenomena in sprouting angiogenesis,
including sprout morphology and tip competition, and explains and predicts perturba-
tion experiments on the D-N signalling pathway. Sprout formation was the interest of
several in silicomodels to date, each one focussing on a particular topic. However, our
model is the first that incorporates all of the aforementionedmechanisms (e.g. D-N and
VEGF signalling, cell cycle model for stalk cell division, non-uniform ECM) together.
Briefly, considering macrophage-mediated VEGFA along with the non-uniform ECM
resulted in a close approximation to the sprout formation as depicted in the schematic
in Figure 5.1. However, although the fixed macrophage allowed for a narrow sprout,
after a certain period of time cells started to surround the macrophage resulting in a
mass of cells. In an attempt to produce a longer sprout we extended our model to al-
low for macrophage motility. By considering the difficulty to achieve a good match
between sprout and macrophage speed, we started with the macrophage moving from
the beginning of a simulation in various cell motilities. Low and medium speeds re-
sulted in sprout formation of a limited length (sprout splitting before reaching the end
of the domain). Interestingly, an alternative way of macrophage motility, that is, the
macrophage moves only when it is in contact with the sprout, resulted in a long, and
straight sprout without splitting. However, the splitting problem was again evident
when we incorporated two moving macrophages in an attempt to produce multiple
sprouts and, ultimately, network formation. We observed that increased cell prolifera-
tion could alleviate the problem, but not always. Therefore, the splitting problem along
with the macrophage speed remain as the main focus of future work.
6.1 Future work
The models presented in this thesis consistently point to the importance of cell-cell in-
teractions in angiogenic processes (e.g. cell aggregation, sprout formation) andCL/tissue
growth. ECs and PCs are the main vascular cell types. Despite their great importance
in regulating several angiogenic processes, PCs have not yet received the attention they
deserve.
In Chapter 2, the results from theODEmodel were based on parameter estimates which
were chosen as reasonably as possible from independent data. However, future work
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may involve a more systematic parameter sensitivity analysis to assess the robustness
of the results (steady states that the system evolves to). PCs are perivascular cells that
are typically associated with ECs in microvessels. Experiments performed by Redmer
et al. in [195] suggest that PCs represent a large proportion of the proliferating cells
during the early stage of the CL development. In the same study, PCs appeared to be
among the first cells (alongwith ECs) tomigrate into the hypoxic granulosa region after
ovulation. It has been suggested that PCs are capable of guiding sprouting processes
by migrating ahead of ECs and expressing VEGF, a potent mitogenic factor that can
induce the ECs to proliferate subsequent to migration [195]. Therefore, it is possible
to amend the model by incorporating more angiogenic factors (e.g. VEGF), and also
more explicitly define the role of PCs in the CL growth and development along with
ECs. In that case, a CL with no stromal cells/PCs (R = 0) could imply a poorly func-
tioning vasculature in vivo. Given also that PCs provide stability to the vasculature,
the model could further suggest that loss of PCs might be a strong candidate for poor
embryo development since a leaky and not stable vasculature (without PCs) is not able
to provide an embryo with the appropriate amounts of nutrients. Perivascular cells,
play a critical role in angiogenesis and PC regulation may provide a novel mechanism
for regulating CL growth and tissue growth in general. Finally, the ODE model could
also be extended in a spatial model by using a cellular potts model (CPM) since cell-
cell contacts and cell area (important variables in a tissue growth model) are explicitly
incorporated in the CPM framework.
In Chapter 3, preliminary results from in vitro CL studies have shed light on possible
cross-talk between ECs and PCs. Our aim is to pursue this direction by doing more
experiments which can allow for further morphological and quantitative data. We are
particularly interested in the number of ECs and PCs in order to evaluate the growth
of the two cell types, the covered area of the two cell types in the culture domain, the
ratio of ECs-PCs within clusters which could provide a measure of the PC recruitment
towards EC clusters, and also the number of PCs being in close proximity with EC
clusters.
In Chapter 4, the interaction of cells with the ECM is regarded as a crucial aspect of cell
aggregation mechanisms. ECs are anchorage-dependent and their growth is contact-
inhibited. In addition, ECs and PCs synthesise matrix components [36], which could
markedly influence EC proliferation.
Several in vitro and in vivo studies [42, 99, 188] indicate that not only physical inter-
actions (by contact), but also a variety of external factors may impact the growth of
vascular ECs. These signals appear to be mediated by both soluble and ECM-bounded
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compounds. The diffusive factors may emanate from the EC themselves or the PCs.
A question is whether and how PCs might inhibit EC growth in a different way to that
suggested by our model (regarding the role of TGF-β). Except from TGF-β, the se-
cretion of TIMP3 and Ang1 from PCs might be another important signalling pathway
to consider in the context of the stabilisation of EC growth. In addition, it is unclear
whether long-range contact inhibition, possibly mediated by long cellular processes
(via filopodia extensions; see Figure 4.13) is active and necessary to explain contact in-
hibition. Therefore, a possible extension of the model to incorporate the role of filopo-
dia would be informative. Our model assumptions were mainly based on the exper-
imental system of Orlidge and D’Amore [173], where PCs were growth arrested. It
would be interesting to assess the role of PC proliferation on the inhibition of the EC
growth.
In Chapter 5, PCs could also be incorporated in the sprouting model as the cells which
can provide stabilisation and maturation to the new sprout. It has recently been sug-
gested (personal communication with Dr. Luisa-Iruela Arispe) that both PCs and as-
trocytes (since they secrete VEGFA) enhance sprout polarisation and it would be an in-
teresting direction to explore. Regarding mitosis, stalk cell division could be enhanced
by VEGFA concentration as was the case in Qutub and Popel [191]. In addition, some
of our model parameters were chosen despite a lack of evidence concerning their plau-
sible values, and therefore, a quantitative validation of the model is difficult at some
points. In order to make it more realistic, we could for instance use realistic values for
Delta threshold for tip cell activation, and ECM density. If we would have more quan-
titative data from experimental observations we could use this information to further
calibrate our model. Finally, in the case where the macrophage is allowed to move,
the problem with sprout splitting and the choice of the macrophage speed remain as
another direction for further investigation.
In conclusion, we believe that the EC-PC interactions along with the ECM environment
will be the focus of future research in angiogenesis and tissue growth and this will be
the direction of our future work.
We would like to close this Chapter by providing some simulation results (see Figure
6.1), where we were attempting to obtain sprouting and network formation starting
from endothelial cell (stalk) clusters integrated in initially uniform VEGFA concentra-
tion which enhances the D-N signalling. This could be thought of as a unification of
work described in Chapters 4 and 5. Stalk and tip cells take up VEGFA, which results
in lower VEGFA at the centre of a cluster, and as we observe at early time points (e.g.
12-18 hrs) we can get a checkerboard-like pattern formation of a cluster with tip cells
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integrated within the whole cluster. However, as time progresses, Delta at the centre
of the cluster drops and, therefore, the tip cells are converted back into stalk cells. As
a result, tip cells only form around the perimeter of the cluster, where the VEGFA is
higher.
0 hrs 12 hrs 18 hrs 24 hrs 
30 hrs 36 hrs 42 hrs 48 hrs 
54 hrs 60 hrs 66 hrs 72 hrs 
Figure 6.1: Representative snapshots at different time points (up to 3 days) in an at-
tempt to get network formation from a cluster of cells in an initially uni-
form VEGFA field taken up by stalk and tip cells. Parameters: VEGFA= 1.
Key: stalk cells (red), tip cells (yellow).
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Glossary
During the literature search, I have tried to compose this list of commonly used biolog-
ical vocabulary found in many of the research papers.
• angiogenesis: is the formation of new blood vessels from pre-existing ones.
• chemotaxis: is the characteristic movement or orientation of an organism or cell
along a chemical concentration gradient either toward or away from the chemical
stimulus.
• corpus luteum: is the tissue that emerges from an ovulated follicle during the
oestrous cycle, and it is responsible for the progesterone production needed for
pregnancy.
• endothelium: is the thin layer of cells that lines the interior surface of blood ves-
sels
• extracellular: is the outside the plasma membrane. The functional barrier be-
tween the inside and outside of a cell.
• extracellular matrix (ECM): is the extracellular part of animal tissue that provides
structural support to the animal cells and regulates the cell’s dynamic behaviour.
• growth factor (GF): is an extracellular signaling molecule. There are two types
of GFs related to angiogenesis. The pro-angiogenic, which stimulate a cell to
grow or proliferate (e.g. vascular endothelial growth factor (VEGF), fibroblast
growth factor (FGF), Ang1), and the anti-angiogenic, which fight angiogenesis
(e.g. angiostatin, endostating, MMPs, Ang2).
• haptokinesis: is the sensitivity of cells to absolute concentrations of ECM com-
ponents.
• haptotaxis: is the directional migration of cells up ECM gradients.
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• in vitro: the recreation of biological processes in an artificial laboratory environ-
ment.
• in vivo: biological processes that take place within a living organism or cell.
• macrophages: (Greek: big eaters) are cells produced by the differentiation of
monocytes in tissues. Their role is to phagocytose and then digest, cellular de-
bris and pathogens. An additional role, with a great impact on angiogenesis is
the secretion of GFs (e.g. VEGFA), which can enhance the angiogenic network
development via the endothelial proliferation and migration.
• matrix metalloproteinase (MMPs): proteolytic enzymes that degrade extracellu-
lar matrix. They are inhibited by tissue inhibitors of matrix metalloproteinases
(TIMPs).
• Notch signalling: is an important signalling pathway for cell-cell communica-
tion, regulation of cell-fate decision (e.g. interchange between the two endothe-
lial cell phenotypes, stalk and tip cells), and many other processes such as neural
function and development, cardiovascular development etc.
• pericytes: are cells that surround the endothelium. They have several roles in
angiogenesis (e.g. provide stability to the angiogenic network), and particularly
on the endothelial cells (e.g. inhibit their growth).
• stalk cells: are specialised endothelial cells present in the stalk (lumen) region
of vascular sprouts (behind the tip cell), which strongly proliferate to allow for
sprout extension.
• tip cells: are specialised endothelial cells. They are lumenless cells characterised
by long filipodia extension. These cells are present at the leading edge of vascular
sprouts that integrate directional cues from their environment. This defines the
direction in which the new sprouts grow. Commonly, tip cells do not proliferate.
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